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ACIA -acquired computerized image analysis 
AIDS - acquired immune deficiency syndrome 
AhpC - alkyl hydroperoxide reductase 
aM0s - alveolar macrophages 
APC - antigen presenting cell 
BMM0s - bone marrow-derived macropages 
BAL - bronchoalveolar lavage 
CD - cluster of differentiation 
CR - complement receptor 
DC - dendritic cell 
DosR - dormancy survival regulator 
ECM - extracellular matrix 
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HIV - human immunodeficiency virus 
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IFN-y - interferon gama 
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Rag ~~ - rag2 deficient 
Rag.iNOS"/_ - iNOS and rag2 deficient 
i.v. - intravenous 
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mAb - monoclonal antibody 
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MHC II - major histocompatibility class II 
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NK - natural killer 
NO - nitric oxide 
NOHA - NG-hydroxy-L-arginine 
NRAMP1 - natural resistance associated macrophage protein-1 
NRP - non replicating persistence 
NTM - nontuberculous mycobacteria 
OAT - ornithine aminotransferase 
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RNI - reactive nitrogen intermediates 
ROI - reactive oxygen intermediates 
SEA - schistosome egg antigen 
SmD - smooth dense morphotype 
SmT - smooth transparent morphotype 
SOD - superoxide dismutase 
SP - surfactant protein 
TGF-p - transforming growth factor beta 
Th - T helper 
TLR - toll like receptor 
TNF - tumor necrosis factor 
WT - wild type 
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Resumo 
Ao contrário do que é observado no caso de Mycobacterium tuberculosis ou M. 
bovis, a capacidade antibacteriana contra M. avium não depende da produção de radicais 
de azoto (RNI). Este trabalho abordou a relação entre M. avium e os RNI. 
A susceptibilidade a RNI foi avaliada para um painel de estirpes de M. avium. O 
teste foi feito em meio axénico, em que os RNI são gerados após a acidificação de um 
meio que contém nitrito, sob a forma de nitrito de sódio. Verifícou-se que as diferentes 
estirpes apresentavam níveis diferentes de resistência aos RNI, e todas apresentaram 
maior resistência do que M. tuberculosis. A susceptibilidade a RNI foi também testada 
através do uso do composto NOC-18, capaz de libertar monóxido de azoto (NO), de 
uma forma controlada. Uma vez mais, observou-se que a resistência do M. avium era 
superior à observada para M. tuberculosis. Verificou-se que o nível de susceptibilidade 
observado para as diferentes estirpes não está relacionado com a virulência das mesmas. 
Adicionalmente, o crescimento bacteriano de diferentes estirpes foi avaliado em 
ratinhos geneticamente deficientes na expressão da sintase indutível do monóxido de 
azoto (iNOS"")• Em estudos anteriores, efectuados com poucas estirpes, tinha sido visto 
que, ao contrário do observado para o caso de infecções por M. tuberculosis, não havia 
uma exacerbação da infecção. Aqui, foi observado que o mesmo acontecia com um 
maior número de estirpes, e entre estas, algumas apresentaram um crescimento menor 
quando na ausêcia da produção de NO. Este tipo de comportamento não tem relação 
com a virulência da estirpe. Uma das estirpes que apresentou este decréscimo de 
crescimento em animais iNOS_/" - M. avium 25291 - foi usada para obter uma biblioteca 
de mutantes, os quais foram obtidos através de mutagénese insercional. Um mutante 
para a nitrato reductase não conseguiu proliferar tão bem como a estirpe parental em 
ratinhos C57BL/6, mas apresentou um crescimento idêntico à estirpe parental quando 
usado para infectar macrófagos derivados da medula. Estes dados sugerem que esta 
enzima é necessária para a adaptação à resposta imune, mas no entanto, sugerem 
também que não é o único factor involvido nessa adaptação. 
Estudos com animais deficientes não só na expressão da iNOS mas também no gene 
activador da recombinação 2 (rag2) mostraram que um sistema imune intacto é outro 
dos factores necessários a essa adaptação. 
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Também foi analisada e comparada a deposição de colagénio em granulomas 
formados após a infecção de ratinhos imunocompetentes C57BL/6 e ratinhos iNOS" ". A 
detecção foi feita através de análise de imagens adquiridas pelo computador de cortes 
histológicos cujas fibras de colagénio foram marcadas pela coloração de tricrómio de 
Masson. Para esse efeito foi desenvolvido um programa especificamente direccionado 
para este tipo de detecção. Foi comparada a infecção provocada por uma estirpe 
altamente virulenta, e outra de viruência intermédia, em ambos os hospedeiros. No que 
diz respeito à distribuição das fibras de colagénio no granuloma, foi observado que estas 
não se restringiam à cápsula do granuloma, e eram também visualizadas dentro dos 
mesmos, conferindo um tipo de estrutura gradilhada. Animais iNOS"" induziram um 
maior grau de deposição do que os animais C57BL/6. Este facto é explicado pelo facto 
da iNOS usar a L-arginina como substracto, o mesmo usado pela arginase na indução da 
formação de colagénio e sua subsequente deposição. Em relação à comparação das duas 
estirpes de difrentes virulências, a de virulência intermédia apresentou uma maior 
deposição de colagénio do que a altamente virulenta, em ambos os hospedeiros. Os 
granulomas que apresentavam menor deposição de colagénio, e que por isso teriam uma 
estrutura menos organizada, foram associados a uma maior virulência. Os dados 
apresentados sugerem que a organização do granuloma deve ser apertada, condição 
favorecida pela presença de fibras de colagénio, de forma a possibilitar uma interacção 
entre as diferentes células involvidas na resposta antimicobacteriana. 
Os dados obtidos para a estirpe 25291, cujo crescimento em animais iNOS"" é 
reduzido quando comparado com o dos animais C57BL/6, chama a atenção para aguns 
pontos interessantes. Por um lado, esta estirpe foi a que apresentou maior resistência a 
RNI. Além disso, foi visto que M. avium 25291 cresceu melhor na presença de 
pequenas quantidades de NO. Por outro lado, quando incapaz de metabolizar nitrato, a 
adaptação à resposta imune é afectada, sendo no entanto necessário também um sistema 
imune intacto para essa adaptação. Adicionalmente, a menor deposição de colagénio 
nos granulomas formados, associada aparentemente a uma forte resposta do tipo Thl, 
parece contribuir para o sucesso da proliferação desta estirpe virulenta. 
Juntamente, estas observações sugerem que a resposta immune induzida por M 
avium 25291, associada à capacidade de resistir e até usar RNI, leva a que haja 
condições tais que permitem uma boa adaptação e proliferação. No entanto, estas 
observações apontam adicionalmente para a possibilidade de haver outros factores que 
podem também contribuir para o sucesso desta estirpe. 
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Abstract 
Contrary to other mycobacterial species such Mycobacterium tuberculosis or M 
bovis, M. avium killing is not dependent on the production of reactive nitrogen 
intermediates (RNI). This work focused on the interplay between Mycobacterium avium 
and the RNI. 
A panel of M. avium strains was tested for their susceptibility to RNI in a cell-free 
system, where RNI was generated by the acidification of nitrite containing media. It was 
observed that the different strains had different susceptibilities to RNI, and all were 
more resistant to RNI than M. tuberculosis. Susceptibility to nitric oxide (NO) released 
in a controlled manner by the NOC-18 compound was also accessed and once again, M 
avium was more resistant than M. tuberculosis. The M. avium strains tested did not 
show a correlation between RNI resistance and virulence. 
Additionally, growth in mice genetically deficient in the inducible nitric oxide 
synthase gene (iNOS"/_) was tested for a panel of M. avium strains. Previously, it had 
been observed for a few strains that, contrary to what happens in the case of M. 
tuberculosis, no exacerbation of the mycobacterial growth was seen. Here, it was seen 
that this observation extended to a wider number of strains, and, among those, several 
showed an improved clearance in the iNOSv" host, which was not related to their 
virulence. One of the strains that showed that clearance pattern - M. avium 25291 - was 
used to make a mutant library using insertional mutagenesis. A mutant for nitrate 
reductase did not thrive as well as the parental strain in C57BL/6 mice, but had an 
identical growth to the parental strain when used to infect bone marrow-derived 
macrophages. These data suggest that this enzyme is needed for the adaptation to the 
immune response, and yet also suggest that this is not the only factor involved in that 
adaptation. 
Studies involving mice that were deficient for both iNOS expression as well as the 
recombination-activating gene 2 (rag2) showed that an intact immune system was 
another factor needed for that adaptation. 
The collagen deposition in the granulomas formed after infection in both the 
C57BL/6 and the iNOS"'" settings was also analysed. Detection was done on histological 
sections stained with Masson's trichrome using acquired computerised image analysis 
and a program that was specifically designed for that purpose. Infection by a highly 
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virulent strain was compared with a moderately virulent one in both hosts. As far as the 
collagen distribution in the granuloma is concerned, it was observed that it was not 
confined to the exterior cuff, and its fibres were actually well into the granuloma itself, 
conferring a mesh-like structure within the granuloma one. When comparing the two 
animal hosts, is was seen that iNOS"7 mice induced a higher collagen deposition than 
C57BL/6 mice, which is explained by the fact that iNOS synthase uses the L-arginine 
substrate, the same used by arginase in the induction of collagen formation and 
subsequent deposition. With respect to the two strains being analysed, the strain with 
intermediate virulence was associated with a higher deposition of collagen when 
compared with the high virulence one, either in immunocompetent host or in the 
deficient one. Granulomas with lower collagen content, and therefore which were less 
organized were associated with higher virulence. The data presented suggest that the 
granuloma organisation should be a tight one, which is helped by the presence of 
collagen fibres within the granuloma, in order to enable the interplay between the 
immune cells involved in the antimycobacterial response to be effective. 
The data obtained for strain 25291, whose growth in iNOS"7" is reduced when 
compared with that observed in C57BL/6 mice, leads to some interesting points. One 
the one hand, this strain was the one that presented a higher level of RNI resistance. 
Furthermore, it was seen that M. avium 25291 actually grew better in the presence of 
small amounts of NO. On the other hand, when unable to metabolise nitrate, the 
adaptation to the immune response is affected, being however an intact immune system 
also needed for that adaptation. Additionally, granulomas with a lower collagen content, 
apparently associated with a strong Thl immune response, seems to contribute for the 
success of this virulent strain. 
Taken together, these data suggest that the immune response induced by M. avium 
25291, together with its capacity to resist and even use RNI, leads to a setting where a 
good adaptation as well as proliferation in the host is achieved. The observations of this 
study also point to the possibility of yet other factors may contribute to the success of 
this strain. 
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Resume 
A 1' inverse d'autres espèces mycobactériennes comme Mycobacterium tuberculosis 
ou M. bovis, la destruction de M. avium ne dépend pas de la production des 
intermédiaires réactives du nitrogen (RNI). L'objectif de ce travail est l'étude des 
interactions entre M. avium et les RNI. 
Plusieurs souches de M. avium ont été testées pour leur suceptibilité au RNI dans un 
système acellulaire, où le RNI est produit par l'acidification des nitrites contenus dans 
le milieu de culture. On a observé que les différentes souches avaient une sensibilité 
variable à l'action du RNI, et que toutes étaient plus résistantes au RNI que M 
tuberculosis. La sensibilité au oxide nitrique (NO) liberté par le composé NOC-18 a été 
aussi évaluée, et a montré, une foi plus, que M. avium était plus résistant. Toutes les 
souches de M avium testées n'ont montré aucune corrélation entre la résistance au RNI 
et la virulence. 
De plus, le développement de M avium a été évalué dans des souris génétiquement 
déficientes en synthase inductible de oxide nitrique (iNOS~ ~) pour plusieurs souches de 
M avium. Il a été reporté chez quelques souches, a l'inverse de M. tuberculosis, 
qu'aucune augmentation de la multiplication mycobactérienne n'est observable. Dans ce 
travail, nous montrons que cette observation est valable à un plus grand nombre de 
souches, et quelques unes montrent une reduction de la croissance quand 1'oxide 
nitrique est absent. En plus, celle-ci n'est pas liée à la virulence des souches. Une de ces 
souches ayant cette propriété - M. avium 25291 - à été utilisée pour la mise au point 
d'une banque de mutants par mutagénèse d'insertion. Un mutant pour la nitrate 
reductase a eu, chez la immunocompétente souris C57BL/6, un développement infériour 
à lequel observé dans le case de la souche parental, mais a eu une croissance normal 
quand a été utilisé pour infecter les macrophages dérivés de la moelle osseuse. Ces 
données suggère que l'enzyme est nécessaire pour l'adaptation à le réponse 
immmunitaire, mais néamoins suggère aussi que cette lá n'est pas l'unique contribuant 
por cet adaptation. 
Études chez les souris déficientes en iNOS et aussi en le gene activateur de la 
recombination 2 (rag2), ont montré qu'un système immunitaire intacte s'est un outre 
contribuant pour l'adaptation observée. 
7 
Le dépôt de collagène dans le granulome formé après l'infection des souris 
C57BL/6 et iNOS" a été également analysé. La détection a été réalisée sur des coupes 
histologiques colorées au trichrome Masson grâce à l'analyse d'image acquise sur 
ordinateur et un programme crée spécifiquement pour ce but. 
L'infection par une souche très virulente a été comparée à celle d'une souche 
moyennement virulente chez les deux lignées de souris. En ce qui concerne la 
distribution du collagène, il a été observé que celui ci n'était pas confiné vers 
l'extérieur, mais que les fibres infiltraient le granulome, conférant une structure en 
réseau à l'intérieur du granulome. 
Quand on compare les deux hôtes animaux, on observe que les souris iNOS_/ 
induisent un dépôt de collagène plus important que les souris C57BL/6. Ceci est du a 
l'utilisation du même substrat - L-arginine - par 1'iNOS synthase et l'arginase laquelle 
enduit la formation de collagène, et son dépôt subséquent. L'analyse comparative des 
deux souches a montré que la souche modérément virulente était associée à un dépôt de 
collagène plus élevé que celui observé avec la souche virulente, quelque soit la lignée 
de souris. Les granulomes avec un contenu en collagène faible et donc moins organisés 
étaient associés a une plus grande virulence. Les résultats présentés suggèrent que 
l'organisation du granulome est de type hermétique grâce à la présence de collagène qui 
permettrait l'interaction entre cellules immunocompétentes participant à la réponse anti-
microbienne efficace. 
Les données obtenues avec la souche 25291, qui a vu aussi son développement 
réduit lorsqu'elle a été utilisée pour 1' infection des souris iNOS"A, offre plusieurs points 
intéressants. Cette souche est celle qui a présenté la plus haute résistance aux RM. Par 
ailleurs, on a été observé que M. avium 25291 se développe mieux en présence d'une 
faible quantité de NO. On a vu aussi que, quand incapable de metaboliser le nitrate, 
cette souche a vu son capacité d'adaptation réduite chez la C57BL/6 souris, étant 
pourtant aussi nécessaire un système imunitaire intacte. De plus, garnulomes avec un 
contenu faible en collagène, apparent associée à une fort Thl réponse, paraît contribuer 
pour le succès de cette virulente souche. 
L' ensemble de ses résultats suggère que la réponse immunitaire induite par M. 
avium 25291, concurremment sa capacité de résister et même utiliser les RM, permettre 
la création d'un millieu que favorise l'adaptation et la croissance chez l'hôte. Les 
données aussi suggérez la possibilité de l'existence d'outrés contribuants pour le succès 
de cette souche. 
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Introduction 
Introduction 
"...There is a method which has now become almost a matter of routine, and the worth 
of which has been fully recognised; we refer, of course, to the examination of the 
sputum for tubercle bacilli. If the result be positive, then it is certain that a tuberculous 
process is proceeding somewhere in the respiratory tract... 
.. .But this is not the whole story, which is not quite so simple. If the result be negative 
it by no means follows that tuberculosis is absent... 
.. .If the case be one of "closed" pulmonary tuberculosis bacilli will not be detected in 
the sputum, and yet the disease may be present..." 
In "The Diagnosis of Pulmonary Tuberculosis" 
The Lancet, September 25th, 1909, p.939 
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Introduction 
I - Mycobacterium 
Bacteria belonging to the Mycobacterium genus are in their majority non-pathogenic 
environmental bacteria. However, the pathogenic bacteria within this genus have been, 
and still are, a major health concern. 
It's main representative, Mycobacterium tuberculosis, which causes tuberculosis, is 
solely responsible for more mortality than any other given pathogen (Brewer and 
Heymann, 2005; Murray and Lopez, 1997). M. leprae and M. ulcer ans, the causative 
agents of leprosy and the Buruli ulcers respectively, are other examples of highly 
successful pathogens within this genus. With the advent of the acquired immune 
deficiency syndrome (AIDS) pandemic, not only were tuberculosis rates increased, but 
there was also some attention drawn to M. avium, one of the major opportunist pathogen 
in AIDS patients (Berlin et al., 1984; CDC, 1987; CDC, 1988). 
The success of mycobacteria is due to the fact that not only can they infect 
macrophages (M0), considered to be professional phagocytes (Rabinovitch, 1995) and 
one of the cells known to have antimicrobial action, but also can proliferate in them. 
Moreover, they can establish a chronic or latent infection in the protective structures 
formed after an effective immune response. The bacteria can then remain unnoticed and, 
as it was drawn to special attention in the beginning of the 20th century, even though it 
is not detected by usual procedures, may still be present. 
I. 1 - Main characteristics of mycobacteria 
A distinctive characteristic of mycobacteria is their unusual cell wall structure which 
is responsible for their capacity to retain the red dye carbol fuchsin after an acid wash, 
used in the specific Ziehl-Neelsen staining, and be therefore classified as acid fast 
bacteria. The mycobacterial cell envelope consists of a highly complex array of 
proteins, carbohydrates and lipids, which are associated to three distinct types of 
macromolecules: mycolic acid, arabinogalactan and mycobacterial peptidoglycan 
(Minnikin, 1991). In their adaptation to the intracellular growth, the cell wall may have 
an important role, and the complexity of this cell envelope is responsible for the fact 
that these bacteria are resistant to a great number of drugs as well as being implicated in 
pathogenicity (Jarlier and Nikaido, 1994; McNeil and Brennan, 1991; Nikaido and 
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Jarlier, 1991; Rastogi, 1991; Rastogi and Barrow, 1994). Also, the majority of 
mycobacteria are slow growing organisms as a consequence of that complexity 
(Brennan and Nikaido, 1995). 
Mycobacteria have been conventionally classified into broad taxonomic groups 
based on certain criteria such as pathogenicity to humans and animals and growth rate at 
optimal temperatures. 
The M. tuberculosis complex consists of M. tuberculosis, M, bovis, M. africanum, 
M. microti and M. canetii, which, although being closely related sharing >99% identity 
at the nucleotide level, differ in certain aspects such as host range and morphology 
(Brosch et al., 2002). 
The M. avium complex (MAC) includes M. intracellulare, M. avium subspecies 
avium and paratuberculosis among others, being the last one the causative agent of 
bovine's Johne's disease, an economic and veterinary health concern, as well as 
associated to Crohn's desease (Kennedy and Allworth, 2000; McFadden et al., 1987; 
Naser et al., 2000; Ott et al., 1999; Stabel, 1998). 
Mycobacteria other than M. leprae and those belonging to the M. tuberculosis 
complex are also referred to as nontuberculous mycobacteria (NTM) and often studied 
as a group when clinical implications are being analysed, especially taking into account 
that there has been an increase in NTM-associated diseases (Holland, 2001; Wagner and 
Young, 2004). 
I. 2- M. avium 
M. avium is an environmental slow growing mycobacteria that can be found mainly 
in water and soil, but can also be found in various animal species including mammals 
(Meissner and Anz, 1977; Thoen, 1994; von Reyn et al., 1994; von Reyn et al., 1993). 
Infection by M. avium can occur through the ingestion of contaminated food and 
water or by the aerosol route (Falkinham, 2003; Gray and Rabeneck, 1989). After 
colonizing the intestinal mucosa, M. avium translocates the epithelial cell layer and 
infects M0s in the lamina propria (Gray and Rabeneck, 1989; Sangari et al., 2000; 
Sangari et al., 2001; Sangari et al., 1999). In the case of the infection being through the 
aerosol route, colonization of the alveolar epithelium can occur as well as an entry into 
the alveolar M0s (aM0s) (Bermudez and Goodman, 1996; Kudo et al., 2004; Roecklein 
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et al., 1992). The fact that these mycobacteria are quite resistant and can persist in the 
environment, results in a continuous exposure, at low levels, to these bacteria 
(Falkinham, 2003; Primm et al., 2004). Contact with the mycobacteria usually does not 
result in outright infection, as the host responds to the challenge and raises an 
appropriate immune response that leads to bacterial clearance or containment. In the 
case of immunosuppressed patients such as those with AIDS, which are impaired in 
their capacity to mount an immune response, disseminated M. avium infection is often 
found, which can lead to bacteraemia, especially in the case of patients with a very low 
number of CD4+ T lymphocytes (Berlin et al., 1984; Havlik et al., 1992; Nightingale et 
al., 1992). Immunocompetent individuals, on the other hand can exhibit lymphadenitis, 
skin infections and pulmonary infections, especially those patients with predisposing 
lung conditions such as pneumococcosis, cured tuberculosis, chronic obstructive lung 
disease and silicosis (Falkinham, 1994; Falkinham, 1996; Inderlied et al., 1993). Other 
cases without such a predisposition have been reported, related with age and a high 
exposure rate related to extensive aerosol formation from contaminated water such as 
those generated by hot tubs or swimming pools (Falkinham, 2003; Prince et al., 1989). 
Furthermore, the fact that M. avium is more resistant to antimicrobial drugs than M. 
tuberculosis, as in the case of isoniazid, one of the drugs currently being used in the 
treatment of tuberculosis, poses a problem, as it is more difficult to treat such infections. 
Hence, M. avium, which started by drawing the attention of researchers by the fact 
of being an important opportunist in AIDS patients, often related to the increase of 
morbidity and mortality of those patients (Jacobson et al., 1991), has currently a broader 
clinical relevance (Koh et al., 2002; Primm et al., 2004; Tobin-DAngelo et al., 2004). 
Therefore studies involving the elucidation of how this environmental nontuberculous 
mycobacteria has adapted to live both in the environment as well as an intracellular 
organism are relevant. 
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Il - Host-pathogen interaction 
After crossing the epithelial layer, or by direct contact in the lungs, M. avium meets 
the resident M0 and, through phagocytosis, bacilli are internalised. Phagocytosis is the 
uptake of particulate matter by cells - the phagocytes. M0s and neutrophils, are 
considered as the professional phagocytes and bacteria are taken up and destroyed 
through this process. The ingested material is contained in a vesicle called a phagosome, 
which then fuses with one or more lysosomes to form a phagolysosome (Janeway et al., 
2001; Rabinovitch, 1995). For phagocytosis to occur, M0s recognize mycobacteria by 
receptor molecules on their surfaces. In the case of M avium uptake has been associated 
to the presence of complement receptor 1 (CRI), CR3, and CR4, scavenger receptors, 
the fibronection receptor, the mannose receptor (MR) and the vitronectin receptor 
(Bermudez et al., 1991; Rao et al., 1993; Roecklein et al., 1992). It was shown that M. 
avium, as well as other pathogenic mycobacteria such as M.tuberculosis and M. leprae, 
have the capacity to associate itself to the C2a complement fragment, and the resulting 
C3 convertase leads to C3b opsonisation and subsequent M0 recognition through CR1 
(Schorey et al., 1997). 
In the lung, pulmonary collectins present in the pulmonary surfactant, namely 
surfactant protein A (SP-A) and SP-D, have been implicated in innate immunity of the 
host, and were recently shown to not only bind to M. avium, but also enhance its 
phagocytosis by aM0 through stimulation of the MR activity (Kudo et al., 2004). 
The major receptor used by M. avium seems to be the CR3 that, like CR1, while it 
promotes phagocytosis, it fails to induce a respiratory burst response upon its ligation, 
as opposed to the immnuglobulin fragment carrying the constant region of the heavy 
chain (Fc) receptor (Wright and Silverstein, 1983). 
Besides the receptors mentioned, toll like receptors (TLRs) are important initiators 
of the innate immune response. These receptors are specific for pathogen associated 
molecular patterns (PAMPs), such as CpG-oligodeoxynucleotides, peptidoglycan or 
flagellin (Kopp and Medzhitov, 2003). Following recognition of ligands TLRs initiate 
signaling events that result in acute innate responses. In addition, TLRs are responsible 
for initiation of adaptive immune responses against pathogen-derived antigens primarily 
through triggering dendritic cell (DC) activation (Brightbill et al., 1999; Krutzik and 
Modlin, 2004; Modlin et al., 1999). TLR-2 has been described as the major receptor 
responsible for the response to mycobacteria, both recognizing the whole microbe as 
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well as mycobacterial PAMPs (Brightbill et al., 1999; Krutzik et al., 2003; Lien et al., 
1999b; Medzhitov and Janeway, 2000; Underhill et al., 1999). Concerning the latter, the 
receptor recognizes lipoarabinomannan (LAM) and its precursor phosphatidylinositol 
monnoside (PIM), as well as the 19kDa M. tuberculosis lipoprotein (Brightbill et al., 
1999; Jones et al., 2001; Means et al., 1999a; Means et al., 1999b; Noss et al., 2001). 
Studies involving TLR-2-deficient mice showed that that receptor was required for an 
optimal immune response against certain virulent M. avium strains (Gomes et al., 2004). 
Deficient mice had a reduced induction of interferon gama (IFN-y) producing protective 
CD4+ T cells as well as a reduced expression of the interleukin-12p40 (IL-12p40) gene, 
suggesting that there was an impairment in the induction of a protective T helper 1 
(Thl) type of response (Castro et al., 1995; Gomes et al., 2004; Silva et al., 2001a). 
Furthermore, TLR activation on M0 also induces molecules with direct anti-microbial 
activity such as reactive oxygen intermediates (ROI) and reactive nitrogen intermediates 
(RNI) (Aliprantis et al., 2001; Brightbill et al., 1999). 
DCs are antigen presenting cells (APCs) by excellence: they can process antigens 
and display their peptide fragments on the cell surface together with major 
histocompatibility class II (MHC II) molecules required for T-cell activation. They 
phagocytose mycobacteria and, even though they do not display anti-microbial activity, 
secrete cytokines and express co-stimulatory molecules that help modulate ensuing 
adaptive responses, leading to a Thl biased T cell response (Demangel and Britton, 
2000; Giacomini et al., 2001; Jiao et al., 2002). They express several receptors, 
including CR3, MR and TLR-2, and imature DCs also express TLR-2 (Hertz et al., 
2001; Kadowaki et al., 2001). So it would seem that TLR help the initiation of a rapid 
response upon mycobacterial infection, namely by activation of antimicrobial activity 
by M0s, and the modulation of a protective adaptive response by DCs, that upon 
maturation migrate to lymph nodes and activate naïf T cells specific for the 
mycobacterial antigens presented by them (Hertz et al., 2001; Krutzik and Modlin, 
2004; Lambrecht et al., 2001; Pulendran et al., 2001). 
Phagocytosis has as a final goal the destruction of the ingested particle. In order for 
that to be achieved phagosomes go through a process in which material that is 
internalised is delivered to lysosomes, acidic vesicles that contain proteolitic enzymes. 
This phagosome maturation occurs either through a series of membrane budding and 
fusion steps involving vesicular transport along the phagosome-endosome pathway or 
through a gradual acquisition of lysosomal marker molecules (Griffiths and Gruenberg, 
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1991; Murphy, 1991). One of the mechanisms to evade the antimicrobial action of M0 
used by pathogenic mycobacteria, including M. avium, is the inhibition of the 
phagosome-lysosome fusion and the arrest of the phagosome maturation (Frehel et al., 
1986). This way mycobacteria avoid the contact with the proteolitic enzymes present in 
lysosomes, as well as the acidification of the phagosome (Crowle et al., 1991; Sturgill-
Koszycki et al., 1994). Of note is the fact that M. avium seems to be more resistant than 
M. tuberculosis to the effects of an acidic environment in a mature phagolysosome 
(Gomes et al., 1999c). 
As the phagosome is formed as a continuum from the M0's membrane, its 
composition is approximately the same. For that reason, receptors found on the M0 are 
also found in the newly formed phagosome (Beron et al., 1995; Desjardins, 1995; Pitt et 
al., 1992). 
Like any other organism, M. avium needs iron for its growth, and iron deprivation is 
a means of growth restriction (Gomes et al., 2001; Gomes et al., 1999a). Extracellular 
iron was clearly shown to be incorporated by infected M0 and delivered to M. avium 
vacuoles through the activity of the transferrin receptor, located at the phagosome's 
membrane (Wagner et al., 2005). 
Another protein located in the M0's membrane that is recruited to the phagosome's 
one is the natural resistance associated macrophage protein 1 (NRAMP1), also recently 
designated Slcllal in the genome annotation (Blackwell et al., 2001; Gruenheid et al., 
1997; Lam-Yuk-Tseung and Gros, 2003). This protein was associated with natural 
resistance in mice infected by intracellular parasites. Nrampl/ Slcllal has two allelic 
forms, and mice carrying the allele Nrampl/SlcllalGl69 (resistant) coded for a 
functional protein, while those that carried allele Nrampl/Slcl lalD\69 (susceptible) 
coded for a protein that had a mutation on position 169, where an aspartate was 
expressed instead of a glycine, and proved to be non-functional (Vidal et al., 1993). It 
was seen that this protein was also involved in resistance to infection by M. avium, and, 
also, that the NRAMP1/ Slcl lal-induced bacteriostasis of that bacteria by mouse M0 
was independent of the respiratory burst (Appelberg and Sarmento, 1990; Gomes and 
Appelberg, 2002). NRAMP1/ Slcllal has been associated with iron transport and 
mycobacterial control, and is suggested to exert its effect by depleting the phagosome of 
iron leading to starvation of the bacilli of the essential nutrient (Gomes and Appelberg, 
1998; Gomes and Appelberg, 2002). This last issue though is still a matter of ongoing 
debate, as some authors defend that this protein works as an efflux pump while others 
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defend that it works as an influx pump (Forbes and Gros, 2001; Gomes and Appelberg, 
2002; Kuhn et al., 2001). 
After phagocytosis, M0s release tumor necrosis factor (TNF) as well as IL-12. The 
latter cytokine is also released from DCs, and together with the former, activates natural 
killer (NK) cells, into producing IFN-y. This cytokine will, in its turn, activate the M0 
into producing more TNF that will act synergistically with the former and activate the 
antimicrobial action of M0s, namely ROI and RNI production. In the meantime, CD4' 
specific T cells arrive at the site and are also a source of IFN-y, and the adaptive 
immune response starts. 
II. 1 - Reactive species 
M0s have the capacity to be potent generators of RNI and ROI, and they do so after 
activation or bacterial infection. This is due to their capacity to induce the expression of 
the inducible nitric oxide synthase (iNOS) as well as assemble the components of the 
NADPH phogocytic oxidase (phox). 
In the presence of molecular oxygen, NADPH oxidase reduces it, generating ROI. 
The primary products generated in this reaction are superoxide (02*) and its various 
dismutation and decomposition products, such as hydrogen peroxide (H202) and the 
hydroxyl radical (*OH), being the last one a very strong oxidant in biological systems 
(figure l)(Saranetal., 1999). 
iNOS, on the other hand, in the presence of L-arginine catalyses the production of 
nitric oxide (NO), and subsequent oxidation reactions of NO with oxygen lead to the 
formation of nitrate (N03), with the production of nitrite (N02~) and nitrogen dioxide in 
intermediate steps (figure 1). 
NO and superoxide react and form peroxynitrite (OONO») one of the most potent 
natural oxidant (Pacelli et al., 1995; Zhu et al., 1992). 
In relation to NO production, there are two other NOS isoforms, nNOS and eNOS, 
that are constitutively expressed in either neuronal or endothelial tissue respectively. 
While NO production by these constitutively expressed NOS is short-lasting, and in 
nanomolar quantities, NO production by iNOS is in the micromolar range and even 
though it is delayed by several hours following stimulation, once induced it is active for 
as long as 5 days (Griffith and Stuehr, 1995; Kolios et al., 2004). 
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Figure 1 - Pathways of ROI and RNI generation 
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III - Nitric oxide and infection 
The importance of the NO production and the action of the reactive nitrogen species 
in relation to infection has been acknowledged since it was identified as one of the 
effector mechanisms of M0. Furthermore, once it was seen in the mid 80's that NO 
production by the M0 was induced not only by IFN-y, a cytokine of paramount 
importance in the control of infections, but also by LPS (Ding et al., 1988; Stuehr and 
Marietta, 1985; Stuehr and Marietta, 1987), it was clear that further investigation was 
required to deepen the knowledge on the interactions between pathogens and NO and 
RNI. 
The importance of NO for the defence against microorganisms has been described 
for a myriad of known pathogens, raging from bacteria to parasites and viruses. 
Studies using both iNOS inhibitors and mice genetically deficient in iNOS (iNOS" "), 
showed that NO was important in the immune defence against such different pathogens 
as Toxoplasma gondii (Hayashi et al., 1996; Scharton-Kersten et al., 1997), Leishmania 
major (Evans et al., 1993; Liew et al., 1990; Stenger et al., 1996; Wei et al., 1995), 
Plasmodium species (Rockett et al., 1991; Taylor-Robinson et al., 1993) and Ectromelia 
virus (Karupiah et al., 1998). 
Studies with other pathogens showed controversial results. 
With respect to Trypanosoma cruzi infection, studies with iNOS inhibitors showed 
that administration of NG-monomethyl-L-arginine (L-NMMA) both in vivo and in vitro 
was detrimental to the host (Vespa et al., 1994). Hõlscher and colleagues, after infecting 
both iNOS_/" mice and mice deficient for the IFN-y receptor (IFN-y-R7"), concluded that 
IFN-y dependent and iNOS mediated NO production was essential for the control of 
infection by M0 (Holscher et al., 1998). A more recent study, using two different 
iNOS"'" mice and two different strains of T. cruzi, including the one used by Hõlscher, 
showed that iNOS was not crucial for the control of infection in mice, but rather just 
one of many factors that collectively contribute to IFN-y-induced protection (Cummings 
and Tarleton, 2004). The fact that Cummings used at least a 10 fold higher inocula 
might account for the difference observed. By infecting mice with a higher dose of 
parasites, mice compensate the lack of iNOS and production, upon stimulation with T. 
cruzi lysate, of cytokines important in the control of infection, such as IFN-y, TNF and 
IL-la, were increased in cells from iNOS"" mice (Cummings and Tarleton, 2004). 
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In the case of Listeria monocytogenes, studies showed that when bacteria were 
exposed to NO generated either by in situ generation within a murine macrophage or by 
NO-donors, bacterial stasis was observed (Ogawa et al., 2001). Also, iNOS_/" mice were 
shown to be more susceptible to listerial infection (MacMicking et al., 1995), and NO 
produced during murine listeriosis was seen to be protective (Boockvar et al., 1994). On 
the other hand, Gregory and co-workers showed that upon L-NMMA treatment there 
was a reduction on the bacterial load, and there was an increased proliferation of T cells 
upon antigen stimulation when treated with this inhibitor. Hence, they proposed that NO 
production had a deleterious effect on the development of protective immune responses 
due to its immunosuppressive action (Gregory et al., 1993). 
In the case of Salmonella typhimurium, NO production contributes to the effector 
antimicrobial role during infection (Mastroeni et al., 2000), although iNOS-independent 
antibacterial activity has been clearly shown by Shiloh and co-workers (Shiloh et al, 
1999). The copper/zinc superoxide dismutase (SOD) of these bacteria has been 
implicated in resistance to RNI because of its inhibition of peroxynitrite formation by 
detoxification of O2 (De Groote et al., 1997). 
Salmonella as well as M. tuberculosis expresses a subunit of 
alkylhydroxideperoxide reductase (ahpC) that confers marked resistance to RNI-
mediated cytotoxicity (Chen et al., 1998). 
The expression of hmp, which encodes for a flavohemoglobin that exhibits a 
dioxygenase activity (detoxifies NO to NO3"), has also been associated to nitrosoactive 
stress in both E. coli, S. typhimurium and M. tuberculosis (Hu et al., 1999; Membrillo-
Hernandez et al., 1999). 
Bacteria are then able to resist NO production and RNI effects by different 
mechanisms. Other resistance mechanisms to RNI used by bacteria will be addressed 
later. 
III. 1 - Mycobacterium 
In 1985 Stuehr and Marietta showed that BCG infection induced the production of 
RNI in mice, as seen by the presence of NO3" in the urine of infected animals (Stuehr 
and Marietta, 1985). Moreover, in vitro studies with this pathogen established a 
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correlation between infection and RNI production and inhibition of the mycobacterial 
growth (Flesch and Kaufmann, 1991; Stuehr and Marietta, 1987). 
It was known for some time that IFN-y is a key cytokine in the inhibition of 
mycobacterial growth, and that it can act in synergy with TNF to achieve bacterial stasis 
in infected M0 (Appelberg et al., 1994; Flesch and Kaufmann, 1990). The antibacterial 
capacity of IFN-y activated M0 was soon linked to the production of RNI (Ding et al., 
1988; Flesch and Kaufmann, 1991). 
With the purpose of determining the mechanism responsible for the anti-
mycobacterial activity of IFN-y, Denis showed that when peritoneal M0s, infected with 
M tuberculosis, were pulsed with IFN-y, the inhibition of bacterial growth not only did 
not depend on the generation of ROI, but also that it was achieved through the 
generation of RNI, and in particular N02" (Denis, 1991). A study done with 
macrophagic cell lines deficient in ROI production confirmed the previous observation 
(Chan et al., 1992). The fact that inhibition of iNOS diminished the antimycobacterial 
capacity of the M0s, and that that capacity was restored after addition of L-arginine 
supported the dependence on RNI for the M. tuberculosis killing. Furthermore, it was 
seen that to achieve optimal RNI generation to kill the pathogen, there was a need for 
both IFN-y and TNF priming of the M0 (Chan et al., 1992), hence supporting the 
observation of the synergistic effect of those cytokines. 
The same study evaluated for the fist time the direct action of RNI on the bacterial 
survival. By using the acidified nitrite protocol, where RNI production is achieved once 
the N02" containing media has an acidic pH, the authors saw an inhibition of 
mycobacterial growth in these conditions (Chan et al., 1992). Similar studies, where 
more strains of M. tuberculosis were used, have established that different strains 
differed in their susceptibility to RNI exposure (O'Brien et al., 1994). The fact that there 
are such differences would point out to the possibility of a direct correlation between 
resistance to RNI and virulence of the strain. Indeed, such a correlation was established 
when virulence in the guinea pig model, determined by the development of pathological 
lesions in the infected organs, was compared with resistance to chemical RNI 
production in vitro (O'Brien et al., 1994). However, other studies, done mainly using the 
mouse model and in vitro analysis, have not been able to establish such a correlation 
(Rhoades and Orme, 1997). 
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In the in vivo study of the importance of RNI during infection, NOS inhibitors have 
been used for a long time. The data support a major role for NO production in the 
control of the infection, as exacerbation of M. tuberculosis growth was seen 
independent of the inhibitor being used (Chan et al., 1995; Ehlers et al., 1999b). 
Taking into account that the transmission of M. tuberculosis is predominantly done 
through the aerosol route, the characteristics of the aM0 as well as the alveolar lining 
have been investigated. With respect to the alveolar lining fluid, the collectins surfactant 
proteins (SP) are one of its major components. Moreover, SP-A was determined as 
being the most abundant one. Interestingly, studies comprising both aM0 and SP-A, 
have shown that the latter mediated the mycobacterial attachment to the former and 
consequent mycobacterial uptake (Downing et al., 1995; Lopez et al., 2003; Pasula et 
al., 1997; Pasula et al., 1999; Weikert et al., 1997). It was seen that subjects with HIV 
are more susceptible to tuberculosis even before the advent of low CD4+ T cell counts. 
These people had an increase in the SP-A in the bronchoalveolar lavage (BAL) and 
addition of this BAL to aM0 enhanced the M. tuberculosis attachment due to the 
mentioned collectin (Downing et al., 1995). Once M. tuberculosis infects aM0 there is 
production of RNI in an IFN-y-dependent manner. However, if these aM0 are in the 
presence of SP-A, the RNI production is inhibited (Pasula et al., 1999). So it would 
seem that by using SP-A as a mediator to the entry into aM0, bacteria can access the 
cells that will serve as their harbour without the drawbacks of eliciting a cytotoxic 
response. There are however contradictory studies suggesting that in the presence of 
infection SP-A augments inflammation (Gold et al., 2004; Weikert et al., 2000), and 
that the enhanced mycobacterial killing observed was NO-dependent (Weikert et al., 
2000). The way the collectin was isolated, and the activation state of the M0s could 
account for the discrepancies observed. Nonetheless, the fact remains that in conditions 
where an enhanced susceptibility to tuberculosis is seen, such as the case of human 
immunodeficiency virus positive (HIV+) individuals and in people with silicosis 
(presence of silica particles in the respiratory tract), there is an enhancement of SP-A in 
their BAL, suggesting that the enhanced attachment, the downregulation of NO 
production and the subsequent safe entry of M. tuberculosis into the host cell is what 
could be happening in vivo. 
In 1995 the first studies describing mice that were deficient for the iNOS gene were 
presented (Laubach et al., 1995; MacMicking et al., 1995; Wei et al., 1995). Although 
using different approaches, namely Listeria monocytogenes infection (MacMicking et 
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al., 1995), Leishmania major infection (Wei et al., 1995) and LPS-induced death 
(Laubach et al., 1995), all corroborate the importance of the induction of this gene in the 
immune response to infection. 
In the case of M. tuberculosis infection, the iNOS locus was identified as a 
protective one (MacMicking et al., 1997), and studies using iNOS ~'~ mice have been 
numerous. It was seen that infection was exacerbated in iNOS" " mice, both when the 
intravenous and the aerosol route of infection were used (Adams et al., 1997; Jung et al., 
2002). 
The fact that immunosuppressive functions have been ascribed to NO is worthy of 
note. Production of RNI by M0s can inhibit T cell proliferation (Albina et al., 1991; 
Albina and Henry, 1991), and in murine tuberculosis it was seen that the proliferative 
response of T cells to mycobacterial antigens was decreased due to NO production 
(Nabeshima et al., 1999). Caspase-1 is responsible for the cleavage of pro-IL-18 into its 
mature form IL-18 (also known as IFN-y-inducing factor), and NO was seen to inhibit 
this caspase (Kim et al., 1998). So the fact that IFN-y is more abundant in iNOS_/" mice 
than in wild type (WT) mice, could be partly due to the fact that IL-18 is available (Kim 
et al., 1998). In the case of M tuberculosis infection of iNOS_/", it was seen that there 
was not a decrease in either IFN-y or TNF (MacMicking et al., 1997). Taking this into 
account, and considering that, still, iNOS"" mice are more susceptible to infection, the 
direct action of RNI on the mycobacteria is important. 
For a long time there was a lot of doubt concerning the ability of human 
monocytes/M0s to express iNOS or to produce NO upon stimulation (Albina, 1995; 
Denis, 1994). However, the lack of such evidence in in vitro studies was probably due 
to the protocols being followed at the time rather than being a characteristic of the cells 
under study. More recently, several groups showed that M. tuberculosis induced NO 
release by human monocytes and aMOs and established a correlation between NO 
release and inhibition of mycobacterial growth in vitro (Jagannath et al., 1998; Pathania 
et al., 2002; Rich et al., 1997; Roy et al., 2004). Of note is the fact that that correlation 
was not seen in all the clinical strains tested (Jagannath et al., 1998). Roy and 
colleagues point out the fact that direct infection of aM0 by itself does not induce 
enough NO to kill the mycobacteria. For that to happen, additional signals such as 
cytokines would be needed, and are probably present in the lung of the 
immunocompetent host (Roy et al., 2004). 
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The fact that active iNOS was detected in tuberculosis patients in a substantially 
greater degree than in healthy controls (Nicholson et al., 1996), indicates that in vivo, 
and in human disease, M. tuberculosis can also induce NO production by alveolar M0. 
Taking into account that iNOS and RNI are detected during tuberculosis infection 
and that bacilli can still survive, mycobacteria must be able to overcome the effect of 
RNI. 
One way to circumvent the actions of NO can be by preventing NO from reaching 
the bacteria. A possible tactic might be by inhibiting the recruitment of iNOS to 
phagosomes. A recent study describes that M. bovis BCG was able to block the iNOS 
recruitment to phagosomes, otherwise observed in M0 stimulated with IFN-y and LPS 
(Miller et al., 2004). Another tactic could be by NO scavenging: the truncated form of 
the haemoglobin-like protein HbN (trHbN) of M. tuberculosis and M. bovis has been 
reported to confer protection to NO in a way similar to the dioxygenase of 
flavohemoglobins, converting NO to nitrate (Ouellet et al., 2002; Pathania et al., 2002). 
As far as the RNI species are concerned, mycobacteria have several genes induced 
by the nitrosoactive as well as oxidative stress. 
Peroxynitrite, due to its capacity to decompose into nitrate while generating 
hydroxyl radical and nitrogen dioxide radical, has a highly cytotoxic potential. The katG 
and ahpC genes of mycobacteria are implicated in the oxidative stress response, and 
have peroxynitrite reductase activity (Bryk et al., 2000; Chen et al., 1998; Manca et al., 
1999; Master et al., 2002). 
OxyR, a transcriptional activator as well as a sensor for oxidative stress, induces the 
expression of both KatG and ahpC genes. The fact that the oxyR homolog in M. 
tuberculosis contains numerous frameshift mutations and deletions does not seem to 
have affected the expression of these genes, suggesting that oxyR is partially functional, 
or else, there are other transcription factors involved (Sherman et al., 1995). Still, the 
capacity for oxidative stress sensing by M. tuberculosis could still be slightly impaired 
due to this. 
Peptide methionine sulfoxide reductase has been reported as essential for the repair 
of peroxynitrite-mediated intracellular damage (St John et al., 2001). So it would seem 
that mycobacteria have developed several means to tackle the detrimental effects of 
peroxynitrite. 
In the late 90's, Nathan's group described two novel antioxidant genes: noxRl and 
noxR3. Studies with noxRl were the first to identify a mechanism used by mycobacteria 
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to resist the deleterious action of RNI (Ehrt et al., 1997). With the idea that this gene 
might be linked to virulence in vivo noxRl mutants were done and virulence analysed in 
murine infection by determining the bacterial loads in the target organs. It was seen that 
M. tuberculosis noxRT" mutants could establish infection as efficiently as the WT 
strain, hence suggesting that there is no link between noxRl and virulence (Stewart et 
al., 2000). Studies using S. typhimurium expressing a mycobacterial library determined 
that the noxR3 gene conferred protection towards RNI exposure (Ruan et al., 1999). 
More recently, the same group, using mutants that were hypersusceptible to 
acidified nitrite, determined the M. tuberculosis proteasome as necessary for RNI 
resistance and further identified the mycobacterial proteasome ATPase (Mpa) activity as 
being responsible, although not sufficient, for RNI protection (Darwin et al., 2003; 
Darwin et al., 2005). 
The a-crystallin homolog, which has been associated with mycobacterial latency 
(Cunningham and Spreadbury, 1998; Desjardin et al., 2001; Yuan et al., 1998), was 
induced upon exposure to NO-donors, suggesting also a role in the response of 
mycobacteria to NO production (Garbe et al., 1999). This protein will be addressed in 
more detail in relation to its implications in latency. 
The induction of hmp has been seen in response to oxygen limitation and 
nitrosoactive stress, suggesting that the flavohemoglobin expressed, which would then 
detoxify NO into nitrate, is important to the bacterial response to NO production in 
microaerophilic conditions (HU et al 99). 
Mycobacteria seem to have developed several ways to overcome the RNI 
production, but not enough to succeed and thrive in immunocompetent hosts. 
///. 2 - Mycobacterium avium 
Contrary to what is seen in the case of M. tuberculosis, the role of nitric oxide is 
much less known in the case of an infection by M.avium. 
Studies done in vitro with MAC bacteria showed a diverse susceptibility among 
these mycobacteria towards RNI. 
Studies involving chemical NO production by nitrite acidification showed 
controversial data. Some authors stated that M. avium was more sensitive to RNI killing 
than M. intracellular (Doi et al., 1993), while others showed the opposite (Tomioka et 
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al, 1997). In this same study, Tomioka and colleagues, using a macrophagic cell line 
and the inhibitor of NO L-NMMA, got to the conclusion that RNI play a definite but not 
a major role in the anti-MAC mechanisms of activated M0. Appelberg and Orme, using 
the same NO inhibitor, showed that bacteriostasis of 3 different M. avium strains, 
induced by IFN-y, did not involve RNI (Appelberg and Orme, 1993). Again, the former 
research group, using activated murine peritoneal M0 in a study where only one strain 
of M avium was tested, showed that infection by M avium induces nitrite released by 
activated M0, and stated that RNI are important effectors of M0 anti-M avium 
antimicrobial activity (Sato et al., 1998). 
Several studies have shown that infection by M. avium of activated M0 does 
undoubtedly induce RNI production (Appelberg and Orme, 1993; Doherty and Sher, 
1997; Doi et al., 1993). However, these authors are not in agreement with Sato and 
colleagues and showed that RNI produced by mononuclear phagocytes have no anti-
mycobacterial effect on M. avium. 
Curiously, the same group that once stated that RNI were important effectors of M0 
anti-MAC activity (Sato et al., 1998; Tomioka et al., 1997), have more recently implied 
that RNI only play a minor role in such an activity (Sano et al., 2002). 
The differences observed in susceptibility by MAC towards RNI may be due to the 
fact that in the different studies, different MAC strains were used. Also, the in vitro 
conditions employed by the researchers were not equal. The importance of the cells 
being used and the way they are treated in the in vitro approach can be clearly seen in a 
study by Sarmento and Appelberg, where it was shown that in resting murine peritoneal 
M0 there was no nitrite release upon M. avium infection (Sarmento and Appelberg, 
1996). 
Once iNOS" mice were made, studies using M0 lacking this enzyme could be 
done. In one such study, Gomes and co-workers showed that upon IFN-y activation 
bone marrow-derived M0s (BMM0s) from iNOS" mice could inhibit mycobacterial 
growth in the same manner as the BMM0 from WT mice, proving that M0 could 
control M. avium growth even when unable to produce NO (Gomes et al., 1999b). 
In a recent study, rat M0 were cultured in the presence of SP-A and infected with 
M. avium (Lopez et al., 2003). SP-A, which is known to mediate mycobacterial 
attachment and entry into the lung M0s (Downing et al., 1995; Pasula et al., 1997; 
Weikert et al., 1997), had been seen to be responsible for the clearance of BCG by M0 
through an NO-dependent way (Weikert et al., 2000). Lopez and colleagues showed that 
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SP-A not only mediated M. avium entry into M0, but also that there was a fivefold 
increase in this uptake. Furthermore, SP-A enhanced the NO production by M0, 
without killing the mycobacteria. The addition of L-NMMA had no effect on M. avium 
survival, confirming that NO is not a major mediator in M. avium killing (Lopez et al., 
2003). 
Studies done with bovine M0 showed that also in this case the macrophagic killing 
of M.avium was not NO- nor 02-related (Weiss et al., 2002). 
As far as human M0 are concerned, Dumarey and colleagues have shown that live 
M. avium induced NO production by M0. Furthermore, inhibition of that production by 
L-NMMA did not enhance the bacterial growth, suggesting that, as observed for rodent 
and bovine M0, M. avium growth was not affected by the presence of RN1 produced by 
human M0 (Dumarey et al., 1994). 
Several studies using iNOS/_ mice have proven that this resistance prevails in an in 
vivo infection. Two different studies showed that, regardless of the virulence of the 
strain used, CFU numbers were not higher in M. avium infected iNOS/_ mice when 
compared to WT controls (Doherty and Sher, 1997; Ehlers et al., 1999c). In a third 
study, not only there was no enhancement of the bacterial load in the target organs, but 
there was actually, at later time points, an improved clearance in the iNOS"" mice 
(Gomes et al., 1999b). 
Immunocompetent mice infected with virulent M. avium strains have highly 
activated M0, where RNI secretion ex vivo is clearly seen, as well as iNOS expression 
in the affected organs, namely in the same M0s that harbour the mycobacteria (Florido 
et al., 1999). Doi and colleagues proposed that the NO induced by mycobacteria upon 
infection suppressed the M0 bactericidal activity through the inhibition of phagocytosis 
as well as 02" generation by M0 (Doi et al., 1993). The fact that fully activated M0, 
which secrete ROI, and that colocalization of mycobacteria and iNOS was seen in 
infected M0, goes against the suggestion made by Doi. 
Several studies have shown that NO has immunosuppressive properties (Albina et 
al., 1991; Albina and Henry, 1991; Eisenstein, 2001; Nabeshima et ai., 1999). Doherty 
and Sher saw that spleen cells removed from infected immnocompetent mice that had 
been stimulated with concanavalin A, a mitogen, did not proliferate as much in the case 
of uninfected mice. Using the same protocol, it was seen that in iNOS_/" mice that 
inhibition of the mitogenic response was reduced. Hence, they suggested that NO had a 
negative role in the suppression of T cell function and that was why in its absence there 
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was no increased bacterial load (Doherty and Sher, 1997). If this was the case, then the 
clearance seen in M. avium infection in iNOS ~ mice would be also seen when other 
mycobacterial species were used to infect these mice. 
Gomes and colleagues showed that iNOS_/" mice controlled the virulent M. avium 
infection better than WT mice, and that IFN-y was needed for that control. This control 
was probably achieved by activating the M0 for intracellular growth restriction or 
killing in an NO-independent way. Also, like Doherty and Sher, they saw that splenic 
cells from iNOS"/_ had two to four times more IFN- y production than the WT mice. The 
presence of IFN- y in the sera of iNOS"/_ infected mice was 10 times higher than in WT. 
The fact that, during the first two months of infection, the number of lymphocytes in 
iNOS" " mice was higher than those of WT, associated with the previous observations 
suggests that the NO produced during the infection hampers the development or the 
maintenance of the protective immune response. However this may, in part, be the case, 
the same reasoning applies as for Doherty's work: why doesn't this happen with other 
intracellular microorganisms, and in particular mycobacteria? 
In a more recent study, the same group, when analysing the factors underlying the 
T-cell loss associated with infection with the highly virulent M. avium strain 25291, saw 
no connection between iNOS induction and apoptosis. As opposed to IFN- y deficient 
mice, iNOS_/" mice still had lymphopenia (Florido et al., 2005). 
All this suggests that the responsibility of the observed resistance by M. avium to 
NO is not due to the immunosuppressive and/or the immunoregulatory action of NO, 
but rather on the specific mycobacterial survival strategy instead. 
As an example, M. avium, might be better prepared for oxidative stress sensing than 
M. tuberculosis, as, contrary to the last, it appears to have an intact oxyR (Sherman et 
al., 1995). 
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IV - Host - mycobacteria standoff: the granuloma 
The hallmark of mycobacterial infections is the formation of an organized structure 
- the granuloma - composed of an array of immune cells. Classically, granulomas are 
described as focal accumulations of mononuclear cells in various stages of 
differentiation and generally appear as well structured lesions consisting of centrally 
located M0s which are surrounded by a lymphocytic cuff (Benini et al., 1999; Mornex 
et al., 1994). Mature granulomas can be classified as caseating or noncaseating. 
Caseating ones have typically a necrotic central core where cell debris and bacilli can be 
found. Patients with active tuberculosis have this type of granulomas, localized in the 
lungs, and upon the core's liquefaction, coughing can spread the bacteria into the air, 
and subsequently disseminate disease. In caseating granulomas a macrophagic area 
containing M0, Langhans Giant cells (resulting from the coalescence of several infected 
M0), epithelioid M0 (differentiated M0 that have an abundant cytoplasm) as well as 
resting M0 surrounds the central core (Co et al., 2004b). In noncaseating granulomas, 
this macrophagic area will form the central core. Lymphocytes will compose a cuff 
surrounding the structure described above, and can also be seen among the macrophagic 
area where they can interact with the infected M0 and activate them to kill the bacteria 
within. Consolidated granulomas also have a fibrotic shell that will circumscribe the 
granulomas within the organ. 
Granulomas will on the one hand, contain the infection, but on the other hand, 
are responsible for the pathology associated to disease as well as, in the case of active 
disease, its propagation (Co et al., 2004b; Saunders and Cooper, 2000). In most cases 
however, when an immunocompetent host is infected by mycobacteria, overt disease is 
not observed: the immune system will react to infection by inducing the formation of 
the granuloma and activated M0s will contain it. However, clearance of the infection 
rarely happens, and some bacteria remain within the host, using the granuloma as a 
haven. So, mycobacteria can and do remain unnoticed within the host's organism for as 
long as a lifetime, within the host's protective structures. 
Recently there has been several reports where attention is drawn to the fact that 
indeed, the effective immune response, where a granuloma is formed, is both beneficial 
to the host as well as the pathogen (Co et al., 2004b; Cosma et al., 2003; Doenhoff, 
1998; Doenhoff, 1999; Flynn, 2004; Flynn and Chan, 2005). Interestingly, mycobacteria 
seem to prefer the granuloma environment above any other. Cosma and co-workers 
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have shown that upon reinfection, the M0s laden with mycobacteria upregulate 
chemokine receptors that will lead them to the already established granuloma (Cosma et 
al., 2004). Also, a known virulence determinant of M tuberculosis - RDI - has been 
implicated in the enhancement of the granuloma formation (Volkman et al., 2004), 
hence suggesting a correlation between virulence and granuloma induction. Its was seen 
that RDI induces M0s to send chemotactic signals that, by affecting cell migration and 
adhesion, will contribute to the early events of granuloma organization. Furthermore, its 
influence seems to extend into later stages of granuloma formation as well (Volkman et 
al., 2004). In a model for the development of necrotic lesions using a low i.v. dose of M 
avium both T cells and bacterial stimulation are required for necrosis to occur (Florido 
et al., 2002), suggesting that bacteria are directly involved in the induction of the 
pathology that will facilitate its dissemination. The fact that a highly virulent strain of 
M. avium - 25291 - induces a stronger IFN-y response than a strain of intermediate 
virulence - M. avium 2447 (Florido et al., 1999), coupled to the fact that IFN-y has 
been implicated in granuloma necrosis (Cooper et al., 2000; Ehlers et al., 1999a; Florido 
and Appelberg, 2004; Florido et al., 2002; Florido et al., 2005) supports the notion that 
virulence and necrotic granuloma formation are intertwined. 
Even though there are still a lot of aspects concerning the granulomatous response 
that are not clear, in the last decade a deeper insight into the events and players of this 
response has been gained. 
IV. 1 - Granuloma formation 
When comparing the histological evolution of the granulomas when mice were 
infected by either the aerosol or the intravenous route, Benini and colleagues have 
thoroughly described the pulmonary granuloma formation during M. avium infection, 
and defined four major categories for these lesions (Benini et al., 1999). 
Mice with category 1 lesions had small, circumscribed mononuclear lesions, 
which occupied the space of just a few adjacent alveoli. These early granulomas were 
composed of M0 and lymphocytes. Mononuclear foci could be scattered throughout the 
lung or close to blood vessels, depending if the infection route had been, respectively, 
the aerosol one or the i.v. one. 
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Category 2 lesions appeared more diffuse than category 1 ones. Loosely 
arranged accumulations of epithelioid and foamy M0 could be seen in the lung. 
Lymphocytes only rarely would be forming a cuff around the central macrophagic area, 
and would otherwise accumulate as small aggregates within the lesion. The fact that 
most cells within the macrophagic area stained for iNOS, pointed out to the fact that 
these cells were activated. 
Mice with category 3 lesions had extensive sheets of epithelioid and foamy M0. 
Some lymphocytes could be found in aggregates or in the periphery of the infiltrations, 
in the vicinity of blood vessels. Within the macrophagic zone, category 3 lesions would 
present the first signs of irreversible cell damage. 
When granulomatous infiltrations further coalesced in such a way that sheets of 
mononuclear cells in various differentiation states occupied more than half the infected 
lung, the lesion was classified as a category 4 lesion. A variably thick layer of 
degenerating neutrophils surrounds large areas of caseating necrosis at the centre of 
granulomas. This layer is in turn surrounded by a wide layer of foamy and epithelioid 
M0. 
The category 3 and 4 lesions, where necrosis in the centre can be seen and can 
evolve to the caseous type of granuloma, is not always seen in the experimental mouse 
model. Indeed, this will depend on the virulence of the strain used as well as the route of 
infection. Highly virulent M. avium strains such as 25291 will induce this type of 
granulomas when administered by the aerosol route (Benini et al., 1999; Saunders et al., 
1998) or when administered i.v. at a low dose (Florido et al., 2002). When a high dose 
of this strain is used via the i.v. route, categories 1 and 2 lesions are the ones observed. 
This can be explained by the early immune response to mycobacteria, where an antigen 
specific response is observed as early as 15 days post infection, and the assembly of 
well organized granulomas can be seen. By day 60 the reactivity is lost and T cell loss 
occurs. In the case of the low dose model, the peak immune reactivity was only 
achieved by day 60, as seen by the IFN-y production by spleen cells upon antigenic 
stimulation, and persisted until day 90. This immune reactivity was associated with 
normal T cell numbers (Florido et al., 2002). 
It has been shown that necrosis requires CD4+ T cells and type 1 cytokines, namely 
IL-12 (p40) and IFN-y (Cooper et al., 2000; Ehlers et al., 2001; Ehlers et al., 1999a; 
Florido and Appelberg, 2004; Florido et al., 2002), while TNF had a role in the 
maintenance and resolution of inflammatory lesions (Benini et al., 1999; Cooper et al., 
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2000; Ehlers et al., 2001; Ehlers et al., 1999a; Florido and Appelberg, 2004; Florido et 
al., 2002). 
When a less virulent strain is used, the necrotic, caseous centre is not observed and 
the neutrophilic influx into the granuloma is minor (Benini et al., 1999; Saunders et al., 
1998). 
The involvement of several types of cells in this organized structure points out to a 
complex interplay of cell types and cell mediators at the local site of infection. Early 
events involve M0s and DCs, which are infected by mycobacteria (Demangel and 
Britton, 2000; Jiao et al., 2002), and NK cells that are thought to be responsible for the 
early production of IFN-y (Florido et al., 2003; Smith et al., 1997). 
NK IFN-y production can be induced by the IL-12 produced by the infected cells. 
Studies with M. tuberculosis and M bovis BCG have shown that DCs are infected with 
mycobacteria and are activated, subsequently inducing several cytokines and 
chemokines (Demangel et al., 1999; Demangel and Britton, 2000; Giacomini et al., 
2001; Henderson et al., 1997; Jiao et al., 2002; Thurnher et al., 1997; Tian et al., 2005). 
Jiao and co-workers showed that both M0s and DCs were host cells for BCG in vivo, 
but only DCs were activated early in infection, secreting IL-12 (Jiao et al., 2002). 
Another study, done with M tuberculosis, showed that upon infection, human DCs 
secreted IL-12 which would enhance IFN-y production by T cells (Giacomini et al., 
2001). Also, in vivo depletion of DCs in M. tuberculosis infected mice was shown to 
delay the specific CD4+ T cell response (Tian et al., 2005) supporting the fact that DCs 
are important not only in the triggering of the innate as well as the acquired immune 
response. IFN-y production by NK cells can also be the result of a non-specific 
response of NK cells to the mycobacterial LAM (Smith et al., 1997). Smith and 
colleagues showed that M. avium 25291 triggered IFN-y production by NK cells. 
Also, TLR2, which has been acknowledged as a pattern-recognition receptor for M 
avium (Lien et al., 1999a; Stenger and Modlin, 2002), was seen to be important in the 
early priming of T cells for IFN-y production after infection with virulent M. avium 
(Gomes et al., 2004). 
The IFN-y will activate M0s, which will in turn produce both IL-12 and TNF. IL-
12 will be responsible, at this stage, for the continual induction of IFN-y production by 
NK cells and T cells. TNF will be used in an autocrine way: acting in a synergistic 
fashion with IFN-y, it will activate the M0s (Appelberg et al., 1994; Appelberg and 
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Orme, 1993). Furthermore, it is responsible for chemokine induction that will be 
responsible of the recruitment of both monocytes and lymphocytes to the site of 
infection (Co et al., 2004a; Saunders and Cooper, 2000; Smith et al., 1997). 
Once the monocytes differentiate into M0, they can phagocytose the bacilli present 
at the site, and with the help of antigen specific T-cells, will mount a protective immune 
response where macrophagic activation will lead to bacterial killing. This is what can be 
seen when low or intermediate virulence strains are the cause of infection, and the 
granuloma will be classified as a category 2 lesion (Benini et al., 1999). However, when 
the infection is caused by a highly virulent strain, this macrophagic activation will not 
suffice and bacterial growth will continue at a steady pace (Pedrosa et al., 1994). In this 
case, the infected M0s will start to coalesce, forming multinucleated giant cells that 
along with foamy and epithelioid M0s will compose a macrophagic core, which will be 
surrounded by a lymphocytic cuff. At this stage, necrosis will start to occur in the 
macrophagic area and some neutrophils home to the site. Fibrosis can occur at this time 
and chronic antigenic stimulation will lead to further necrosis and fibrosis of the lesion. 
IV. 2 - Fibrosis 
The effective response of a granulomatous response comes to an end with fibrous 
resolution, terminating local inflammation. Fibrosis encompasses fibroblast 
proliferation, extracellular matrix (ECM) production and deposition, and an imbalance 
between collagen production and degradation. ECM is composed of fibronectin, 
vitronectin, osteopontin, elastin and collagen among others, and its deposition provides 
cell-cell contact and cell-ECM adhesion, therefore enabling the different players of the 
immune response to interact effectively and also giving some stability to the final 
structure formed (Boros, 2003; Chiaramonte et al., 1999). However, fibrosis is also 
partly responsible for the organ damage associated with granulomatous diseases (Boros, 
2003; Sandler et al., 2003). 
The balance of collagen deposition and degradation is important for the final 
outcome of the granulomatous response (Singh et al., 2004). Too much of such a 
deposition will be the cause for excessive adjacent tissue damage and pathology. Too 
little a deposition will mean that there will be a loose structure formed, as opposed to a 
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tight structure where all the key players of the immune response are in close contact, 
and where the infection is contained. 
In the context of granulomatous diseases, some mediators have been implicated in 
fibrosis such as fibroblast growth factors and cytokines involved in fibroblast 
proliferation, ECM production and deposition (Bitterman et al., 1983; Borós, 2003; 
Boros et al., 2003; Chensue and Kunkel, 2003; Chiaramonte et al., 1999; Co et al., 
2004a; Fallon et al., 2000; Jakubzick et al., 2003; Lukacs et al., 2001; Ruth et al., 2000). 
Transforming growth factor-beta (TGF-p) can directly increase the gene expression of 
ECM molecules, can inhibit collagenase production, and promotes fibroblast 
proliferation by the induction of fibroblast growth factors (Khalil et al., 1989). In 
experimental schistosomal fibrosis TGF-p has clearly a pro-fibrotic action (Farah et al., 
2000) and an elevated gene expression of TGF-p mirrored that of collagen gene, 
suggesting a direct correlation between the two (Singh et al., 2004). 
Epithelioid M0s have been shown to be strong inducers of TGF-p within the 
tuberculosis granuloma (Toossi 1995), suggesting that this cytokine will have a role on 
this type of granulomas. Also, in M. avium infection, there was also an increase of 
TGF-p expression early in the infection process (Champsi et al., 1995). The presence of 
this cytokine in these contexts might act not only as a suppressor of the macrophage 
function, but also as an inducer of fibrosis. 
Several studies involving Th2-mediated granulomas, which have been associated to 
excessive fibrosis, have also identified IL-13 as an important pro-fibrotic agent. Of note 
are studies involving the pathology following Schistosoma mansoni infection where 
IL-13 has been identified as a key mediator of tissue fibrosis involved in collagen 
deposition (Fallon et al., 2000; Kaviratne et al., 2004; Sandler et al., 2003). 
Chiaramonte and colleagues showed that IL-13 was the major Th2-type cytokine 
responsible for collagen production and hepatic fibrosis in mice infected with the 
mentioned parasite (Chiaramonte et al., 1999). In the same study, it was shown that, in 
vitro, IL-13 could directly stimulate collagen production by fibroblasts. On the other 
hand, it was suggested that the pro-fibrotic action of IL-13 was due to the fact that it 
stimulated TGF-p production (Lee et al., 2001). However, more recent studies have 
shown that IL-13 driven pathway of fibrogenesis is independent of that cytokine, as 
TGF-p blockade did not affect the IL-13 dependent liver fibrosis (Kaviratne et al., 
2004). Studies involving pulmonary fibrosis, as the case of interstitial pneumonia, have 
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also identified IL-13 as a major pro-fibrotic agent in those cases (Jakubzick et al., 
2003),. 
As the Th2 response is associated with increased fibrosis, IL-4 was also studied in 
the granulomatous response. With regard to this cytokine, it was considered to be both a 
critical and a non-critical pro-fibrotic mediator (Farah et al., 2000; Jakubzick et al., 
2003), and its importance was associated with the stage of the fibrotic response (Farah 
et al., 2000; Huaux et al., 2003). Its capacity of inducing TGF-p production by 
fibroblasts can lead to ECM synthesis and subsequent deposition (Hogaboam et al., 
1999). However, several studies in type 2 mediated granulomatous responses have 
compared IL-4 and IL-13 with respect to their pro-fibrotic capacity, and state that the 
major cytokine responsible for fibrosis is IL-13 and not IL-4 (Chiaramonte et al., 1999; 
Fallon et al., 2000; Sandler et al., 2003). The fact that IL-4 receptor a (IL-4Ra) KO 
mice fail to develop granulomatous pathology after S. mansoni infection, while IL-4 KO 
mice do (Jankovic et al., 1999), also favours the importance of IL-13, as this cytokine 
also signals through that receptor. In the case of leishmaniosis, where the cytokine 
profile is mixed, both cytokines seem to be less important in the collagen deposition in 
the L. donovani-induced granulomas, although they are important for the granuloma 
maturation (Kaye and Engwerda, 2003; Stager et al., 2003). 
Taking into account that the Th2-type of response is associated with enhanced 
fibrosis, it is not surprising that anti-fibrotic characteristics have been attributed to type 
1 cytokines (Boros and Whitfield, 1999). IFN-y and IL-12 have been associated with an 
anti-fibrotic activity in S. mansoni infection and also in an experimental model for 
pulmonary fibrosis (Henri et al., 2002; Kimura et al., 2004; Vaillant et al, 2001; Wynn 
et al., 1994). IFN-y, as opposed to the effect of the type 2 cytokine IL-13 that induces 
arginase, induces macrophagic iNOS. While the induction of the latter will lead to NO 
production, arginase induction will lead to collagen production and deposition. As both 
enzymes have the same substrate - L-arginine - collagen production and deposition will 
be prevented as the substrate is being used elsewhere. Furthermore, the intermediate by-
product of the iNOS mediated NO production NG-hydroxy-L-arginine (NOHA) also 
acts as a potent inhibitor of the arginase activity, further preventing the collagen 
production (Hesse et al., 2001; Pearce and MacDonald, 2002; Wynn, 2003; Wynn, 
2004). 
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In a study where a model of antigen-elicited pulmonary granuloma formation was 
used to compare mycobacterial - type 1 - responses, with schistosomal- type 2 -
responses, it was seen that both IL-13 and IL-4 expression in the type 1 response was 
lower than in the type 2 one, but still impaired the IFN-y production (Ruth et al , 2000). 
Experiments using a recombinant BCG expressing IFN-y, showed that a higher 
expression of IFN-y was associated with reduced tissue pathology (Wangoo et al., 
2000). Hence, it seems that, also in the case of type 1 mediated granuloma formation, 
IFN-y acts as an anti-fibrotic agent, and IL-13 and IL-4 can favour the fibrotic 
response, at least by inhibiting the IFN-y expression. 
The fact that TGF-p is a known suppressor of macrophage function, having an 
inhibiting effect on IFN-y and IL-12 mediated responses (Bright and Sriram, 1998; 
Letterio and Roberts, 1998), suggests that TGF-P expression can further enhance its 
fibrotic capacity by suppressing the anti-fibrotic activity of the mentioned Thl type 
cytokines. 
The interplay between type 1 and type 2 responses is therefore quite important in a 
granulomatous response, as a balance should be achieved to guarantee containment of 
the infection and its resolution without a too damaging effect on the affected organs. IL-
13, TGF-P and IFN-y are apparently the key players in the collagen production and 
deposition, where IL-13 and TGF-p are important in a pro-fibrotic response, whereas 
IFN-y acts as an anti-fibrotic cytokine. 
IV. 2.1 - Fibrosis and nitric oxide 
Macrophage NO production occurs after activation by cytokines produced by CD4+ 
Thl lymphocytes, notably IFN-y, when L-arginine is used by the synthase, and NO and 
citruline are obtained, in what is termed the classically activation of M0s (Ding et al., 
1988; Stuehr et al., 1989; Stuehr and Nathan, 1989). However, an alternative metabolic 
pathway of L-arginine is catalysed by arginase, which converts the substrate to L-
oraithine and urea. By the action of ornithine-decarboxilase (ODC) and ornithine-
aminotransferase (OAT), L-ornithine is transformed into polyamines and proline, 
respectively (Hesse et al., 2001). As proline is an essential amino acid used for collagen 
production, this type of pathway favours a fibrotic response. Several studies have shown 
that type 2 cytokines induce arginase, suppressing in the process NO synthesis, and, 
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conversely, type 1 cytokines induce iNOS, and inhibit a fibrotic response (Brunei et al., 
1999; Corraliza et al., 1995; Hesse et al., 2000; Hesse et al., 2001). With respect to the 
key players in this Thl/Th2 regulation of fibrosis, as referred in the previous section, 
IFN-yhas been identified as the key anti-fibrotic cytokine, responsible for iNOS 
induction, while IL-13 has been identified as the key pro-fibrotic cytokine, responsible 
for the arginase induction as well as, through both TGF-P dependent and independent 
ways, inducing collagen production by fibroblasts. 
In the case of granulomatous pathology, it seems that the outcome is directly related 
with the regulation of the arginase and iNOS induction and the fate of L-arginine. 
Indeed, there is a relation between iNOS and the number and size of granulomas in 
several granulomatous settings: in the absence of iNOS induction, there are more 
granulomas found in the affected organs, which are bigger than the granulomas found 
when an immunocompetent host responds to the infection, a response that involves NO 
production. This can be seen both in mycobacterial (Ehlers et al., 1999b; Gomes et al., 
1999b) and in parasitic infections (Murray and Nathan, 1999; Nascimento et al., 2002). 
In experimental lung granuloma models, beads coated with either purified peptide-
derivative (PPD) from M. tuberculosis or schistosome egg antigen (SEA) were used to 
study Thl type and Th2 type granulomatous immune response respectively. In these 
studies it was shown that NO regulates the size and composition of granulomas, and that 
collagen deposition is induced after NO inhibition (Hogaboam et al., 1997; Hogaboam 
et al., 1998). 
Taken together, in a pro-fibrotic granulomatous response, the players involved are 
IL-13, TGF-p and a Th2 type of response, where arginase is induced and collagen 
production is observed, whereas in an anti-fibrotic response, where a Thl type of 
response is involved, IFN-y acts as the key anti-fibrotic cytokine, which by activating 
M0 and inducing iNOS will limit the access of L-arginine to arginase, as well as 
inhibiting arginase directly and therefore inhibiting collagen production (figure 2). 
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Figure 2 - Interplay between the different players involved in fibrosis. iNOS - inducible 
nitric oxide synthase, ARG1 - arginase 1, NOHA - NG-hydroxy-L-arginine, ODC -
ornithine decarboxilase, OAT - ornithine aminotransferase. Adapted from Bronte and 
Zanovello and from studies of Wynn and co-workers (Bronte and Zanovello, 2005; 
Hesse et al., 2001 ; Wynn, 2004). 
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V - Mycobacterial adaptation to the granuloma 
environment - persistence 
Formation of a protective granulomatous structure depends, as it was mentioned in 
chapter IV, on the balance between type 1 and type 2 responses, where elimination of 
the pathogen as well as confinement of the infection is, from the host's point of view, 
the effective way of limiting infection. However, in the mycobacterial case, this is not 
the end of its pathogenic cycle as some bacilli still remain in the granulomas. Bacterial 
persistence is something that has been studied with regard to several types of bacteria 
and the fact that distinct pathogenic bacteria can cause a chronic infection suggests that 
persistence is not the result of an unbalanced immune response, but in fact a phase in 
pathogenesis (Hornef et al, 2002; Rhen et al., 2003; Rhen et al., 2000). The fact that 
some bacilli persist in these structures is the reason why nearly 2 billion individuals 
around the world are believed to be carrying bacilli (Dye et al., 1999). 
As the success of mycobacterial infections is partly due to the capacity to establish 
these latent/persistent infections, virulence of the strains might involve genes and 
factors that allow for the maintenance of viable bacteria during long-term chronic 
infections. Even though the microenvironment created by granulomas has not been 
properly described, it is believed that reduced oxygen tension, nutrient limitation, low 
pH and both ROIs and RNls will be present therein and bacilli are thought to remain 
there in a latent form (Fenton and Vermeulen, 1996; Nathan and Shiloh, 2000; Wayne 
and Sohaskey, 2001). Hence a lot of studies have been made where focus has been 
directed to the adaptation of mycobacteria to what is believed then to be the 
microenvironment within granulomas. Microarray technology has allowed for a more 
directed study of gene expression in those conditions (Bacon et al., 2004; Muttucumaru 
et al., 2004; Park et al., 2003; Sherman et al., 2001; Voskuil, 2004). Other studies have 
directed their attention to mycobacterial characteristics, such as the cell wall, and tried 
to establish a relation between persistence and those characteristics. 
Wayne developed a system where bacilli are grown under oxygen-limited 
conditions based on controlled agitation of sealed liquid cultures exposed to limited 
headspace volumes of air. This way, a gradual depletion of available 0 2 is observed, 
forming then a temporal oxygen gradient. Using this approach, bacilli first enter a 
microaerophilic/hypoxic stage, where the oxygen concentration is approximately 1% of 
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that of a solution saturated with air and where cultures terminate exponential growth. 
Next, headspace depletion continues and the anaerobic/anoxic stage is reached when 
dissolved oxygen concentration drops to approximately 0,06% of saturation (Wayne, 
2001; Wayne and Hayes, 1996; Wayne and Sohaskey, 2001). Mycobacteria, be it M 
tuberculosis, M. bovis BCG or M. smegmatis, in this hypoxic environment are in a 
reversible, apparently diploid, synchronized state of low metabolic activity, in which the 
cells maintain the viability for long periods of time without dividing (Dick et al., 1998; 
Lim et al., 1999; Wayne and Hayes, 1996). Bacteria that present these characteristics 
can be defined as being in a state of physiological dormancy (Kaprelyants et al., 1993). 
Even though such studies have not been documented on M. avium, it is anticipated that, 
being an organism that is capable of establishing a long-term chronic infection, it would 
employ similar strategies to persist as the ones used by M. tuberculosis. 
Segal and Bloch demonstrated that mice infected with M tuberculosis had enhanced 
activity of enzymes involved in the breakdown and utilization of fatty acids as source of 
carbon and energy (Bloch and Segal, 1956). One of the pathways present in many 
bacteria that uses fatty acids is the glyoxylate cycle. Isocitrate lyase (ici), one of the 
enzymes of this cycle, is encoded by aceA which is upregulated during infection of M0 
with both M. tuberculosis and M. avium (Dubnau et al., 2002; Graham and Clark-
Curtiss, 1999; Honer Zu Bentrup et al., 1999; Hou et al., 2002) and was seen to be 
essential for persistence of M. tuberculosis in an in vivo mouse model, as mutants for 
this enzyme were unable to establish a latent infection (Gomez and McKinney, 2004; 
McKinney et al., 2000). When M. tuberculosis enters a low-oxygen-induced state in 
vitro, there is a fourfold induction of ici (Wayne and Lin, 1982), supporting the idea of 
there being a direct relation between persistence and this enzyme. Furthermore, the fact 
that ici was detected in human necrotic granulomas, does not only point out to the 
importance of the ici enzyme in the human disease, but also confirms that the genes 
identified in models of persistence are also important in the human host (Fenhalls et al., 
2002). 
Another protein whose expression is upregulated in oxygen starved M. tuberculosis 
cultures is the 16KDa a-crystallin homolog, which is encoded by acr (also known as 
hspX) and was also seen to be required for intracellular growth in M0 (Cunningham 
and Spreadbury, 1998; Desjardin et al., 2001; Rosenkrands et al., 2002; Yuan et al., 
1996; Yuan et al., 1998). Using the Wayne dormancy model it was observed that in M. 
bovis BCG cultures, induction of hspX was also upregulated (Boon et al., 2001; Lim et 
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al., 1999). However, this upregulation was not specific of a hypoxic response, as it was 
also seen in aerated stationary-phase cultures (Boon et al., 2001; Desjardin et al., 2001). 
There are three classes of a-crystallin genes in mycobacteria: hspX (acrl), acr2 and 
acr3. M. avium possesses genes encoding for one ACR2 and four ACR3 chaperons 
(Stewart et al., 2005; Wilkinson et al, 2005). Even though studies involving hypoxia 
and M. avium have not been documented, the fact that M. tuberculosis acrl was seen to 
be upregulated in hypoxic conditions and its expression contributed to mycobacterial 
persistence suggests a role for these proteins in the adaptation to latency (Muttucumaru 
et al., 2004; Stewart et al., 2005). Taking into account that a-crystallins have a chaperon 
function, they may have a role in enhancing long-term protein stability and hence in 
long-term survival (Yuan et al., 1996). Also, these protein have been associated to cell 
wall thickening (Cunningham and Spreadbury, 1998), so they might be involved in the 
rearrangement of the mycobacterial cell wall. Cell wall rearrangements were observed 
after nutrient starvation in dormant M. avium (Archuleta et al., 2005). 
In hypoxic conditions, it was seen that the hspX induction requires the presence of 
the response regulator Rv3133c (Kendall et al., 2004; Sherman et al., 2001). This 
response regulator has been also termed devR and, due to its importance in the 
induction of genes involved in the adaptation to hypoxia, an environmental condition 
thought to prevail in the granuloma during latent infection, has been recently designated 
DosR for dormancy survival regulator (Boon and Dick, 2002). 
DosR is the response regulator of the two component system DosR/DosS 
(devR/devS or Rc3133c/Rv3132c) and has been implicated in the persistence and 
adaptation to hypoxia of not only M. tuberculosis, but also M. bovis and M. smegmatis 
(Bacon et al., 2004; Malhotra et al., 2004; Mayuri et al., 2002; O'Toole et al., 2003; 
Park et al., 2003; Sherman et al., 2001). In microarray studies, where M. tuberculosis 
was grown under low oxygen conditions, this DosRS two component system was also 
upregulated, along with several genes that have been shown to be regulated by this 
system, such as the aforementioned hspXmà genes involved in nitrogen metabolism, as 
well as genes involved in the biosynthesis of cell wall precursors (Bacon et al., 2004; 
Park et al., 2003; Sherman et al., 2001). 
Taking into account that two-component signal transduction systems are frequently 
involved in the control of adaptive responses by bacteria to changes in the 
environmental conditions (Bijlsma and Groisman, 2003; Stock et al., 2000), it is not 
surprising that such a system would be involved in mycobacterial adaptation to hypoxia. 
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Zahrt and Deretic established a role for one of these types of systems in M. tuberculosis 
virulence and showed that the response regulator Rv0981, termed mycobacterial 
persistence regulator (mprA), was required for the maintenance of a persistent infection 
in the lung (Zahrt and Deretic, 2001; Zahrt et al., 2003). Further studies involving both 
the response regulator mprA and the sensor kinase mprB, supported that the mprAB 
two-component system did have a role in virulence and possibly in persistence (Zahrt et 
al., 2003). 
Sigma factors, subunits of RNA polymerase, are another type of transcription 
factors that have been studied in relation to mycobacterial growth and adaptation. SigF 
is expressed in stationary phase and a mutant M. tuberculosis strain for this factor was 
less able than the WT strain to persist during the later stages of infection (DeMaio et al., 
1996). M. tuberculosis sigH gene was upregulated during macrophagic infection 
(Graham and Clark-Curtiss, 1999), and infection of mice with a AsigH mutant showed a 
reduction in the lung histopathology during the persistent phase, pointing out to a 
possible role of this factor in latency (Kaushal et al., 2002). 
When studying the importance of cyclopropanated mycolic acids, present in the cell 
wall of both M bovis BCG and M. tuberculosis, in virulence and persistence, Glickman 
and co-workers found out that a cyclopropane synthase - pcaA - was required for long-
term persistence and virulence (Glickman et al., 2000). This suggested once again that 
the cell wall was an important factor in persistence. 
Also regarding the cell wall, several surface-associated cell wall proteins are 
encoded by genes belonging to the PE/PPE gene family, and have been associated to 
virulence and persistence (Li et al., 2005; Ramakrishnan et al., 2000). The fact that they 
are involved in surface protein expression infer on their importance on antigen 
presentation and hence interaction with the host cell (Banu et al., 2002; Brennan et al., 
2001; Voskuil et al., 2004). During M0 infection M. avium upregulates genes belonging 
to this family suggesting that they are required for the adaptation to the intracellular 
environment of the host cell and the mutant for one of these genes had less capacity to 
thrive in vivo (Hou et al., 2002; Li et al., 2005). Recently it was shown that a M. 
smegmatis recombinant strain expressing a protein belonging the PE family not only 
showed enhanced survival in primary bone marrow M0 cultures in vitro but was also 
responsible for the observed prolonged persistence in mouse tissues after intraperitoneal 
infection (Dheenadhayalan et al., 2005). The fact that regulation of these genes in M 
tuberculosis is not done as a group, but rather separately, suggests that differential gene 
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regulation could be a means to adapt to the changing environment by creating 
differential antigen display (Voskuil et al., 2004). 
V. 1 - Persistence and nitric oxide 
When M. tuberculosis is exposed to NO-donors, it was seen that the a-crystallin 
homolog protein is induced (Garbe et al., 1999). As DosR is known to be responsible 
for the induction of hspX in hypoxic conditions, it is not surprising that this regulator 
was seen to be induced upon NO exposure. M. tuberculosis subjected to the NO-releaser 
S-nitrosoglutathione (GSNO), had a 50 fold induction on the expression of the DosR 
(Kendall et al., 2004) 
Voskuil and colleagues showed that there was a difference in the gene induction 
when M. tuberculosis was exposed to low (normoxic) or to high concentrations of NO. 
While in the first case the genes induced are the ones described to be induced by 
hypoxia, via DosR, in the second case the genes induced are mostly involved in the 
oxidative stress response (Voskuil et al., 2003). The fact that, in a study where the 
phagosomal environment was the main focus, it was shown that IFN-y activated BMM0 
infected with M. tuberculosis induced the hypoxia/dormancy-related genes in a NO-
dependent manner (Schnappinger et al, 2003), further support a role for NO in 
adaptation to chronicity. Moreover, the fact that genes associated to adaptation to the 
latent phase of infection can be induced by NO suggests that the metabolic change 
observed during that phase may involve NO and RNI. 
Importantly, some of the genes known to be induced upon hypoxia are related to 
nitrogen metabolism. For example, induction of M. tuberculosis genes such as narX 
and narK2, whose gene products are a fused nitrate reductase and a nitrite extrusion 
protein respectively, was shown to be dependent on DosR (Bacon et al., 2004; Florczyk 
et al., 2003; Kendall et al., 2004; Muttucumaru et al., 2004; O'Toole et al., 2003; Park et 
al., 2003; Purkayastha et al., 2002). acg, a gene encoding for a putative nitroreductase, 
whose function may involve detoxification by reducing nitroaromatic compounds 
within granulomas, was also seen to be upregulated upon hypoxia in a DosR dependent 
manner (Florczyk et al., 2003; Kendall et al., 2004; Purkayastha et al., 2002). When 
exposed to RNI, M. tuberculosis upregulated the expression of DosR, as well as hspX, 
narK2, narX and acg (Ohno et al., 2003). 
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Wayne and Hayes, after developing their low-oxygen induction latency model 
(Wayne model) went on to look at the metabolic changes that could be seen with respect 
to the adaptation of mycobacteria to the persistent state achieved and showed that nitrate 
reduction was increased (Wayne and Hayes, 1998). Hence, nitrate reductases seem to be 
of extreme importance in the adaptation to a hypoxic environment, and most likely in 
the latent stage of mycobacterial infection. Even though narX, which encodes a putative 
fused nitrate reductase, has been described to be induced by hypoxia in both M bovis 
BCG and M. tuberculosis (Hutter and Dick, 1999; Sherman et al., 2001), its significance 
in vivo has not been approached. 
The sequencing of the genome of M. tuberculosis showed that narKl, which 
encodes a nitrite extrusion protein, and narX are oriented in the same direction and 
partially overlap (Cole et al., 1998), suggesting that their expression might be co-
ordinated. With the intent of studying this relation better in M. bovis BCG, Hutter and 
Dick, described a promoter, localized upstream of the narKl coding sequence that is 
weakly active in aerobic conditions whereas it appears to be upregulated in hypoxia 
(Hutter and Dick, 2000). Further, they suggest that not only does the promoter induction 
occur during entry into dormancy, but also that nitrate or nitrite might be needed for this 
induction. 
Weber and co-workers have reported that BCG also expresses narGHJI, a nitrate 
reductase encoded by four genes, clustered together in an operon, where narG, H and I 
are subunits of nitrate reductase, narG the catalytic subunit of the complex, and narJ is 
required for the assembly of the enzyme (Moreno-Vivian et al., 1999; Weber et al., 
2000) A narG M. bovis BCG mutant was less virulent in the mouse, suggesting that 
nitrate respiration might be important for virulence (Weber et al., 2000). Furthermore it 
was shown that narG was essential for M. bovis BCG persistence in lungs, livers and 
kidneys of infected mice (Fritz et al., 2002). 
M. tuberculosis has an narGHJI locus, capable of nitrate reduction activity when 
cloned into M. smegmatis (Cole et al., 1998; Weber et al., 2000). Studies using the 
Wayne latency model showed that nitrate reduction in M. tuberculosis is due to 
narGHJI and not to narX (Sohaskey and Wayne, 2003). However, even though hypoxia 
increased nitrate reductase activity, it did not induce narGHJI, whereas it induced both 
the narX and narKl. Upon hypoxia, narK2 is a major factor in the regulation of nitrate 
reductase and controls the transport of nitrate into the cell and nitrite out of the cell. 
(Sohaskey and Wayne, 2003). 
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Even though the studies done in vitro indicate that NO and RNI seem important in 
the establishment of latency, these studies were done with the assumption that certain 
conditions, such as hypoxia and the presence of RNI, are present in the granuloma 
environment. With the need to better describe and understand the mechanisms 
underlying the persistence phenomena, studies done in in vivo models of latency were 
needed. The ones that are more commonly used are the low dose model and the 
Cornell/drug induced model. In the first case, it was seen that infection with a low dose 
inocula, in the 102 CFU range, lead to the establishment of a chronic infection, where 
the bacillary burden remained steady, and where reactivation spontaneously occurred 
after as much as 18 months after infection (Orme, 1988). In the second model, the 
infected mice are treated with antimycobacterial drugs in such a way that clearance is 
achieved as determined by lack of viable bacilli found in the target organs. However, as 
in the case of the low dose model, reactivation occurs after several months and also after 
the administration of an immunosupressant (McCune et al., 1966; Scanga et al., 1999). 
Using the low dose aerosol model, Voskuil and co-workers saw that the 
NO/dormancy/hypoxia induced gene response was detected during the persistent 
infection (Voskuil et al., 2003), suggesting that the in vitro determinations were, indeed, 
also observed in the host's infection context. Shi and co-workers showed that at the 
onset of an adaptive, protective Thl immune response there was an induction of the 
same type of genes induced in Wayne's in vitro model of adaptation to low O2 tension, 
and showed that some of these genes saw their expression delayed in IFN-y -KO mice, 
where no iNOS expression was detected. The fact that there was a delay in that 
expression and not an inhibition of it was justified by the possible presence of NO 
generated by eNOS and/or the presence of hypoxic areas within the lung - the target 
organ analysed (Shi et al., 2003). 
The use of aminoguanidine, which prevents the production of RNI, in latency 
models has been documented to be responsible for reactivation (Botha and Ryffel, 2002; 
Flynn et al., 1998). Other reactivation studies have focused on the importance of TNF in 
the maintenance of the latent stage of infection. (Botha and Ryffel, 2003; Mohan et al., 
2001; Roach et al., 2002). In one such study, a low i.v. dose was used to infect the 
animals and an anti-TNF monoclonal antibody (mAb) treatment was given 6 to 8 
months after infection. Such a treatment resulted in reactivation and iNOS expression 
was inhibited in the treated mice as compared with the control animals, which had a 
chronic infection. Again there was an in vivo observation that associated RNI 
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production with latency (Mohan et al., 2001). Taking into account the fact that IL-10, a 
Th2 type cytokine, reduces antimicrobial functions of activated M0, including 
decreasing NO production (Bogdan et al., 1991; Gazzinelli et al., 1992; Moore et al., 
2001), it is feasible that that cytokine may have a role in latency and reactivation. In a 
study where the highlight is the relationship between IL-10 production and reactivation 
in pulmonary tuberculosis in mice, it was seen that reactivation-prone mice - CBA/J -
had higher IL-10 production than reactivation-resistant C57BL/6 mice. Furthermore, 
transgenic C57BL/6 mice overexpressing IL-10, showed a similar pattern of bacterial 
growth to CBA/J mice where, at later stages of infection, recrudescence is observed 
(Turner et al., 2002). Feng and co-workers, using also a transgenic mouse that expressed 
human IL-10 under MHC II control, showed than in the case of M. avium infection the 
transgenic mice had higher bacterial loads and died around the fourth month of infection 
while control mice stabilized the infection. Of note was the fact that the transgenic mice 
had a significant decrease in NO expression and had also increased hepatic fibrosis 
(Feng et al., 2002). In another study, where the receptor for IL-10 (IL-10R) was blocked 
by mAb treatment, RNI expression was enhanced in mice where the treatment was 
done, as measured by the capacity of peritoneal M0 to produce RNI upon antigenic 
exposure (Silva et al., 2001b), but the bacterial loads present in their organs were 
different. 
The data described above supports the link between RNI and latency and, hence, the 
induction of dormancy-related genes predicted by the in vitro studies. However this link 
was not exclusive, and both RNI-dependent and independent mechanisms were 
suggested as being responsible for preventing reactivation of disease (Flynn et al., 1998; 
Scanga et al., 2000). Flynn and co-workers observed that RNI inhibition was 
responsible for reactivation in a low dose model but not in a drug-induced model of 
latency (Flynn et al., 1998). Even though the last model is technically difficult and was 
shown to be unpredictable for studies involving the immunologic basis of latency and 
reactivation (Scanga et al., 1999), the fact is that Scanga and colleagues, using the low 
dose model, identified CD4+ T cells as critical for the maintenance of a latent infection, 
and showed that, in animals depleted of that T cell subset, iNOS activity was still 
observed, while reactivation occurred (Scanga et al., 2000). 
So in mycobacterial latency NO seems to have a very important role, even though it 
shares the latency induction and maintenance responsibility with several other factors 
such as hypoxia and possibly nutrient starvation. 
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The overall purpose of this study was to try to unravel the interplay between 
Mycobacterium avium and nitric oxide production. In order to address this issue, the 
aims of this thesis were as follows: 
• Study the in vivo effect of the nitric oxide (NO) and reactive nitrogen 
intermediates (RNI) production in M. avium growth. To analyse it, the 
growth pattern of M. avium in mice genetically deficient in the inducible 
nitric oxide synthase gene (iNOS_/), was evaluated with a greater number of 
strains than those done in former studies. Furthermore the creation of a 
mutant library of one of the strains that showed an improved clearance in the 
iNOS ~~ host was set as an aim in order to obtain a mutant incapable of 
metabolising nitrate, one of the RNI produced. 
• Determine which gene was affected in each of the mutants that showed to be 
incapable of metabolising nitrate, and study their pattern of growth both in 
vivo and in vitro. 
• Evaluate the effect of the lack of an NO-generating system in the absence of 
an intact immune system. For that purpose, mice that were both deficient for 
iNOS and the recombination-activating gene 2 (rag2) were obtained and the 
growth of M. avium analysed. 
• Evaluate the susceptibility of M avium to RNI. 
• Evaluate the effect of NO on fibrosis. Given that NO affects granuloma 
formation and granulomas are central to anti-mycobacterial resistance we 
aimed at analysing one previously unstudied aspect, that of granuloma 
fibrosis. For that purpose, the collagen deposition in granulomas both in the 
immunocompetent and the iNOS A host, will be analysed, in the case of an 
infection with two strains of different virulence. In order to be able to do that 
quantification there was a need to develop an image analysis program to be 
used in an Acquired Computerized Image Analysis system in order to 
quantify the collagen content in tissue sections. 
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Abstract 
Mycobacterium avium killing does not depend on the production of nitric oxide. In this 
study we evaluated if it was the bacteria themselves that were resistant to the reactive 
nitrogen intermediates (RNI) known to be responsible for the bacterial killing. A panel 
of M. avium strains was therefore tested for their susceptibility to RNI in a cell-free 
system, where RNI was generated by the acidification of nitrite containing media. 
Mycobacteria were subjected for a period of 10 days to different NaN02 concentrations 
ranging from O.lmM to lOmM, at pH 6.5, 5.5 and 4.5. It was observed that the different 
strains had different susceptibilities to RNI, but all were more resistant to RNI than M. 
tuberculosis. Susceptibility to NO released in a controlled manner was also assessed. In 
that case, strains were exposed to a NO-donor, at concentrations ranging from 0.0 ImM 
to 2mM. Once again, M. avium was more resistant than M. tuberculosis. The M. avium 
strains tested did not show a correlation between RNI resistance and virulence. It was 
also seen that M. avium was quite resistant to low pH, a characteristic that has been 
previously described. The capacity M. avium has to survive in the presence of RNI and 
the fact that in previous studies mice deficient for the inducible nitric oxide synthase 
(iNOS) showed an improved clearance of these mycobacteria suggests that they have 
adapted to survive after an immune response has been mounted and also seem to depend 
on the presence of NO to survive within the host. 
SI 
Susceptibility of M. avium to RNS 
Introduction 
Mycobacterium avium is an intracellular pathogen that infects mononuclear 
phagocytes. M. avium growth in immunocompetent mice will vary depending on the 
virulence of the strain used (Pedrosa et al., 1994), and even though activated 
macrophages can restrict mycobacterial growth (Appelberg et al, 1994; Appelberg and 
Orme, 1993), virulent strains can overcome the immune response mounted and kill the 
host. Activated macrophages use reactive species, such as reactive oxygen intermediates 
(ROI) and reactive nitrogen intermediates (RNI) to kill pathogens. With respect to ROI, 
it was seen that M. avium killing did not depend on their production (Gomes and 
Appelberg, 2002; Sarmento and Appelberg, 1996). 
As far as RNI are concerned, their induction was seen after activated macrophages 
were infected by M. avium (Appelberg and Orme, 1993; Doherty and Sher, 1997; Doi et 
al., 1993).When mice were infected with virulent strains, highly activated macrophages 
were present and RNI secretion ex vivo was seen. (Florido et al., 1999). Also, the 
inducible nitric oxide synthase (iNOS) expression was detected in the infected organs, 
in the same macrophages that harbour the mycobacteria. Several studies using nitric 
oxide inhibitors suggest that RNI has, if any, a minor role in M. avium control by 
activated macrophages (Appelberg, 1994; Appelberg and Orme, 1993; Sano et al., 2002; 
Tomioka et al., 1997) 
Importantly, it has been previously described that, unlike M. tuberculosis, where the 
iNOS locus was identified as a protective one towards this infection (MacMicking et al., 
1997), M. avium does not have an exacerbated growth in INOS-KO mice (Doherty and 
Sher, 1997; Ehlers et al., 1999b; Gomes et al., 1999b), indicating once again, that RNI 
production was not responsible for the control of M avium growth. In fact, certain 
strains not only do not grow better in the absence of NO but also see their growth 
inhibited in such conditions (Gomes et al, 1999b). 
Chemical NO production can be achieved by acidification of nitrite and by exposing 
mycobacteria to such conditions, susceptibility to RNI can be determined (Doi et al., 
1993; Rhoades and Orme, 1997; Stuehr and Nathan, 1989). In the case of M 
tuberculosis, Chang and colleagues, using this type of approach, first saw a direct 
inhibition of mycobacterial growth due to RNI (Chan et al., 1992). Another study 
showed that susceptibility to the same RNI differed among strains of M. tuberculosis 
and that resistance to RNI could be correlated to virulence in the guinea pig model 
(O'Brien et al., 1994). However, the fact that the RNI susceptibility was determined 
82 
based on a 24h exposure to the acidified nitrite, seems a very short time frame in the 
case of a bacterium whose doubling time within macrophages is 2.2 days (Gomes et al., 
1999c). A more thorough study involving M. tuberculosis and longer incubation times 
showed that susceptibility to RNI varied among different strains and a higher resistance 
to RNI was not related to virulence (Rhoades and Orme, 1997). In the case of M avium 
some authors stated that it was more sensitive to RNI killing than M. intracellulare (Doi 
et al., 1993), while others showed the opposite (Tomioka et al., 1997). However in these 
studies few strains were analysed, and in each case different strains were used. 
While the growth of M. tuberculosis is exacerbated in iNOS-KO mice as compared 
to normal B6 mice (MacMicking et al., 1997) the absence of a functional iNOS does not 
lead to increased growth of M avium (Doherty and Sher, 1997; Ehlers et al., 1999b; 
Gomes et al., 1999b; Lousada and Appelberg, 2004). This led us to question if M.avium 
is more resistant to RNI than M. tuberculosis. Would that be the case, another 
interesting question to address is if there is a correlation between virulence of the strain 
and its resistance to RNI. 
In the current study 9 different strains of M. avium, with different virulence levels, 
were tested for their susceptibility to RNI produced by acidification of nitrite. It was 
seen that all had a higher threshold for RNI resistance when compared to M 
tuberculosis. Susceptibility to RNI was not related, as seen in the case of M 
tuberculosis strains, to the virulence of the strain. However, one of the more virulent 
strains had a much higher capacity to grow in the presence of RNI when compared with 
the others suggesting that such resistance might contribute to the overall capacity of 
virulent strains to thrive in the immunocompetent host. 
Assays using an NO-releasing compound were also performed. NO donors are 
pharmacologically active substances that, in vivo or in vitro, release NO. In the case of 
NOC-18, the NO-donor used in this study, it is a stable NO-amine complex that can 
release NO spontaneously in solution under physiological conditions without the need 
for a cofactor (Hrabie and Klose, 1993; Seccia et al., 1996; Shibuta et al., 1995; 
Shimaoka et al., 1995; Yamamoto and Bing, 2000). By using this compound 
mycobacteria were exposed to NO in controlled manner. Again M. avium could 
withstand better the presence of NO when compared with M. tuberculosis. 
Taken together, these data clearly state that M. avium has a better capacity than M 
tuberculosis to overcome the RNI production by the immune response to infection. 
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Materials and methods 
Bacteria 
Mycobacterium avium strain 25291, exhibiting a smooth transparent morphotype (SmT) 
was obtained from the American Type Culture Collection (Manassas,VA). Strains 2-
151 SmT and 2-151 exhibiting an opaque morphotype (Op) were obtained from Dr I. 
Orme (Colorado State University, Colorado, USA). Strains 2447 SmT and 1983 SmT 
were given to us by Dr F. Portaels (Institute of Tropical Medicine, Antwerp, Belgium). 
Table 1 describes the characteristics of the different strains used, with respect to the in 
vivo virulence and the origin of each strain which has been reported previously (Pedrosa 
et al., 1994). M. tuberculosis H37Rv was kindly provided by Dr Peter Andersen 
(Statens Serum Institut, Copenhagen, Denmark). M. avium strains were grown in 
Middlebrook 7H9 medium containing 0.04% of Tween 80 at 37°C until the mid-log 
phase of growth. Bacteria were centrifuged and resuspended in a small volume of saline 
containing 0.04% of Tween 80. The suspension was then sonicated at low power (40 
W) in a Branson sonifier so that bacterial clumps would be disrupted. After dilution, 
aliquots were made and stored at -70°C until use. Before use, bacterial aliquots were 
thawed at 37°C and diluted in saline to the desired final concentration. In the case of M 
tuberculosis, it was grown in 7H9 broth supplemented with oleic acid-albumin dextrose 
(OAD) enrichment at 37°C until the mid-log phase of growth and used afterwards as the 
initial inoculum. 
Media and reagents 
For experiments with M. avium strains Middlebrook 7H9 broth (Difco Laboratories, 
Detroit, MI) supplemented with albumin dextrose (AD) was used, while in the case of 
the more fastidious M. tuberculosis the supplement used was the OADC. NOC-18 was 
obtained commercially (Calbiochem®). 
Mycobacterial nitrite tolerance assay 
7H9 broth was acidified to pH 4.5, 5.5 or 6.5 by the addition of IN HC1 and filter 
sterilized. A solution of sodium nitrite 1M was done and filter sterilized. This was used 
to add to the media so that final concentrations of 0.1, 1, 5 and 10 mM were obtained. 
For control of bacterial growth there were cultures with no added nitrite. The protocol 
used was adapted from another one described elsewhere (Rhoades and Orme, 1997). 
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Volumes of lmL were used and 50uL of a bacterial suspension, containing 
approximately 105 bacilli, were added to each millilitre. All assays were done in 
triplicate and in some cases repeated once. In the case of M tuberculosis, the modified 
media were added to sterile, capped, tall glass tubes while in the case of M. avium the 
assay was performed in 24 well plates. The cultures were incubated at 37°C and agitated 
daily and serial dilutions were plated onto Middlebrook 7H10 agar at the indicated days 
after infection and counted as described bellow. 
NO controlled release assay 
M. avium 25291, 2447 and 1983 as well as M tuberculosis H37Rv were used for this 
assay. Bacteria were initially diluted so that the initial concentration would be 
approximately 105 CFU/mL. Volumes of 200uL were used and 10 uT of NOC-18 was 
added every third day in such a way that the final total concentration would be 0.01, 
0.03, 0.1, 0.5 and 2mM. NOC-18 was reconstituted in PBS, pH 7.4, diluted to the final 
concentration and filter sterilized before each addition. For control of bacterial growth 
there were cultures with no added NOC-18. All assays were done in triplicate. The 
cultures were incubated at 37°C and serial dilutions were plated onto Middlebrook 7H10 
agar at the indicated days after infection and counted as described bellow. Assays 
involving M avium had the duration of 9 days, being the NOC-18 compound added at 
times zero, 3 and 6 days. The assays with M. tuberculosis had the duration of 15 days, 
and the compound was added at times zero, 3, 6, 9 and 12 days. 
Bacterial quantification 
At each time point, serial dilutions were made using H2O containing 0.05% of Tween 
80. In the case of the M. avium cultures, each mL was sonicated at low power (40 W) 
with a Branson sonifier before being diluted to ensure the dispersion of the bacilli. After 
incubation at 37°C, colonies appeared after 2 to 3 weeks in the case of M avium, and 
after 3 to 4 weeks in the case of M tuberculosis. They were counted and the logio viable 
bacilli per millilitre was determined. In both cases, the plates were left for a longer time 
after being counted as some delayed growth sometimes occurred. 
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MIC and MBC determination 
The minimum inhibitory concentration (MIC) is the concentration required for the 
growth rate to be nil. In the case of the acidified nitrite assay, it was calculated by 
determining the concentration of added NaNÛ2 needed to generate a growth curve with 
an average slope of zero over the course of 10 days at pH 6.5 and pH 5.5. For the NO 
controlled release assay, it was determined as the concentration of added NOC-18 
needed to generate such a curve over the course of 9 days in the case of M. avium. For 
M tuberculosis the determination was done after 9 and 15 days of growth. The 
minimum bactericidal concentration (MBC) is the concentration required for the 
reduction of 99.9% of the initial inoculum. For the acidified nitrite assay it was 
determined over a period of 10 days of incubation at pH 6.5 or 5.5. In the case of the 
NOC-18 assay, determinations were done over a period of 9 days for both M. avium and 
M. tuberculosis, and an additional one for M. tuberculosis at day 15. 
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Results 
Nitrite tolerance ofM. avium in 7H9 broth 
Mycobacteria were subjected to different concentrations of nitrite in acidified 7H9 
broth, over a period of 10 days. In these conditions, nitric oxide is formed (Stuehr and 
Nathan, 1989). Typical growth curves are depicted in figures la and lb for two strains 
of M avium. M. avium 25291 was an exception as it exhibited a slightly different type 
of growth curve, especially with respect to the higher concentrations of nitrite (fig. lc), 
suggesting a higher resistance to NO. There was some variability in the susceptibility to 
acidified nitrite of the 10 strains tested (table 2). MIC values at pH 6.5 ranged from 4.93 
± 2.14 to 13.16 ± 4.80 mM for 8 out of the 9 strains tested. The highly virulent strain 
25291 had a higher MIC value of 23.92 ± 0.97 mM. MIC values at pH 5.5 were lower, 
ranging from 0.45 ± 0.20 to 4.96 ± 0.97. 
With respect to MBC values, there was less variability but, again, strain 25291 had a 
higher value than the other strains when the MBC was determined at pH 6.5 (table 2). 
At the lower pH of 5.5 the MBC values for all strains were lower than the ones at pH 
6.5 and ranged from 3.39 ± 0.21 to 9.31 ± 2.06. 
Differences of MIC and MBC were not due to differences of growth as all bacteria 
grew in the same fashion. Also, changes in the pH never varied more than 0.3 pH units, 
and therefore did not interfere with determined MIC and MBC values. 
NO tolerance ofM. avium in 7H9 broth 
When M. avium was exposed to NO in a controlled manner by the NOC-18 
compound, growth was only inhibited when the highest concentration (2 mM) was 
being used (figure 2). In the case of strain 25291 (figure 2a) it is quite clear that only a 
high concentration of NO exposure can affect its survival. When the added 
concentrations of NOC-18 ranged from 0.01 to 0.5 mM, bacterial growth was just little 
or not affected when compared with the control. In the case of strains 2447 (figure 2b) 
and 1983 (figure 2c), their growth was greatly impaired when 0.5 mM NOC-18 or 2 
mM NOC-18 was added, respectively. However, MIC and MBC values of these three 
strains were similar (table 3). Of note is the fact that M. avium 25291 had actually a 
small increase in its growth for the lower concentrations of the compound, and M. 
avium 1983 also saw its growth slightly increased when 0.01 mM of compound was 
added. 
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Nitrite tolerance ofM. tuberculosis in 7H9 broth 
M. tuberculosis growth under acidified nitrite conditions was as shown in figure 3. 
The type of kinetics was similar to the one described by Rhoades and colleagues, and 
the values obtained for the MIC at pH 6.5 and the MBC values at pH 6.5 and 5.5 were 
also in accordance with that study (Rhoades and Orme, 1997). M. tuberculosis exhibited 
lower values of MIC and MBC than M. avium (table 2), and in the case of the MIC 
determination for pH 5.5, it was not possible to determine as the effect of the pH by 
itself was enough to affect the mycobacterial growth (figure 3, when no nitrite was 
added ). 
NO tolerance ofM. tuberculosis in 7H9 broth 
When M. tuberculosis was exposed to NO in a controlled manner by the NOC-18 
compound, growth was below the detection level after 9 days of incubation when the 
highest concentration (2 mM) was being used (figure 4). When the concentration used 
was 0.5 mM, there was approximately a 5 log decrease in the bacterial growth after 15 
days of incubation. MIC and MBC values observed were 0.3Í mM and 
0.60 mM of added NOC-18 respectively. 
Mycobacterial growth in acidified conditions 
With respect to the ability of bacteria to grow in an acidic environment (controls in 
figures 1 and 2), it was observed that M. avium and M. tuberculosis differed in the 
capacity to survive in such conditions. When the pH was 4.5, M. avium had a decrease 
of up to 1 log, whereas in the case of M. tuberculosis CFU numbers were below the 
detectable level as early as the fourth day of incubation, i.e. the decrease in viability was 
greater than 3 logs in four days. 
All mycobacteria grew well at pH 6.5 during the 10 day period. M. avium had log 
increases normally ranging from 3.62 to 4.82 log CFU/mL, while the M. tuberculosis 
strain tested here had a log increase of only 2.03 log CFU/mL, illustrating its slower 
growth rate. 
While in the case of M. tuberculosis there was a detrimental effect on the bacterial 
survival when the pH was lowered to 5.5 (figure 3), that effect was not seen in the case 
ofM avium (figure 1). 
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Discussion 
Previous studies using M. avium strains, where the susceptibility to acidified nitrite 
was analysed, were poor in information (Doi et al., 1993; Tomioka et al., 1997). These 
studies were done using a time frame of only 24 hours and few strains were analyzed. 
Information on MIC and MBC values lacked, as growth rates were not determined for a 
longer period of time. Also, by using different assays, the reports preclude a comparison 
between the relative resistance to RNI of M. avium and M. tuberculosis. This latter 
information is pertinent to understand why growth of M. avium is not affected or indeed 
is lower in vivo in the absence of a functional iNOS whereas such deficiency 
exacerbates the growth of M tuberculosis (Gomes et al., 1999b; MacMicking et al., 
1997; Rhoades and Orme, 1997). 
In this report, resistance to RNI exposure was assessed during 10 days of culture, 
and compared between 9 different M. avium strains, differing in virulence and origin. 
Resistance to RNI exposure was also analysed for M. tuberculosis H37Rv to compare 
the resistance to RNI in the two species. The assay we adopted was the one Rhoades 
and Orme used so that we might compare their data on several M. tuberculosis straips 
(Rhoades and Orme, 1997) with our own data. This is, in our view, legitimate as the 
values determined here for M. tuberculosis H37Rv were similar to the ones obtained in 
that study. MIC values at the pH 6.5 for the M. tuberculosis strains tested ranged from 
1.64 ± 0.08 to 4.40 ± 0.33 mM and our own data for strain H37Rv was within that range 
(3.72 mM). MIC values at that pH for M. avium strains determined here were higher 
and varied from 4.93 ± 2.14 to 23.92 ± 0.97 mM. MBC values were also higher for M 
avium than for M. tuberculosis, and as in the case of the latter, values of MBC were 
lower when the pH of the growth media was lowered from 6.5 to 5.5, but still much 
higher than the values observed for M. tuberculosis. 
The above data gives us information regarding the susceptibility of mycobacteria to 
two factors acting simultaneously, NO plus low pH. In order to analyse the 
susceptibility to NO in neutral pH, an NO-donor - NOC-18 -was used, and the effect of 
its controlled NO release was assessed. There was also a difference in the capacity to 
survive in the presence of NO by this type of exposure. MIC and MBC values for M 
avium were once again higher than the values observed for M. tuberculosis. Whereas M 
tuberculosis only needed 0.38 mM of added NOC-18 to see its growth inhibited, M 
avium needed a higher concentration of 1.98 ± 0.81 mM of NOC-18. Of note is the fact 
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that strain 25291, when in the presence of 0.01 mM to 0.1 mM of added NOC-18 could 
grow better than in the absence of the compound. 
Overall, our data show that M. avium is more resistant to NO than M. tuberculosis. 
Some authors have suggested that the action of NO as a suppressor of the immune 
response, namely of T cell function and interferon-gamma (IFN-y) production, was, at 
least in part, responsible for the difference observed in the iNOS-KO mice and wild-
type (WT) controls, where the former can restrict the M. avium growth better than the 
latter (Doherty and Sher, 1997; Gomes et al., 1999b). More recently, Flórido and 
colleagues reported that while lymphopenia associated to infection with the highly 
virulent strain M. avium 25291 was abolished in IFN-y deficient mice, the same did not 
hold true when iNOS-KO mice were studied (Florido et al., 2005). 
As seen in the case of M. tuberculosis (Rhoades and Orme, 1997), the panel of M. 
avium strains tested have different susceptibilities towards RNI but different 
susceptibilities did not correlate with the virulence of the strain. It thus appears that 
beyond a certain threshold of resistance to RNI which may determine the differences 
already discussed between M. avium and M. tuberculosis, other virulence determinants 
are responsible for the different in vivo growth patterns of M avium. This threshold 
may coincide with the concentrations of NO achieved inside the phagosomes of 
activated macrophages. 
Several authors have reported some data concerning the NO release, as measured by 
the presence of NO2", in activated macrophages and after their subsequent infection with 
mycobacterium. Flesch and Kaufman reported that lxl05 IFN-y stimulated murine 
macrophages could release 10.3 nmol of NO in 96h after infection (Flesch and 
Kaufmann, 1991), while Doi and colleagues found that 2.5xl05 murine macrophages 
treated in the same fashion could release as much as 27.92 nmol of NO in 72h (Doi et 
al., 1993). Chan and co-workers, using IFN-y activated peritoneal murine macrophages, 
reported that 2xl05 cells could release 202.4 nmol of NO 48h after infection (Chan et 
al., 1992). 
Nitrite acidification was seen to release, after 24h, and when the pH was 5.0, 101.04 
nmol NO per millilitre when the sodium nitrite concentration was 5mM, and 465.6 nmol 
when the concentration was lOmM (Doi et al., 1993). Even though that type of 
quantification was not done in this study, one could assume that, at pH 5.5, only the 
concentration of lOmM of sodium nitrite would release NO quantities that were outside 
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the range of the macrophagic production. With respect to the release of NO by NOC-18, 
a clear correlation was established by Shimaoka and co-workers (Shimaoka et al., 1995) 
that enabled us to determine that the NO released in 24h in our experiment ranged from 
1.38 nmol to 276.48 nmol. Once again, the higher concentration might be the one that is 
not observed in a physiological environment. 
As M. avium was seen to be resistant even when the higher concentrations of both 
sodium nitrite and NOC-18 were present, it would indeed seem that NO production by 
activated macrophages during the immune response would not be able to restrain 
mycobacterial growth. 
The fact that M. avium is more resistant to low pH values than M tuberculosis is 
also in agreement with other studies. When mycobacteria infected macrophages were 
co-infected with Coxiella burnetii, the acidic vacuole containing the latter fused with 
the vacuole containing the former, hence subjecting the mycobacteria to a lower pH 
(Gomes et al., 1999c). While in the case of M tuberculosis this fusion resulted in an 
inhibition of the bacterial growth, M. avium was not affected, and these bacteria grew 
equally well in co-infected cells, and therefore in an acidic environment. Also, the fact 
that M. avium can enter the organism through the digestive tract suggests that it has a 
high resistance to an acidic condition. Indeed, studies done with M avium grown in 
such conditions showed that these mycobacteria were naturally tolerant to pH < 3 
(Bodmer et al., 2000). 
All the data presented here could partly be responsible for the differences observed 
in the in vivo infection of iNOS-KO mice, where M. tuberculosis thrives while M. 
avium does not, indicating once again that NO production has a major role in the anti M. 
tuberculosis capacity of immunocompetent mice. However, it does not explain why, in 
the absence of NO production, there is more M. avium clearance than in its presence 
(Gomes et al., 1999b). 
The fact that one of the highly virulent strain - 25291 - is much more resistant to 
RNI than the other strains tested and actually seems to grow better when small amounts 
of NO, ranging from 1.38 to 13.82 nmol per day, are present, may explain the 
previously referred observation in iNOS-KO mice. 
Taken together, it would seem that M. avium has adapted itself to being able to 
thrive after an immune response has been mounted and points out to an actual 
dependence of mycobacteria on the production of NO for its survival within the host. 
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Tables 
TABLE 1 - description of the M. avium strains used 
Strain Virulence Origin 
25291 High Chicken 
2447 Medium AIDS patients - bone marrow 
1983 Low Non-AIDS humans 
8637 High Armadillo 
M520 Low Pig 
2606 High Armadillo 
2-151 SmT High/medium AIDS patients - unknown origin 
2-151 Op Medium AIDS patients - unknown origin 
PE9 High Wild birds 
2-29 low/medium AIDS patients - unknown origin 
TABLE 2 - Nitrite tolerance of 9 M. avium strains and M. tuberculosis H37Rv 
MIC (mM) MBC (mM) 
Strains pH6.5 pH5.5 pH6.5 pH5.5 
25291 23.92 ± 0.97 4.03 ±0.81 35.30 ±1.06 7.63 ±0.11 
2447 4.93 ±2.14 2.55 ±1.14 22.35 ± 6.74 6.85 ±1.63 
1983 5.59 ±5.50 4.96 ± 0.97 19.18 ±13.71 8.40 ± 0.93 
M520 11.58 ±1.63 2.78 ± 1.50 22.43 ± 3.51 7.59 ± 0.37 
2-151 SmT 9.77 ±2.08 3.90 ± 0.34 22.19 ±4.83 7.85 ± 0.90 
2-151 Op 7.70 ±1.35 1.98 ±1.85 22.80 ±1.51 9.31 ±2.06 
PE9 13.16 ±4.80 0.66 ± 0.35 19.61 ±6.97 6.22 ± 3.84 
8637 5.25 ±1.73 1.15 ±0.83 13.61 ±2.58 3.41 ±0.50 
2606 12.85 ±2.61 0.45 ± 0.20 18.84 ±3.76 3.39 ±0.21 
H37Rv 3.72 7.88 0.49 
a MIC values indicate the concentration of sodium nitrite required to prevent growth at pH 6.5 and 
5.5 of the original inoculum for a period of 10 days; b MBC values indicate the concentration of 
sodium nitrite required to kill 99.9% of the original inoculum for a period of 10 days. M. avium 
strains were tested three times and M. tuberculosis once. 
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TABLE 3 - NO tolerance of M. avium 
25291, 2447 and 1983, and M. 
tuberculosis H37Rv  
MICa MBCb 
S t r a i n s (mM) (mM) 
25291 2.51 ±1.26 3.95 ±1.84 
2447 1.75 ±0.24 2.75 ±0.18 
1983 1.40 2.24 
H37Rv 0.38 0.60 
a MIC values indicate the concentration of 
added NOC-18 required to prevent growth of 
the original inoculum for a period of 9 days; 
b MBC values indicate the concentration of 
added NOC-18 required to kill 99.9% of the 
original inoculum for the same period 
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Fig.l ­ M. avium was incubated under different conditions for over a period of 10 days. 
Middlebrock 7H9 broth was acidified to the indicated values of pH, and final nitrite 
concentrations were obtained after the addition of NaN02. The majority of the strains tested had 
a similar growth pattern as the ones observed in a (M. avium 8637) and b (M. avium M520); c ­
M. avium 25291 growth under the different conditions. The limit of detection used was 2 logs 
CFU/mL. Each value represents the means of three counts ± SD. All strains were tested three 
times, and the growth curves shown here are representative of the 3 experiments. 
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Figure 2 - Bacterial growth for 10 days in the presence of different concentrations of a NO-
donor (NOC-18); concentrations refer to the added concentration of NOC-18 every third day; 
a) M. avium 2529 l;b) M. avium 2447; c) M. avium 1983; each value represents the means of 
three counts ± SD; a and b are representative of two different experiments. 
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Figure 3 - M. tuberculosis was incubated under acidified nitrite conditions and its growth was 
followed over the course of 10 days. Final nitrite concentrations were obtained after the addition 
of NaN02 to the broth. The limit of detection (L.D.) used was 1 log CFU/mL. Each value 
represents the means of three counts ± SD. 
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Abstract 
The growth of a panel of strains of Mycobacterium avium was followed in mice 
genetically deficient in the inducible NO synthase gene (iNOS"/_). Contrary to what has 
been described for other mycobacterial species, there was no exacerbation in the iNOS" " 
host. Some of the strains analysed showed an improved clearance when in the absence 
of iNOS, which was not related to their virulence. A group of mice was treated for 20 
days with iron-dextran and infected with M. avium 25291, one of the strains that 
exhibited that clearance. While C57BL/6 control mice with iron overload showed 
increased mycobacterial growth as compared with untreated mice, in the case of the 
iNOS ~~ host such a difference was not observed. That same strain was used to make a 
mutant library using insertional mutagenesis, and mutants incapable of metabolising 
nitrate were selected for further studies. A narG mutant was seen to grow well in bone 
marrow-derived macrophages but not as well when used to infect C57BL/6 mice, 
suggesting that the reductase is needed for the adaptation to the immune response 
mounted by the organism. Studies using mice that were deficient in both iNOS as well 
as rag2 suggest that it is not only the capacity to use RNI that dictates the outcome of 
the disease, but also the presence of a protective immune response conferred by T cells. 
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Introduction 
Mycobacterium avium is a non-tuberculous mycobacterium that has gained some 
relevance due to the fact that it is one of the major opportunists in AIDS patients (Berlin 
et al., 1984; CDC, 1987; CDC, 1988). Being an intracellular pathogen that infects 
macrophages, and taking into account that these cells are known for their antimicrobial 
activity, some studies have been done which focus on the interplay between the bacteria 
and the macrophages activity. It was seen that activated macrophages could restrict M 
avium growth (Appelberg et al., 1994; Appelberg and Orme, 1993) but virulent strains 
could overcome the immune response mounted and kill the host. Furthermore, M. avium 
killing did not depend on the production of reactive species, either reactive oxygen 
intermediates or reactive nitrogen intermediates (RNI) (Appelberg, 1994; Appelberg 
and Orme, 1993; Gomes and Appelberg, 2002; Sano et al., 2002; Sarmento and 
Appelberg, 1996; Tomioka et al., 1997). 
Moreover, studies involving inducible nitric oxide synthase (iNOS) deficient mice 
(iNOS" ") have shown that, contrary to what is observed in the case of M. tuberculosis 
infection, M. avium does not have an exacerbated growth in those mice (Doherty and 
Sher, 1997; Ehlers et al., 1999; Gomes et al., 1999; MacMicking et al., 1997). These 
studies were done with a small number of strains, and in one of them, it was seen that 
not only does M. avium not grow better in the absence of NO but also see their growth 
inhibited in such conditions (Gomes et al., 1999). 
Studies involving the susceptibility of mycobacteria to RNI have also shown that M. 
tuberculosis is more susceptible than M. avium, suggesting that the difference observed 
in vivo is due to an inherent characteristic of the mycobacteria themselves (Doi et al., 
1993; Lousada and Appelberg, 2006; Rhoades and Orme, 1997). 
With the aim of determining if the resistance observed in iNOS" ~ mice in relation to 
M avium infection extended to more strains than the few described in previous work 
(Doherty and Sher, 1997; Ehlers et al., 1999; Gomes et al., 1999), iNOS"'" mice were 
infected with a panel of M avium strains of different virulence. 
Furthermore, in the case of the strain where an improved clearance was actually 
seen in previous work done with iNOS"" mice (Gomes et al., 1999) - strain 25291 - , a 
group of mice was treated with an iron overload before being infected by this strain. M. 
avium growth in mice is strongly dependent on the availability of iron, and situations of 
iron excess have been reported to enhance that growth (Dhople et al., 1996; Gomes and 
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Appelberg, 1998). Hence, by treating mice with iron we went on to see if that clearance 
was due to lack of access to nutrients. 
Taking into account that this strain grows better when in the presence of small 
amounts of RNI (Lousada and Appelberg, 2006), there might be a dependence on RNI 
production for the survival of M avium 25291 within an immunocompetent host. With 
this in mind, we set out to create a mutant that lacked the capacity to reduce nitrate, the 
more stable form of RNI. In order to create such a mutant we used insertional 
mutagenesis: random gene knockouts were done by using a transposome system, 
consisting of a stable synaptic complex formed between the hyperactive Tn5 
transposase and a Tn5-derived transposon. The transposome used - EZ::TN™ <KAN2> 
- contains a kanamycin-selectable marker, so mutants can be retrieved after culture in 
kanamycin containing media. Of the approximately 600 mutants obtained in this 
manner, four of them were found to be incapable of reducing nitrate. Once they were 
sequenced, it was seen that one of them was mutated for the nitrate reductase. In vivo 
studies in C57BL/6 immunocompetent mice showed that they had an impaired capacity 
to thrive. This impairment was not seen when they were used to infect bone marrow-
derived macrophages, suggesting that the reductase is needed for the adaptation to the 
immune response mounted by the organism. 
Using mice that were deficient in both iNOS and rag2, we set out to analyse the 
effects of the lack of NO-generating system in the absence of an intact immune system. 
We saw that the growth of M. avium 25291 was less than that observed in the case of 
immunocompetent or Rag" ~ mice, but not as low as the one observed for iNOS" " mice, 
suggesting that an NO-generating system is not the sole responsible for the successful 
adaptation to the host tissue. 
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Materials and methods 
Mice 
Inducible nitric oxide synthase (iNOS)-deficient mice in a C57BL/6 background were 
obtained in our facilities after backcrossing the original strain (kindly provided by Drs J. 
Mudgett, J.D. MacMicking and C. Nathan, Cornell University; New York, NY) into a 
C57BL/6 background for seven generations. C57BL/6 mice were purchased from 
Harlan Ibérica (Barcelona, Spain) or from Instituto Gulbenkian de Ciência (Oeiras, 
Portugal). Rag2-defícient mice (Rag"") were from the Centre de Développement des 
Techniques Avancées pour l'expérimentation animale (CDTA, Orleans, France), 
Rag.iNOS"" mice were obtained in our facilities as follows. Fl mice resulting from 
crossing iNOS"" mice with Rag"" mice were backcrossed with iNOS"" mice. F2 mice 
were then selected for the disrupted iNOS gene by PCR as described below. Mice 
selected in this manner were then crossed with each other, and selection for the rag2 
deficiency was functionally monitored by flow cytometry as described below. Once 
mice showed to be deficient for the rag2 gene, they were selected and chosen to be the 
breeders for the ensuing Rag.iNOS"" mice that were used in the experiments. All mice 
were kept in our animal facilities in high-efficiency particulate air (HEPA)-filter-
bearing cages and fed autoclaved chow and water. The animals were used at 8-12 weeks 
of age. 
Rag.iNOS"'" mice selection 
PCR Genomic DNA samples were obtained from each mouse by treating a portion of 
the ear with proteinase K (Sigma). Specific primers for both the wild-type iNOS gene as 
well as the disrupted iNOS gene were used, and the amplification was performed using 
Taq DNA polymerase (Bioron, GmbH) and a Gene Amp PCR System 9600 (Perking-
Elmer-Roche, Branchburg, NJ). The mice that amplified only the disrupted gene were 
selected. 
Flow cytometry Blood was collected from the tail of each mouse using a capilar 
hemocytometer and treated with FACS lysis solution (BD Bioscience) in order to lyse 
erythrocytes and isolate leukocytes. 10 cells were incubated in a 96-well microtiter 
plate with fluorescein isothiocyanate (FITC)-conjugated anti-CD4 antibody (dilution, 
1:100; BD Pharmingen, San Diego, CA) in phosphate-buffered saline (PBS) containing 
3% fetal calf serum (FCS). The cells were then washed twice with PBS containing 3% 
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FCS and analysed. The analysis was based on the acquisition of 10000 events in a 
Becton Dickinson FACSort instrument equipped with CellQuest software. Positive 
(Rag"A mice) and negative (C57BL/6 mice) controls were used and mice that had the 
same staining profile as the positive control were selected for the deficiency for the rag2 
gene. 
Bacteria 
Mycobacterium avium strain 25291, exhibiting a smooth transparent morphotype (SmT) 
was obtained from the American Type Culture Collection (Manassas,VA). Strains 2-29 
SmT, 2-151 SmT and 2-151 exhibiting a smooth dense morphotype (SmD) were 
obtained from Dr I. Orme (Colorado State University, Colorado, USA). Strains 2447 
SmT, M520 SmT, and 1983 SmT were given to us by Dr F. Portaels (Institute of 
Tropical Medicine, Antwerp, Belgium). Mutant strains SLS445, SLS503, SLS532 and 
SLS592 were obtained by transposome mutagenesis as described below. Mycobacteria 
were grown in Middlebroock 7H9 medium containing 0.04% of Tween 80 at 37°C until 
the mid-log phase of growth. Bacteria were centrifuged and resuspended in a small 
volume of saline containing 0.04% of Tween 80. The suspension was then sonicated at 
low power (40 W) in a Branson sonifier so that bacterial clumps would be disrupted. 
After dilution, aliquots were made and stored at -70°C until use. Before inoculation, 
bacterial aliquots were thawed at 37°C and diluted in saline to the desired final 
concentration. 
In vivo infection 
Mice were infected intravenously with lxlO6 colony forming units (CFU) of M.avium 
through a lateral tail vein. Mice were killed at different time points and the target organs 
(liver, spleen and lung) were aseptically removed and homogenised in a 0.04% Tween 
80 solution in distilled water. Serial dilutions of the homogenates were done, followed 
by plating onto 7H10 agar medium (Difco, Detroi, MI) supplemented with oleic 
albumin dextrose (OAD). In the case of the studies using the mutant strains, these 
bacteria were also plated in 7H10 agar medium containing 100mg/L kanamycin as a 
means to follow the stability of the mutation. The number of bacterial colonies was 
counted after culture for 10 to 15 days at 37°C. 
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Infection of BMM0 
Macrophages were derived from the bone marrow as follows. The femurs of mice were 
aseptically removed, and each femur was washed with 5mL of Hank's balanced salt 
solution (HBSS; Gibco Invitrogen, Carlsbad, CA). The resulting cell suspension was 
centrifuged and the pellet resuspended in Dulbecco's modified Eagle's medium 
(DMEM; Gibco) supplemented with 10% fetal bovine serum (FBS; Gibco) and 10% 
L929 cell-conditioned medium (LCCM) as a source of M-CSF. The cells were 
distributed in 24-well plates, at a concentration of 5 x 105cells/mL, and incubated at 
37°C in a 7% CO2 atmosphere. Three days after seeding, another O.lmL of LCCM was 
added. On the 7* day, the medium was renewed. 
On the 10* day of culture, when cells are fully differentiated into macrophages, they 
were infected with M. avium. To each well, 0.2mL of DMEM was added, which 
contained approximately 106 CFU of M avium. After 4 hours of incubation at 37°C in a 
CO2 atmosphere, cells were washed with warm HBSS in order to remove the non-
internalised bacteria present. New DMEM containing 10% FBS and 10% LCCM was 
added and cells were reincubated at the above mentioned conditions. In some of the 
wells the macrophages were immediately lysed and the number of viable intracellular 
bacteria counted as described below (time zero). The remainder of the cells was 
incubated up to 7 days, and intracellular bacterial growth was assessed at days 3, 5 and 
7. Some of these macrophages were treated from day 0 to day 4 of infection with 
recombinant murine IFN-y (100U/well/day) in combination with recombinant murine 
TNF (50U/well/day) (both cytokines from Genzyme). 
The measurement of the intracellular mycobacterial growth was done by counting CFU. 
Briefly, at each time point the cells were lysed by adding 0.1% saponin to each well. 
The resulting bacterial suspension was serially diluted in water containing 0.04% 
Tween 80, and then plated onto 7H10 agar medium supplemented with OAD. After 
incubation for 10 to 15 days at 37°C, the number of colonies was counted. For each 
strain and each condition tested, three culture wells were used. The results are presented 
as the mean log increase, which is the difference, in terms of log 10 CFU/well, between 
the time point being analysed and the initial bacterial load. The SD was calculated 
taking into account both time points, i.e. the one to which the log increase refers to and 
time zero, using the following formula: 
Vi * V [(SD(T0))2+(SD(T))2]. 
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Iron overload assay 
Mice were treated with iron-dextran, following a protocol described elsewhere (Gomes 
and Appelberg, 1998). Briefly, a solution of iron-dextran was prepared so that the mice 
were given, via the i.p. route, 0.4 mg of iron every other day, for a period of 20 days. At 
the end of that time mice were infected and bacterial burden was quantified as described 
previously. 
Preparation of mycobacteria for electroporation 
As mycobacteria have an extremely complex cell wall, special adaptations have to be 
made in order to make the bacilli electro-competent. The protocol followed was based 
on the protocol supplied by Dr Joel Maslow (Philadelphia Veterans Administration 
Medical Center, Philadelphia, USA) and the one described by Lee and co-workers (Lee 
et al., 2002). Briefly, M. avium 25291 was grown in Middlebrook 7H9 broth containing 
0.04% of Tween 80, supplemented with OADC, 22mM of dextrose and 0.5M sucrose, 
to an OD6oo around 0.4. At this point, glycine was added to a final 1.5%, and the 
bacteria were left for a further 18h at 37°C before being pelleted and washed with an 
electroporation solution. This solution was a 10% glycerol/0.5M sucrose solution that 
was used at 37°C for these washes. By the end of the third wash bacteria were 
resuspended in electroporation solution at 1/100 of the starting volume. The electro-
competent cells obtained in this manner were kept at -80°C in 100p.L aliquots before 
being electroporated, as this freezing step was shown to improve the process efficiency. 
Tranposome mutagenesis of electro-competent mycobacteria 
The insertional mutagenesis was done by using a transposome complex (EZ::TN™ 
<KAN2> complex, Epicentre, Madison, WI). Before electroporation was made, the 
transposome complex was prepared following the supplier's information, and incubated 
for 24h at 4°C. This last step was added in order to get the highest efficiency 
transposome complex (Hank Daum, Epicentre, personal communication). Once the 
complex was ready to be used, aliquots of electro-competent cells were unfrozen and 
transferred to 0.2 cm gap electroporation cuvettes. The transposome complex was added 
and electroporation settings were 2.5kV, 25uP and 1000 Q. The cuvette as well as the 
electroporation cuvette chamber were previously heated at 37°C in order to improve 
efficiency. After electroporation, Middlebrook 7H9 broth/0.5M sucrose was added and 
the mixture was transferred to culture tubes and kept o.n. in a shaking incubator, at 50 
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rpm at 37°C. After the incubation, the bacterial solution was plated onto Middlebrook 
7H10 agar medium with 100ug/mL kanamycin. 
Mutant selection 
The mutants selected by plating onto media containing kanamycin were further selected 
for their capacity to reduce nitrate to nitrite. To be able to analyse so many mutants each 
one of the mutant colony was transferred to 2 wells of a 96 well plate: one of them 
containing 7H9 broth alone and the other containing 7H9 broth supplemented with 
lg/mL of KNO3. After growth during 10 days, at 37°C, in an environment where 
oxygen was replaced by argon, the nitrite presence was assessed with the Griess reagent 
using an adaptation of the protocol described elsewhere (Appelberg et al., 1992). The 
mutants that were negative for this test were further tested. 
Mutant chromossomal DNA extraction 
DNA was extracted by one of two protocols. Each mutant bacteria was grown in 
Middlebroock 7H9 medium containing 0.04% of Tween 80 at 37°C until the mid-log 
phase. Cells were harvested by centrifugation and the pellets obtained were used as the 
starting material for the protocols. For cell lysis, and using the first protocol, the pellets 
was resuspended in TE buffer pH 8.0 containing 0.75M sucrose and 5mM DTT. After 
adding EDTA to a final concentration of 50mM, lysozyme to a final concentration of 
6mg/mL, and achcromopeptidase to a final concentration of 0.5mg/mL, the bacteria 
were incubated for 90 minutes at 37°C. After lysis, SDS was added to a final 
concentration of 1%, as well as proteinase K (to a final concentration of lmg/mL) and 
NaCl (to a final concentration of 125mM). Incubation occurred for 60 minutes at the 
same temperature. SDS was added again so that the final concentration was 2%, and 
this solution was incubated at 65°C for 10 minutes. The lysates were extracted first with 
phenol/chloroform (1:1 v/v) and then with chloroform. Sodium acetate was added to the 
extracts so that the final concentration was 0.3M and nucleic acids were precipitated 
with ice-cold isopropanol. This solution was further incubated o.n. at -20°C. The 
precipitates were isolated by centrifugation and washed with ice-cold ethanol (70%). 
After drying, the precipitates were resuspended in sterile water. When the second 
protocol was being used, the pellets were resuspended in TE buffer pH 8.0 and 
incubated for 20 minutes at 80°C. After this step lysozyme was added to a final 
concentration of lmg/mL, and an incubation at 37°C, for at least 1 hour, took place. 
110 
RNI production. M.avium infection and nitrogen metabolism 
After cell lysis, proteinase K and SDS were added to a final concentration of, 
respectively, O.lmg/mL and 1%, and the resulting solution was incubated for 10 
minutes at 65°C. NaCl was then added to a final concentration of 0.6M and cetyl 
trimethyl ammonium bromide (CTAB) was also added to a final concentration of 
12mg/mL. After thorough shaking the solution was incubated at 65°C for 10 minutes. 
The lysates were extracted with chloroform-isoamylalcohol (24:1 v/v). Nucleic acids 
were precipitated by the addition of isopropanol followed by an -20°C incubation for at 
least 30 minutes. Ice-cold alcohol (70%) was used for washing that precipitate. After 
drying, the precipitates were resuspended in sterile water. 
E. coli transformation 
Isolated chromosomal DNA was digested with either Sacl or Notl restriction enzymes. 
Digestion occurred at 37°C, and 10U of the enzyme was added three times with one 
hour interval between each addition, being the total amount used of 30U per enzyme. 
Enzymes were chosen according to two factors: one, that they did not cut within the 
inserted transposon, and two, that the resulting number of fragments was between 2000 
and 3000 base pairs. The plasmid pBLUESCRIPT (pBS) was digested with the same 
enzyme being used at each separate digestion. After digestion, the DNA of both mutants 
and plasmid purified using a GFX PCR DNA and Gel Band Purification kit (Amersham 
Biosciences). For ligation, ligase was added to the mutant DNA as well as the pBS and 
ATP (the last for improving the efficiency of ligation). After incubation at RT for lh, 
the solution was further incubated o.n. at 4°C. The solution was then incubated at 65°C 
for 10min and centrifuged at maximum speed for circa 2min. Then, competent E. coli 
was added and, after 20min in ice and 90sec at 42°C, SOC medium was added. This 
solution was incubated at 37°C for lh, and plated afterwards in LB-agar containing 
100mg/L of ampicilin and 25mg/L of kanamycin. 
Selection of positive clones 
As the pBS conferred ampicilin resistance, and the transposon conferred kanamycin 
resistance, only the bacteria that had been transformed with a plasmid containing the 
DNA fragment that contained the transposon would grow in a medium containing both 
antibiotics. The clones obtained in this manner were grown o.n. at 37°C in LB 
containing ampicilin and kanamycin in the above mentioned concentrations. Plasmid 
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DNA was then isolated and purified using a GenElute™ Plasmid Miniprep Kit (Sigma-
Aldrich), and sent to sequence at Stabvida (Oeiras, Portugal). 
Gene sequencing 
The primers used for sequencing were the ones provided with the EZ::TN <KAN-2> 
insertion kit, that anneal to a region near the ends of the tranposon (figure 1- está no fim 
deste documento). The sequence of that mosaic end was used as a landmark to 
distinguish vector sequence from mutated gene sequence. The sequence selected that 
way was used in the Basic Local Alignment Search Tool (BLAST) of the National 
Center for Biotechnology Information (NCBI), National Institutes of Health (Bethesda, 
USA). Briefly, each sequence was used as a template for the nucleotide-nucleotide 
BLAST, and compared with known bacterial genomes. The sequence was analysed by 
using the known M avium paratuberculosis genome as a template for the search, done 
at the Institute for Genomic Research, TIGR-CMR search engine. 
Statistical analysis 
Statistical analysis was performed using the t-test for independent samples and the 
Statistica program (StatSoft, Tulsa, OK, USA) or using ANOVA and the post-hoc 
Turkey's test and the GraphPad PRISM program (San Diego, CA, USA). 
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Results 
M. avium growth in iNOS-KO mice 
As can be seen in figure 2, none of the strains tested here showed an exacerbation of its 
growth when in the iNOS"'" host. Strains 1983, 2.29, 2-151 SmD and 2-151 SmT 
showed no change in the bacterial proliferation in the liver, when iNOS were 
compared to C57BL/6 mice. On the other hand, iNOS"" mice infected with strains 
25291, 2447 and M520 showed an improved control or clearance of infection when 
compared with the controls. This difference had no correlation with the virulence of the 
strain, as strains of similar virulence like 2447 and 2-151 SmT, or strains 2.29 and 
M520, did not have similar growth patterns in the iNOS" mice. 
The reduced growth of certain strains of M. avium could be explained in different ways. 
Since NO is an immunomodulatory molecule that frequently results in reduced immune 
responses namely by T cells, it could be argued that iNOS-deficient animals may 
exhibit enhanced immune responses leading to improved immunity. A different reason 
might be related with the requirement, by the mycobacteria, of NO or one of its 
oxidation products such as nitrate, for growth in the hypoxic granuloma. Nitrate would 
provide an alternative oxidant for anaerobic respiration. We therefore experimentally 
addressed the two hypothesis. 
M. avium 25291 growth in iron-treated mice 
If NO-derived products are required for growth of M. avium it can be expected that 
overcoming other growth-limiting nutrients such as iron would have no growth 
exacerbating effects in iNOS-deficient animals as their growth would be limited by the 
lack of the NO-derived products. To test this we compared the growth of M. avium in 
control and iron-loaded C57BL/6 and iNOS-deficient hosts. Mice were killed at day 53, 
a time point where it was seen previously that iNOS"" mice had a lower bacterial load 
than the one observed in C57BL/6 mice. Iron-overloaded C57BL/6 mice had a 
significant increase in the bacterial burden when compared with untreated mice, 
whereas no exacerbation of growth of M avium was seen in iNOS" " mice following iron 
overloading (figure 3). Clearly, the availability of iron does not influence the growth of 
M. avium in an iNOS"7" setting, hence suggesting that growth is already limited by the 
lack of NO-derived products. 
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M. avium 25291 mutant library 
One of the possible roles of nitrogen metabolites in M. avium metabolism is through the 
use of nitrate as an electron acceptor during anaerobic respiration. Thus, we generated 
M avium mutants unable to reduced nitrate into nitrite. By using the transposome 
insertion approach, the mutations were done at random, hence allowing for a great 
variety of different mutants to be obtained. To the present date, approximately 600 
mutants have been obtained, and of those, 4 did not convert nitrate to nitrite. 
M. avium 25291 mutant sequencing 
The four selected mutants were successfully sequenced. Mutant SLS503 was mutated 
for a gene that had a 98% homology to a gene that coded for a hypothetical protein in 
M. avium paratuberculosis. Mutants SLS445 and SLS592 both showed to be mutated in 
a gene that showed to by homologous to a sequence from M. avium paratuberculosis 
known to include both GlnA2, which codes for a glutamine synthetase, and GlnE, which 
codes for adenylyltransferase, which is predicted to control the enzymatic activity of 
glutamine synthetase (Pashley et al., 2006). Glutamine synthetase is a known virulence 
factor, which is involved in the nitrogen metabolism (Collins et al., 2002; Harth et al., 
2005). Finally, SLS532 was mutated for a gene that had 97% homology to the narG 
gene of M. avium subsp. paratuberculosis (figure 4), which codes for nitrate reductase. 
The shaded area of figure 4 represents the place where transposon insertion took place. 
The sequence directly affected this insertion was homologous not only to this narG 
sequence, but also had an 87% homology with the sequence coding for the alpha 
subunit of nitrate reductase of M. MCS as well as the sequence coding for a nitrate 
reductase-related protein of M. tuberculosis CDC1551. A sequence coding for a 
probable nitrate reductase narX of both M. tuberculosis H37Rv and M. bovis subsp. 
bovis AV2X22I91 was also found to have an 87% homology with the affected sequence. 
Concerning M. tuberculosis CDC 1551, there was an antisense homology of 84% with 
the alpha subunit of nitrate reductase. In the same manner, there was an antisense 
homology of 84% with sequences coding for a probable respiratory nitrate reductase 
(alpha chain) narG of both M. tuberculosis H37Rv and M. bovis subsp. bovis 
AF2122/97. An antisense homology of 87% was also seen for the sequence present in 
M bovis BCG putative nitrite extrusion protein (narK2) and fused nitrate reductase 
(narX) genes. The proximity of identities between these organisms regarding the 
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homology of their sequences to the sequence belonging to the mutant can be seen in 
figure 5. 
In vivo growth of different M. avium 25291 mutants 
When the mutant for narG (AnarG) was used for infecting mice, there was an 
impairment of its growth when compared with the parental strain M. avium 25291, 
which was significant only after 3 months of infection (figure 6a). When the mutant 
used was the one affected in the glutamine sinthetase activity (AGlnA2) the impairment 
was observed as soon as the first month of infection and the differences between the 
mutant growth and the parental strain was statistically significant for the organs 
analysed (figure 6b). 
In vitro growth of different M. avium 25291 mutants 
When M. avium 25291 was used to infect BMM0s it grew slightly less in BMM0s 
from iNOS-deficient mice than in BMM0s of C57BL/6mice. As seen before in our lab 
(Gomes et al., 1999), the killing observed in IFN-y and TNF-activated BMM0s was not 
NO-dependent, as the decrease in bacterial numbers was similar in both 
immunocompetent and iNOS-deficient strains (figure 7a). When AnarG was used for 
infecting the BMM0s, there was no impairment of its growth in both strains. These 
bacteria were killed after activation and, again, in an NO-independent fashion, as the 
presence of NO production did not kill more than in its absence (figure 7b). In the case 
of a mutant for a virulence factor, AGInA2, a completely different pattern of growth was 
observed. In this case, the bacteria had clearly an impairment in its growth even in 
resting BMMOs, and bacterial loads were highly decreased in the case of activated 
BMM0S (figure 7c). 
M. avium 25291 growth in double-KO 
To test the alternative hypothesis, i.e. that iNOS~~ mice have an improved protective 
immune response, we set out to analyse the effects of the lack of NO-generating system 
in the absence of an intact immune system, studying the growth of M avium 25291 in 
mice that were deficient in both iNOS and rag2. The growth of M. avium was 
consistently lower in iNOS" ~ as compared to control C57BL/6 mice in all organs studied 
and to a similar degree (ca. 2 log 10 differences) (figure 8). In contrast, in rag2-deficient 
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mice the iNOS deficiency did not protect in the spleen. However, the protective effect 
of the iNOS deficiency was still observed in the liver and lung of lymphocyte-deficient 
mice albeit to a smaller degree than that observed in lymphocyte-sufficient animals (ca. 
OJloglO). 
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Discussion 
This work confirms with a larger panel of M avium strains that, contrary to the case 
of a M. tuberculosis infection, no exacerbation of the infection was seen in the iNOS" " 
host. As seen here, all the strains studied showed either no change in the bacterial load 
in iNOS ~~ mice as compared with C57BL/6 mice, or an actual improved clearance in the 
case of deficient mice (figure 2). 
Moreover, it was shown that even when there was a higher availability of iron, an 
essential nutrient, which induces an exacerbation of the M. avium 25291 growth in 
immunocompetent mice, the growth of that same strain was unaltered in iNOS" " mice 
(figure 3). So it seems that mycobacteria, even when given the best conditions for 
thriving, are unable to do so in the absence of NO production. 
When an improved clearance is seen in iNOS"' mice, the difference from 
immunocompetent mice starts to be significant approximately a month after the 
infection, when a specific/adaptive immune response starts to occur. Taking into 
account that a specific response involves granuloma formation, one can assume that the 
impairment is at the level of the mycobacterial adaptation to the granulomatous 
environment. That being so, it suggests that in the case of M avium, the adaptation to 
this environment depends on the nitrogen metabolism. 
Several studies done with M. tuberculosis have also pointed to this type of 
metabolism as important in the adaptation to the granuloma's environment and hence to 
chronicity and latency. Regarding the precise composition of the granuloma's 
environment it has been believed that it is a hypoxic environment where lack of 
nutrients and the presence of macrophagic antimicrobial agents such as RNI are seen. 
Recently, Aly and colleagues showed the lungs of mice chronically infected with M 
tuberculosis were not severely hypoxic (Aly et al., 2006). The implications regarding 
this study were mostly directed at drawing attention to the fact that data taken from 
studies using this animal model and M. tuberculosis treatment, should be treated 
carefully. In the same study, it was shown that mice chronically infected with M. avium 
TMC724 did in fact show hypoxia surrounding necrotizing granuloma centres (Aly et 
al., 2006). Studies focusing on the adaptation to a hypoxic environment showed that this 
involved the induction of dosR, the dormancy survival regulator, the response regulator 
of the two component system DosR/DosS (devR/devS or Rc3133c/Rv3132c). This 
response regulator has been implicated in the persistence and adaptation to hypoxia of 
not only M. tuberculosis, but also M. bovis and M. smegmatis (Bacon et al., 2004; 
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Malhotra et al., 2004; Mayuri et al., 2002; O'Toole et al., 2003; Park et al., 2003; 
Sherman et al., 2001). 
In those conditions, genes involved in nitrogen metabolism such as narK2, narX, or 
acg, which code for a fused nitrate reductase, a nitrite extrusion protein, and a putative 
nitroreductase respectively, were induced in a DosR dependent manner (Bacon et al., 
2004; Florczyk et al., 2003; Kendall et al., 2004; Muttucumaru et al., 2004; O'Toole et 
al., 2003; Park et al., 2003; Purkayastha et al., 2002). 
On the other hand, when exposed to RNI, M. tuberculosis upregulated the 
expression of that same dosR, therefore linking it to mycobacterial adaptation to the 
granuloma environment (Ohno et al., 2003). 
Furthermore, using the Wayne model for the adaptation to the persistence state, 
where latency is induced by low oxygen concentration, it was seen that an increase of 
nitrate reduction occurred (Wayne and Hayes, 1998). This suggests that in the absence 
of oxygen such as is thought to be the case of the granuloma's environment, 
mycobacteria might use nitrate as a final electron acceptor. Therefore, nitrate reductases 
seem to be of extreme importance in this type of adaptation, and in fact it was shown 
that M. bovis needed narG, the catalytic subunit of the narGHJI nitrate reductase, for its 
persistence in lungs, livers and kidneys of infected mice (Fritz et al., 2002). 
Also using the Wayne model, Khan and Sarkar showed recently that nitrate 
reductase inhibition during the anaerobic phase had a great impact on M. smegmaiis 
growth (Khan and Sarkar, 2006). 
Even though these studies have been done in M. tuberculosis, M. bovis and M 
smegmatis we can assume that M. avium will have similar adaptation mechanisms. If 
that is the case, and taking into account that M.avium is more resistant to RNI than M. 
tuberculosis (Lousada and Appelberg, 2006), and as we saw in the current studies 
M.avium apparently needs iNOS induction to be able to adapt to the granuloma, we 
suggest that, at least in the case of this mycobacterium, the adaptation to the hosts 
immune system depends on it, at least partly, for its survival. 
From the bacteria's perspective this is the most advantageous adaptation possible. If 
a bacterium can benefit from the host's immune response, it would certainly guarantee 
its propagation, even if the maintenance of the bacteria within the host organism is in a 
different metabolic state than the proliferative state. Bacteria adopting a lower 
metabolism would be kept in the organism and once it had more favourable conditions 
would actively proliferate. With this in mind a possibility would be that the more 
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virulent a strain was, the higher the capacity to be able to adapt to the immune response, 
and hence the greater the difference observed in the growth in the absence or in the 
presence of RNI. For instance, it was seen that a narG M. bovis BCG mutant was less 
virulent in the mouse, pointing out to the importance of nitrate respiration in virulence 
(Weber et al., 2000). 
Data from this study and others (Gomes et al., 1999) have shown that the highly 
virulent strain 25291 has a greater difference in the growth in INOS " mice when 
compared with C57BL/6 mice. At the same time, this strain was also seen to be more 
resistant to RNI than the other, less virulent, ones suggesting that virulence could be 
intertwined with the nitrogen metabolism (Lousada and Appelberg, 2006). 
However, other factors have to be involved, as it was seen that a moderately 
virulent strain - 2-151 SmT - did not show an improved clearance as M avium 2447, a 
strain of similar virulence did. 
Irrespective of the virulence issue, the fact is that NO metabolism seems to play an 
important role in the M. avium's adaptation to the granuloma. 
Here, studies with an M. avium mutant for narG showed that the growth of this 
mutant was affected when it was grown in vivo but not when it was grown in vitro 
(figures 6a and 7b). Comparing these results with those observed for a mutant for a 
virulence factor (AGlnA2, figures 6b and 7c), it can be seen that whereas the latter has 
its development affected regardless of the type of immune response involved, the 
former appears to have difficulty only when an adaptive immune response has been 
mounted. Of note is the fact that in the present study an i.v. infection with 106 CFUs 
was used, an infection that does not lead to necrosis. Taking into account that Aly and 
colleagues report the presence of hypoxia in necrotizing granulomas (Aly et al., 2006), 
we can only suggest that in our case the granuloma could have lower oxygen content 
but does not present severe hypoxia. We can put forward the hypothesis that if the 
mutant was growing indeed in a hypoxic granuloma, it would see its growth affected to 
a greater extent. 
In the case of M. avium growth in iNOS7" mice and taking into account that the 
granulomas formed are more fibrotic (Lousada et al., 2006), there could be less access 
to oxygen and therefore, as bacteria did not have nitrate present for a possible 
alternative respiration, they would have difficulty in thriving. 
Another aspect put forward concerns how important is NO in the development of 
the infection and how much it affects the outcome of an infection with M. avium. 
119 
RNI production. M.avium infection and nitrogen metabolism 
Florido and colleagues have reported recently that virulent M. avium induced 
lymphopenia (Florido et al., 2005). With this in mind we set out to evaluate if the 
absence of NO production had a pivotal role in the development of the disease, or, 
rather, if an intact immune system had a greater impact in the disease's outcome. In 
order to do that, we analysed the growth of M. avium 25291 in mice that were both 
deficient for both iNOS and rag2. We saw that the absence of NO production did 
ameliorate the outcome of the disease in Rag.iNOS" " mice when compared with Rag" ~ 
mice, but only to a small extent. This suggests that what happens is a combination of 
both, where cell loss as well as the ability to use RNI account for the clinical outcome. 
The results shown here also point out to a possible role of another factor involved that 
leads to the final outcome of the disease. 
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Legends for the figures 
Figure 1 - EZ::TN transposon insertion site. 
Figure 2 - M. avium growth in iNOS ~~ mice ( ■ ) and C57BL/6 mice ( □ ). Mice were 
infected with different strains, and mycobacterial growth assessed at different time 
points. Data indicates the logio colony forming units (CFU) observed in the liver of the 
infected mice. 
Figure 3 - M. avium 25291 growth in C57BL/6 and iNOS ~'~ mice treated with iron-
dextran, or simply dextran as a control, before being infected. Data indicates the logio 
CFU observed in the liver of the infected mice at day 53 of infection. The exacerbation 
of mycobacterial growth in iron-treated C57BL/6 mice was statistically different 
(p<0.001). 
Figure 4 - Sequence of the mutated gene for the mutant M. avium SLS532 and its 
alignment with known genome sequences. Genomes shown are the ones that, comparing 
with the sequence being queried, had sequences that had less mismatching letters. The 
shaded area corresponds to where the transposon was inserted. M. avium pTB stands for 
Mycobacterium avium subsp. paratuberculosis str. klO complete genome; M sp. MCS 
stands for Mycobacterium sp. MCS complete genome; M. tb - A stands for 
Mycobacterium tuberculosis CDC 1551 complete genome; M. tb — B stands for 
Mycobacterium tuberculosis H37Rv complete genome, segment 4/13; M. tb - C stands 
for Mycobacterium tuberculosis sequence from clone y348; M. tb - D stands for 
Mycobacterium tuberculosis H37Rv complete genome, segment 6/13; M. bovis - A 
stands for Mycobacterium bovis subsp. bovis AF2122/97 complete genome, segment 
4/14; M. bovis - B stands for Mycobacterium bovis subsp. bovis AF2122/97 complete 
genome, segment 7/14; M. bovis - C stands for Mycobacterium bovis BCG putative 
nitrite extrusion protein (narK2) and fused nitrate reductase (narX) genes, complete cds, 
and unknown genes; P. sp JS666 stand for Polaromonas sp. JS666, complete genome. 
Figure 5 - Dendrogram of results, a) complete dendrogram of results; b) detail of the 
subtree that shows the unknown sequence. Distances were calculated taking into 
account the mismatching letters between any two sequences in the alignment. From a 
matrix with those distances, BLASTN used the Jukes-Cantor method to calculate de 
distances. Blue coloured circles corresponds to unknown organisms, green coloured 
circles corresponds to high GC content bacteria, and rose coloured circles corresponds 
to P-proteobacteria. 
Figure 6 - Growth in C57BL/6 mice of M. avium 25291 and the mutant strains, a) 
growth of strain SLS532, AnarG; b) growth of strain SLS445, AGlnA2. Mice were 
infected with the different strains, and mycobacterial growth assessed at different time 
points. Data indicates the geometrical mean of CFU observed in the spleens and livers 
of the infected mice, and the SD. Statistically significant differences between each 
mutant strain and the control strain were evaluated by the Student's t test, and are 
labelled **, p<0.01 and ***, pO.001. 
Figure 7 - Growth of M. avium 25291 and mutant strains in BMM0s of C57BL/6 and 
iNOS" mice, a) growth of M avium 25291; b) growth of AnarG; c) growth of AGlnA2. 
BMM0s were infected with the different strains, and mycobacterial growth assessed at 
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different time points. Part of the BMM0s were activated as described. Data shows the 
bacterial increase observed, represented as log increase, after 7 days of infection. 
Statistically significant differences were evaluated by the Student's t test, and are 
labelled *, p<0.05, **, p<0.01 and ***, pO.001. This is one representative experiment 
of three independent experiments. 
Figure 8 - Growth of M. avium 25291 in Rag.iNOS"'" mice, compared with iNOS ' , 
Rag" and immunocompetent C57BL/6 mice. Growth curves are shown for spleen (a), 
liver (b) and lung (c). Mice were infected, and mycobacterial growth assessed at 
different time points. Data indicates the geometrical mean of CFU observed in the target 
organs of the infected mice. Statistically significant differences between the four groups 
(shown in the graphs) were evaluated by ANOVA. Differences between double-KO as 
well as immunocompetent C57BL/6 and the other groups at the third month of infection 
(shown in table d) were assessed by the post-hoc Turkey's test. Significant differences 
are labelled *, p<0.05, **, p<0.01 and ***, pO.001. ND - not determined; NS - not 
significant. This is one representative experiment of a total of three independent 
experiments. 
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M.sp.MCS 4802 630 
M sp. MCS 2 578493 
M.tb-k 1288087 
M.tb-k 3802377 
M.tb-B 254812 
M. bovis-k 302971 
M.tb-C 20118 
TC7CCCCGTCCTCGGTCGGGGCGGCCCGCACACTGAGCGCCGGCACCAGGTCGCCCAGGT 
.G  
. T CCGAA. 
.T CCGAA. 
. 7 CCGAA. 
.T CCGAA. 
2578494 
5063985 
234 
2956985 
4802 651 
2578485 
1288056 
3802395 
.-: 54'/HI 
302940 
20087 
SLS532 
M. avimpTB 
M.tb-k 
M.tb-B 
M. bovis - A 
M tb - C 
2 35 CCAGG77CCACTTCCCCACGCCCGACTCGCCGTACCGGAAGCCCAGCGAACCATGCGGCA 2 94 
2956986 G 2957045 
1288055 A. .A. . GTC . ..A...A.A 7 7..G..C 1287996 
2 54780 A. .A. . G7C . ..A...A.A 7 7..G..C 254721 
3 02 93 9 A. .A. . G7C . ..A. ..A.A 7 T..G..C 302880 
2 008 6 A. .A. .GTC. . .A. . .A. A 7 T. .G. . C 20027 
SLS532 295 
M.avimpTB 295704 6 
M. sp. MCS 935558 
M s p . MCS 435071 
M.tb-k 1287995 
M.tb-B 2 5472 0 
M. bovis-k 302879 
M.tb-C 2002 6 
CCGCAACCGAATTGGTGGTCTCGTCGAGCAGCGCGGGCTTGAGCGCCGCATTC7CGACCG  
T  
.GA. 
.GA. 
.GA. 
.GA. 
. G . T . . . C . . A A G . 
. G . T . . . C . . A A G . 
. G . T . . . C . . A A G . 
. G . T . . . C . . A A G . 
.G T. . . .A G ACTTT 
.0 7 . . . .A G AC777 
.G T. . . .A G AC777 
.G 7 . . . .A G AC777 
3 54 
2957105 
935553 
435066 
1287936 
254661 
302820 
19967 
SLS532 355 
M.avimpTB 2 957106 
M s p . MCS 935552 
M s p . MCS 43 5065 
M.tb-k 1287935 
M.tb-B 254660 
M. bovis-k 3 02 819 
M.tb-C 199 6 6 
SLS532 
M. avimpTB 
M.tb-k 
M.tb-B 
M. bovis ~ A 
M. tb - C 
415 
2957163 
1287875 
254600 
302759 
19906 
CTTCGCCGAGGTCGGCCGCGGTGAGGTTCTTGCCGGGCACCAGCATGTCGCCGCGCTCTT 
.C A — 
. . . C . . . . T . . 
. . . C . . . . T . . 
CGAGCTTGATCAAGAACGGCAGATCGGTGTAGCGGCGGGCATAGTCGGTGAAGAACGGAA 
.C.A. 
.C .A. 
.C .A. 
.C .A. 
C A . . . . . . . . A C A 
C A . . . . . . . . A C A 
C A . . . . . . . . A C A 
C A . . . . . . . . A C A 
414 
2957162 
935539 
435046 
1287876 
254601 
302760 
19907 
474 
2957222 
1287816 
254541 
302700 
19847 
Figure 4 
131 
RNI production. M.ovium infection and nitrooen metabolism 
SLS532 1 7 5 
M.avimpTB 2 9 5 7 2 2 3 
M.avimpTB 1 9 8 5 7 7 
M. sp. MCS 
M. sp. MCS 
M.tb-A 
M.tb-A 
M.tb-B 
M. bovis - A 
M.th-C 
13 6 8 4 1 4 
2 7 6 1 8 6 1 
1 2 8 7 8 1 5 
6 7 5 0 9 2 
2 5 4 5 4 0 
3 0 2 6 9 9 
1 9 8 4 6 
CCTGTTTTTGCACATAGCATTCCGAGAGGATGACGTGACCCATCGCCATCGCCAGGGCCC  
C. . . . 
. A C . G . . G . .A C. 
. G . . A C . G . . G . . A . 
. G . . A C . G . . G . . A . 
. G . . A C . G . . G . . A . 
. G. 
. GG 
. GG 
, GG 
GG 
5 3 4 
2 9 5 7 2 8 2 
4 9 8 5 8 0 
13 6 8 4 5 3 
2 7 6 1 8 5 7 
1 2 8 7 7 5 6 
6 7 5 0 8 3 
2 5 4 4 8 1 
3 0 2 6 4 0 
1 9 7 8 7 
SLS532 5 3 5 CGTCGGTGCCGGCGGCGCAGGGCATCCACTCGTCGGCGAACTTGGTGTTGTCGGCGTAGT 5 9 4 
M. avhnpTB 2 9 5 7 2 8 3 2 9 5 7 3 4 2 
M.avimpTB 1 9 8 5 8 1 
M sp. MCS 13 6 8 4 5 4 
M. sp. MCS 
M.tb-A 
M.tb-A 
M.tb-B 
M. bovis - A 
M.th-C 
2 7 6 1 8 5 6 
1 2 8 7 7 5 5 
6 7 5 0 8 2 
2 5 4 4 8 0 
3 0 2 6 3 9 
1 9 7 8 6 
TA. 
TA. 
TA. 
TA. 
.CC. 
.CC. 
.CC. 
.CC. 
4 9 8 6 0 3 
1 3 6 8 5 1 3 
2 7 6 1 8 4 3 
1 2 8 7 6 9 6 
6 7 5 0 6 6 
2 5 4 4 2 1 
3 0 2 5 8 0 
1 9 7 2 7 
SLS532 5 9 5 CCGGGCTGACGGTGACCACCTTGGTGCCGCGGTAGCGCGCCTCGGCCATCCAGTGCGCGT 6 5 4 
M. avimpTB 2 9 5 7 3 4 3 2 9 5 7 4 0 2 
M. avimpTB 4 5 6 7 1 5 8 
M sp. MCS 13 6 8 5 1 4 
M sp. MCS 1 5 6 1 4 0 7 
M.tb-A 1 2 8 7 6 9 5 
M.tb-B 2 5 4 4 2 0 
M. bovis-A 3 0 2 5 7 9 
M. tb-C 1 9 7 2 6 
. ACA. 
.AC A. 
.ACA. 
.ACA. 
A . C . 
A . C . 
A . C . 
A . C . 
. A . . T . 
. A . . T . 
■ À . . T . 
. A . . T . 
4 5 6 7 1 7 6 
13 6 8 5 7 3 
1 5 6 1 4 3 1 
1 2 8 7 6 3 6 
2 5 4 3 6 1 
3 0 2 5 2 0 
1 9 6 6 7 
SLS532 6 5 5 
M. avimpTB 2 9 5 7 4 0 3 
M. avimpTB 3 7 3 2 8 5 4 
M. sp. MCS 13 6 8 5 7 4 
M.tb-A 1 2 8 7 6 3 5 
M.tb-A 1 9 5 4 2 8 0 
M.tb-B 2 5 4 3 6 0 
M. bovis - A 3 0 2 5 1 9 
M. tb-C 1 9 6 6 6 
M.tb-D 2 3 2 1 6 5 
M. bovis - B 3 4 8 1 9 
M. bovis - C 2 4 0 5 
CGGGCGTGCGGGTGATCGGGACGTTGGAGCCCCACATCATCAAATACGCCGCGT-CC-AC 
- . . C . . 
TG  
. . . . T C G A C . . - . . 
C G.C A. . . A . - . . C . . 
. G . C . 
. G . C . 
. G . C . 
7 1 2 
2 9 5 7 4 6 1 
3 7 3 2 8 8 0 
13 6 8 6 3 2 
1 2 8 7 5 7 7 
1 9 5 4 2 8 3 
2 5 4 3 0 2 
3 0 2 4 6 1 
1 9 6 0 8 
2 3 2 1 6 8 
34822 
2402 
SLS532 7 1 3 CAGTCCCCGGATTCGGGGACGTCGGTCTGGTCGCCGAACÀCCTGGGGCGAGGCCACCGGG 7 7 2 
M. avimpTB 2 9 5 7 4 6 2 2 9 5 7 5 2 1 
M.sp.MCS 1 3 6 8 6 3 3 A C C 1 3 6 8 6 9 2 
M. sp. MCS 2 6 6 6 0 4 1 2 6 6 6 0 2 3 
M.tb-A 1 2 8 7 5 7 6 G C C C 1 2 8 7 5 1 7 
M.tb-A 1 9 5 4 2 8 4 . . A . . T C . . C . . C C . . G C 1 9 5 4 3 4 3 
M.tb-A 3 9 9 3 9 5 9 3 9 9 3 9 7 8 
M.tb-B 2 5 4 3 0 1 G C C C 2 5 4 2 4 2 
M. bovis-A 3 0 2 4 6 0 G C C C 3 0 2 4 0 1 
M. tb-C 1 9 6 0 7 G C C C 1 9 5 4 8 
M.tb-D 232169 ..A..T C..C..C C..G C 232228 
M.bovis-B 34823 ..A..T C..C..C C..G C 34882 
M.bovis-C 2401 ..A..T C..C..C C..G C 2342 
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SLS532 
M. avimpTB 
M. avimpTB 
M sp. MCS 
M.tb-k 
M.tb-A 
M. tb - B 
M. bovis - A 
M.tb-C 
M.tb-D 
M. bovis - B 
M. bovis - C 
SLS532 
M. avimpTB 
M. sp. MCS 
M.tb-k 
M.tb-k 
M.tb-k 
M.tb-B 
M. bovis - A 
M.tb-C 
M. tb - D 
M.tb-D 
M. bovis - B 
M. bovis - C 
P. sp 
SLS532 
M. avimpTB 
M. sp. MCS 
M. sp. MCS 
M.tb-k 
M. tb - A 
M. tb - B 
M. ÒOVÍA' - A 
M.tb-C 
M.tb-D 
M. bovis - B 
M. bovis - C 
773 
2957522 
1172573 
13 68693 
1287516 
1954344 
254241 
302400 
19547 
232229 
34883 
2341 
833 
2957581 
13 68752 
1287457 
1954403 
1891452 
254182 
302341 
19488 
232283 
169393 
34942 
2282 
4871600 
893 
2957641 
1368812 
3827978 
1287397 
1954463 
254122 
302281 
19428 
232348 
35002 
2222 
AGGTCGGCATACCAGTCGTAGAACGAGGTCATCGGGGGCGCCGATCAGCTCGAAGAACCG 
.A. 
.-.C.C. 
.AC.C-. 
. G C ACCC 
.A G C AC.C-
. A G C AC.C-
. A G C AC.C-
.ACCC- T. 
.ACCC- T. 
.ACCC- T. 
. . . C . 
.C.C. 
.C.C. 
.C.C. 
.C.C. 
.C.C. 
.C.C. 
.C.C. 
.C.C. 
GGAGCCGGCGGTGTAGGACACCATCGACATCGCCGGGATCGGCGAGAATCCGGCCACCCG 
SLS532 953 
M. avimpTB 2957701 
M. avimpTB 1601985 
M sp. MCS 13 68872 
M. tb - A 1287337 
M.tb-k 1954523 
M. tb - A 4024829 
M. tb - A 2858620 
M.tb-B 254062 
M. bovis - A 302221 
M.tb-C 193 68 
M.tb-D 232408 
M. bovis - B 35062 
M. bovis - C 2162 
SLS532 1013 
M. avimpTB 2957760 
M. avimpTB 1601973 
M. sp. MCS 1368931   
M.tb-k 1 2 8 7 2 7 8 
M. tb - A 1 9 5 4 5 8 2 
M. tb - A 2 6 5 8 6 1 7 
M.tb-B 2 5 4 0 0 3 
M. bovis - A 3 0 2 1 6 2 
M.tb-C 1 9 3 0 9 
M.tb-D 2 3 2 4 6 7 
M. bovis - B 3 5 1 2 1 
M. bovis - C 2 1 0 3 
.C C . C . . G . C T  
. C . C . . . . C A . G . C T G T . 
. C . . C . . . . C . . G . C T G. 
.C G. 
.G G. 
.G A. 
. C . C . . . . C A . G . C T G T . 
. C . C . . . . C A . G . C T G T . 
. C . C . . . . C A . G . C T G T. 
, C . C . . . . C . G . C T G. 
.G G. 
.G G. 
. G G. 
.G A. 
C . C . C . . . C . . G . C T . 
C . C . . C . . . . C . . G . C T . 
. T . 
. T . 
. T . 
. T . 
. T . 
. T . 
. T . 
. T . 
. C . C 
GGA. 
. C . C 
. C . C 
. C . C 
GGA. 
GGA. 
GGA. 
GGCCCAGGT GGATC CGGA CCÃGTC :AC CCTTGCCGCGGGCCCGCTGGTAGC GGCGGCGGC 
. - . C . 
c 
. . c. . . . T T . A. . . . . . . . T . T . . 
. . . . C . r. . . G . 
.-.c.. 
c 
r. 
. . . c. . . . T T . A. . . . . . . . T . T . . 
. . . . c . . . . T T . A. . . . . . . . T . T . . 
r c 
c 
GC TC GGGGTC GGC C TGGATGTC GGC C C AGGCC AGC ACCGGATCGCC GAGGC GTGC C TTGG 
.CGC . GC. 
T  
.C G . T  
. C A A C. 
A. .C A C  
A. .C A C  
A. .C A C  
.CGC GC. 
.CGC GC. 
.CGC GC. 
. G . T . 
. G . T . 
. G . T . 
. C . 
.c . 
.c . 
.CA A C. 
.CA A C. 
.CA A C. 
832 
2957580 
1172554 
1368751 
1287458 
1954402 
254163 
302342 
19489 
232287 
34941 
2283 
892 
2 9 5 7 6 4 0 
1 3 6 8 8 1 1 
1 2 8 7 3 9 8 
1 9 5 4 4 6 2 
1 8 9 1 4 7 0 
2 5 4 1 2 3 
3 0 2 2 8 2 
1 9 4 2 9 
2 3 2 3 4 7 
1 6 9 4 1 1 
3 5 0 0 1 
2 2 2 3 
4 8 7 1 6 2 8 
GTCGGGGCCGTAGGTCTTGATGGTGTGCACGTGGGCGGCGGCGATCAGCTCGGTGGCCTC 9 5 2 
2 9 5 7 7 0 0 
1 3 6 8 8 7 1 
3 8 2 7 9 9 6 
1 2 8 7 3 3 8 
1 9 5 4 5 2 2 
2 5 4 0 6 3 
3 0 2 2 2 2 
1 9 3 69 
2 3 2 4 0 7 
3 5 0 6 1 
2 1 6 3 
1 0 1 2 
2957759 
1601974 
13 68930 
1287279 
1954581 
4024806 
2858618 
:-:1.4 í 
302163 
19310 
232466 
35120 
2 1M4 
1072 
2957819 
1601967 
1368990 
1287219 
1954641 
2858602 
253944 
302103 
19250 
232526 
35160 
2044 
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.c. 
SLS532 1 0 7 3 CTTCCCGGTACATCTCGACCAGGACGCCGCGGGCGTACGGGTAGCGCACCCGGGTGGGCG 113 2 
M. avimpTB 2 9 5 7 8 2 0 T 2 9 5 7 8 7 9 
M s p . MCS 13 6 8 9 9 1 
M.tb-A 1 2 8 7 2 1 8 
M. t b - A 1 9 5 4 6 4 2 
M.tb-B 2 5 3 9 4 3 
M.bovis-A 3 0 2 1 0 2 
M.tb-C 1 9 2 4 9 
M.tb-D 2 3 2 5 2 7 
M.bovis-B 3 5 1 8 1 
M.bovis-C 2 0 4 3 
C G C C. 
c c  
. A . . C  
. . . .c c . . . . 
c c  
c c  
. A . . C  
. A . . C  
. A . . C  
. A . . . 
. A . G . 
. A . . . 
. A. . . 
. À . . . 
. A . G . 
. A . G . 
. A . G . 
. C . . C . 
. c . . c . 
. c . . c . 
. c . . c 
. c . . c 
. c . . c . 
. c . . c . 
. c . . c . 
. c . . c . 
13 6 9 0 5 0 
1 2 8 7 1 5 9 
1 9 5 4 7 0 1 
2 5 3 8 8 4 
3 0 2 0 4 3 
1 9 1 9 0 
2 3 2 5 8 6 
3 5 2 4 0 
1 9 8 4 
SLS532 113 3 
M. avimpTB 2 9 5 7 8 8 0 
M s p . MCS 1 3 6 9 0 5 1 G C . . G . . A .C . . . À . .C 1 3 6 9 1 1 0 
AGTAGCTGTACCAGGAAAACGACGCGCCGCGGGGGCAGCCCCGCGGCTCGTACTCGGGCC  
G  
M.tb-A 1 2 8 7 1 5 8 . A . 
M . t b - A 1 9 5 4 7 0 2 . A . 
M.tb-B 2 5 3 8 8 3 . A . 
M.bovis-A 3 0 2 0 4 2 . A . 
M.tb-C 1 9 1 8 9 . A . 
M.tb-D 2 3 2 5 8 7 . A . 
M.bovis-B 3 5 2 4 1 . A . 
M.bovis-C 1 9 8 3 . A . 
.CG. 
,CG. 
,CG. 
,CG. 
.G. 
.G. 
.G. 
.A. 
.A. 
.A. 
.A. 
.A. 
.A. 
.T. 
.G. 
.T. 
.T. 
.T. 
.G. 
.G. 
.G. 
1192 
2957939 
1287099 
1954761 
253824 
301983 
19130 
232646 
35300 
1924 
SLS532 1 1 9 3 
M. ai'impTB 2 9 5 7 9 4 0 
M. sp. MCS 13 6 9 1 1 1 
M.tb-A 1 2 8 7 0 9 8 
M. t b - A 1 9 5 4 7 6 2 
M.tb-B 2 5 3 8 2 3 
M.bovis-A 3 0 1 9 8 2 
M.tb-C 1 9 1 2 9 
M.tb-D 2 3 2 6 4 7 
M.bovis-B 3 5 3 0 1 
M. bovis - C 192 3 
P.sp.JS666 4 8 7 1 9 5 3 
GGTCCC-GACCCACCGACGGGTAGTCGGTCTGCTGGGTCTCCCAGGTGATGATGCCGTCCT 
. G . 
. G . 
. G . 
. G . 
. G . 
. G . 
. G . 
. G . 
. G . 
. G . T . 
. T . 
.T . 
.T . 
. T . 
. T . 
. T . 
. T . 
,T . 
. T . 
. T . 
. T . 
. C . C . 
1 2 5 2 
2 9 5 7 9 9 9 
1 3 6 9 1 7 0 
1 2 8 7 0 3 9 
1 9 5 4 8 2 1 
2 5 3 7 6 4 
3 0 1 9 2 3 
1 9 0 7 0 
2 3 2 7 0 6 
3 5 3 6 0 
1 8 6 4 
4 8 7 1 9 9 6 
SLS532 1 2 5 3 TGACGTAGATCTTCCACGAGCACGACCCGGTGCAGTTCACCCCGTGCGTGGAGCGAÀCCA 1 3 1 2 
M avimpTB 2 9 5 8 0 0 0 2 9 5 8 0 5 9 
M s p . MCS 1 3 6 9 1 7 1 G . . G G G . . G . 1 3 6 9 2 3 0 
M. tb-A 
M. tb - A 
M.tb-B 
M. bovis - A 
M.tb-C 
M.tb-D 
M.bovis-B 3 5 3 6 1 
M.bovis-C 1 8 6 3 
1 2 8 7 0 3 8 
1 9 5 4 8 2 2 
2 5 3 7 6 3 
3 0 1 9 2 2 
1 9 0 6 9 
2 3 2 7 0 7 
. T . 
. A . 
. T . 
- T . 
. T . 
. A . 
. A . 
. A . 
. G . 
. G . 
. G . 
. G . 
. G . 
. G . 
. A . 
. A . 
. A . 
. G . 
. G . 
. G . 
. G . 
. G . 
. G . 
. G . 
. G . 
P. sp. JS666 4 8 7 1 9 9 7 . . . . A . . A A T . 
1286979 
1954881 
253704 
301863 
19010 
232766 
35420 
1804 
4872042 
.T. 
.T..A. 
SLS532 1 3 1 3 CCTTGTCGTGGCTCCACCGGTCGCGGTAGAACACGTCGGCCTCGCGGCCGC 13 63 
M. avimpTB 2 9 5 8 0 6 0 A 2 9 5 8 1 1 0 
M. sp. MCS 1 3 6 9 2 3 1 C C . T . . C . 
M.tb-A 1 2 8 6 9 7 8 
M . t b - A 1 9 5 4 8 8 2 
M.tb-B 2 5 3 7 0 3 
M.bovis-A 3 0 1 8 6 2 
M.tb-C 1 9 0 0 9 
M.tb-D 2 3 2 7 6 7 
M.bovis-B 3 5 4 2 1 
M bovis - C 1 8 0 3 
. T . 
. T . 
. T . 
. A . 
. A . 
. A . 
A C T . 
C G . 
.A A C T . 
.A A C T . 
.A A C T . 
. . . . T . .A C G . 
. . . . T . .A C G . 
T . . À C G . 
1 3 6 9 2 8 1 
1 2 8 6 9 2 8 
1 9 5 4 9 3 2 
2 5 3 6 5 3 
3 0 1 8 1 2 
1 8 9 5 9 
2 3 2 8 1 7 
3 5 4 7 1 
1 7 5 3 
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41 { • 
; Propionibacterium acnes KPA171202, complete genome 
^Nitrobacterwinogradsk^ Nb-255, complete genome 
a Nitrobacter alkalicus nitrite onidoneduct*se alph* subunit (norA) <3<-n«, partial cds 
Nitrobacter hamburgensis X14, complete genome 
* 
« Nitrobacter hamburgensis nitrite o nid on ductus e alphasubunit(norA) gene, partial cdi 
■y Geobacter metallireducens 65-15, complète genome 
C*Thermusthennophilusnaroperon(narCGHIJK genes) 
streptomyces coelicolor A 3(2) complete -genome; segment 1/29 
Streptomyces liuidus liuidomycin biosynthesis gene cluster 
a RubrobaeterKytanophilus D S M 9941, complete genome 
; Coryne bacterium effkiens V5- 314 DNA, complete genome 
4 NocardiafarciniealFM 10152 DNA, complete genome 
x— Rhodocotcus «qui NarO gene, complete cds 
^ cowebacterium diphtheria* grauis NCTC13129, complete genome; seg 
r ■■■* streptomyces kanamyceticus kanamycin biosvnlhetic gene cluster, strain: N BRC 1Î414 
Streptomyces coelicolor A 3(2) complete genome; segment 2 5/29 
streptomyces coelicolor A3(2) complete genome; segment 19/29 
« A20WCUS sp. EbN1 complete genome 
Thiobacillus denitrificans ATCC 25259, complete genome 
Burtholderiapseudomallei i? 10b chromosome il, complete sequence 
Á, eurkholdtria pseudomallei strain K9624 3, chromosome 2, complete sequence 
<i Burfcholderiathailandensis E264 chromosome il, complete sequence 
^ Burkholderia cepacia A MMD chromosome i , complete sequence 
a Hyphomonas neptunium ATCC 15444, complete genome 
J Brucella suis 13 30 chromosome ll, complete sequence 
3 Brucella melitensis 16 M chromosome II, section 90 of 107 of the complete sequence 
<>d Brucella melitensis biouar Abortus chromosome ll, complete sequence, strain 2 308 
<* Brucella abortus biouar1 sir. g-g4i chromosome n, complete sequence 
——9 Rhodoterw terrireducens 05M 152se, complete genome 
a Paracoccus pantotrophus bicyclomycin resistance BcrA (bcrA) gene, partial cds, methyl transferase Ad» 
Pseudomonas sp. MT-1 nar gene duster (orfi, orf2, oris, narL, narX, narK, ort4, narm, naro, na.. 
i^seu >se«domon&5 s-hjtzeri narx gene [partial), nwK operon and nato gene (partial), slram ATCCH405 
Pseudomonas fluorescens nitrate reductase alpha-subunit(narO) and beta-subunit (nam) genes, partiaj cds 
Pseudomonas fluorescens nitrate/nitrite response regulator (narL), ni trate jhilrite sensor prote 
jt Pseudomonas aeruginosa narX, narL, narK 1, narK2, naro, nam, narJ, nart, nifM, moaA genes 
0 Pseudomonas aeruginosa PACM, complete genome 
■ Pseudomonai aeruginosaUCBPP- PA14, complete genome 
Pseudomonas stutzeri DnrE (dnrE) gene, complete cds; NarL- like (narL) and NarX- like (narX) genes, complete sequence; N. 
'-' Alkalilimnlcolaehrtkhei MLHE-1, complete genome 
Halomonas maura nitrate reductase operon, complete sequence 
Halomonas halodenitrificans nitrate reductase gene cluster, complete cds 
* Escherichiacoli 0157:H7 str. Sakai DNA, complet» genom 
<* Escherichiacoli CFT07Î, complete genome 
v .-¾ ." KJ .-i. ' . II 
4 
f RaJstoniametallidurans CM 34, complete genome 
o> Shigellasonnei 5S046, complete genome 
4 Escherichia coli 536, complete genome 
•Escherichiacoli W3110DNA, complete genome 
9 Shigelladysenteriae 5di97, complete genome 
Shigellaflexneri 5 str. 8401, complete genome 
shigella flenneri 2a s*. 301, complete genome 
9 Escherichi»coli015?:H7 ED L9SS, complete gen 
o 0 l » Shigellaflenneri 2astr. 24571, complete genome 
0 Escherichia coli UTI89, complete genome 
O Escherichia coli K12 MGI655, complete genome 
Escherichia coli A P E C O I , complete genome 
t Maricaulls maris MCSto, tomp 
chromohalobactersalenigensDSM 3043, complete genome 
a Chromobacterium uiolaceum ATCC 12472, complete g 
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Summary 
Collagen deposition within granulomas formed after Mycobacterium avium infection 
was analysed on histological sections stained with Masson's trichrome using 
acquired computerized image analysis and a program that was specifically designed 
for that purpose. Comparison was made between immunocompetent C57BL/6 mice 
and mice genetically deficient in the inducible nitric oxide (NO) synthase gene 
(iNOS~ /_ mice) infected with either a highly virulent strain or a moderately virulent 
strain of M. avium. iNOS-deficient mice were more resistant to the highly virulent 
strain than control C57B1/6 mice, but both strains were equally susceptible to the 
less virulent M. avium strain. Collagen distribution in the granuloma was found in 
the cuff surrounding the granuloma in an area rich in lymphoid cells as well as 
inside the granuloma itself, conferring a mesh-like structure within that lesion. It 
was seen that iNOS" / _ mice induced a higher collagen deposition than C57BL/6 
mice and that such collagen deposition varied with the mycobacterial strain used to 
infect the animals. 
Keywords 
cell-mediated immunity, fibrosis, macrophages, mycobacteria 
Granuloma formation is seen in a variety of pathological set-
tings. These structures are required for protection against 
infectious organisms such as mycobacteria but can also be 
detrimental to the host, because the organs harbouring the 
granulomas undergo adjacent tissue destruction and 
displacement due to their presence (reviewed by Agostini 
& Semenzato 2003; Kaye & Engwerda 2003; Schwander 
& Ellner 2003; Turner et al. 2003). Typically, granulomas 
are defined as focal accumulations of mononuclear cells in 
various stages of differentiation that generally appear as 
well-structured lesions consisting of centrally located macr-
ophages which are surrounded by a lymphocytic cuff, and 
by an exterior fibrotic capsule. This encapsulation serves as 
a demarcation of the granulomas from the surrounding 
i 2006 Blackwell Publishing Ltd 307 
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tissue (Benini et al. 1999; Flórido et al. 2002) and physically 
restrains mycobacterial spread (Saunders et al. 1999; Ehlers 
et al. 2000; Saunders & Cooper 2000). 
In a pro-fibrotic response, the arginase present in macro-
phages is activated and leads to the production of proline 
and collagen (Hesse et al. 2001; Wynn 2003, 2004). This 
reaction has L-arginine as its substrate, the same substrate 
used by the inducible nitric oxide (NO) synthase (iNOS) for 
the production of NO. Therefore, it is not surprising that 
iNOS and NO production have been correlated with an 
antifibrotic effect in granulomatous diseases (Brunet et al. 
1999; Hesse et al. 2000, 2001; Nascimento et al. 2002; 
Pearce & MacDonald 2002; Wynn 2004). The regulation of 
fibrosis by NO in mycobacterial granulomas has not been 
thoroughly studied. In a nonfibrotic granuloma model 
induced by purified protein derivative (PPD)-beads, NO was 
involved in the formation of the granulomas, and NO inhi-
bition induced collagen deposition (Hogaboam et al. 1997, 
1998). In human tuberculosis, active iNOS was detected in 
epithelioid and multinucleated giant cells in granulomas, and 
evidence was presented correlating iNOS expression and 
granuloma formation, independently of their aetiology (Fac-
chetti et al. 1999). Fibrosis was studied in experimental 
tuberculosis using BALB/c mice and it was shown to be 
regulated by interleukin (IL)-4(Hernandez-Pando et al. 
2004). In a different model involving the transfer of polar-
ized T-helper cell subsets, it was shown that whereas Thl 
lymphocytes conferred protection, Th2 cells were responsible 
for pulmonary fibrosis and increased morbidity during a 
high-dose Mycobacterium tuberculosis infection (Wangoo 
et al. 2001). The study of M. tuberculosis infection in 
iNOS-deficient mice to analyse the issue of fibrosis regula-
tion by NO is problematic, because these animals are more 
susceptible to the infection than normal mice, and the corre-
lation between lack of NO and fibrosis would be confoun-
ded by the differences in bacterial loads. Whereas in the case 
of infection by M. tuberculosis iNOS expression has been 
associated with protection (MacMicking et al. 1997), the 
same does not hold true for Mycobacterium avium infection 
(Doherty & Sher 1997; Ehlers et al. 1999; Flórido et al. 
1999, 2005; Gomes et al. 1999). Thus, the M. avium-
infection model is better suited for an analysis of the role of 
NO in fibrosis induced by mycobacterial infection. iNOS 
expression was associated with granuloma formation in mu-
rine M. avium infection. Treatment with L-NIL, a selective 
iNOS inhibitor, significantly increased the number, size and 
cellularity of granulomas (Ehlers et al. 1999). iNOS-deficient 
(iNOS-KO) mice also had more and bigger granulomas 
when compared with wild-type (WT) mice, and those 
granulomas had a well-structured core of epithelioid 
macrophages, surrounded by a mantle of lymphoid cells 
(Gomes et al. 1999). In the current study, collagen depos-
ition was analysed in granulomas of iNOS-KO mice infected 
with two M. avium strains of different virulence, and com-
pared with WT mice. Although tissue deposition of collagen 
can be quantified by chemical detection of hydroxyproline, 
this type of analysis does not discriminate between deposi-
tion of collagen in the granulomas themselves vs. a generali-
zed organ fibrosis often seen in infected hosts. Therefore, an 
image analysis program was designed, so that collagen con-
tent could be determined within the granulomas. The infec-
tion was via the intravenous route, in which case, most of 
the inoculum is trapped in the liver, and the granulomas 
formed are localized especially in that organ. Furthermore, 
the fact that granulomas and the surrounding parenchyma 
are clearly distinguishable in the liver justifies the choice of 
doing the analysis of those structures in the liver and not, 
for example, in the spleen where the borders of the granulo-
ma are less clearly identified. 
We found that collagen content was higher in granulomas 
from iNOS-KO mice than WT mice when either strain was 
being used, that the collagen deposition increased as infec-
tion progressed and did not confine itself to delimitating the 
granuloma but also appeared deep within the granulomatous 
structure, and that the collagen deposition was noticeably 
lower in the case of an infection with the highly virulent 
strain. 
Materials and methods 
Mice 
iNOS-deficient mice in a C57BL/6 background (MacMicking 
et al. 1995) were obtained in our facilities after backcrossing 
the original strain (kindly provided by Drs J. Mudgett, 
J.D. MacMicking and C. Nathan, Cornell University, 
New York, NY, USA) into a C57BL/6 background for seven 
generations. C57BL/6 mice were purchased from Harlan 
Ibérica (Barcelona, Spain). All mice were kept in our animal 
facilities in high-efficiency particulate air-filter-bearing cages 
and fed autoclaved chow and water. The animals were used 
at 8-12 weeks of age. 
Bacteria 
The highly virulent Mycobacterium avium strain 25291, 
exhibiting a smooth transparent morphotype (SmT), was 
obtained from the American Type Culture Collection (Man-
assas, VA, USA). The lower virulence strain of M. avium, 
strain 2-151 SmT, was obtained from Dr I. Orme (Colorado 
© 2006 Blackwell Publishing Ltd, International journal of Experimental Pathology, 87, 307-315 
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State University, Fort Collins, CO, USA). Mycobacteria were 
grown in Middlebrook 7H9 medium containing 0.04% of 
Tween 80 at 37 °C until the mid-log phase of growth. Bac-
teria were centrifuged and resuspended in a small volume of 
saline containing 0.04% of Tween 80. The suspension was 
then sonicated at low power (40 W) in a Branson sonifier, 
so that bacterial clumps would be disrupted. After dilution, 
aliquots were made and stored at -70 °C until use. Before 
inoculation, bacterial aliquots were thawed at 37 °C and 
diluted in saline to the desired final concentration. 
In vivo infection 
Mice were infected intravenously with 1 x 106 colony-form-
ing units of M. avium through a lateral tail vein. Mice were 
killed at different time points, and the target organs (liver, 
spleen and lung) were aseptically removed and homogenized 
in a 0.04% Tween 80 solution in distilled water. Serial dilu-
tions of the homogenates were done, followed by plating 
onto 7H10 agar medium (Difco, Detroit, MI, USA) supple-
mented with oleic-albumin-dextrose-catalase. The number of 
bacterial colonies was counted after culture for 10 days at 
37 °C. 
Histology 
Portions of the organs of the infected mice were fixed in buf-
fered formaldehyde and embedded in paraffin. Consecutive 
tissue sections were stained with haematoxylin and eosin 
and with Masson's trichrome using standard histological 
techniques. The first staining was used for the determination 
of the granulomatous area, while the second one was used 
to assess the collagen content in the granulomas. For the 
detection of acid-fast bacteria, sections were stained by the 
Ziehl-Neelsen method and counterstained with methylene 
blue. 
Development of programs to quantify the granulomatous 
area and the collagen content in the lesions 
To assess the percentage of tissue area occupied by granulo-
mas as well as the collagen content in the stained sections, 
an acquired computerized image analysis (ACIA) system was 
used. This system consists of a Leica DM-LB microscope 
(Leica, Wetzlar, Germany) equipped with a 3-chip charged-
coupled device (3CCD) colour camera (XC-003P, Sony, 
Itasca, IL), and an image analysis software (Leica QWIn and 
Quipps version 2.3, Leica Microsystems, Cambridge, UK). 
An acquired colour image captured using the referred ACIA 
system is divided in 756 x 756 pixels. The system was 
calibrated with the use of a micrometer and, taking into 
account the magnification lens being used, each pixel was 
then expressed in urn2. The camera has three channels of 
acquisition - red, green and blue - and each is expressed in 
256 levels, allowing a separation of 16,777,216 different 
colours. The colour threshold values can be applied to a 
red-green-blue (RGB) representation of the colour image or 
to a hue-saturation-intensity (HSI) representation of the col-
our image. Hue concerns the colour itself, saturation relates 
to the colour depth, and intensity reflects its brightness. In 
this manner, the pixels in the colour image with the values 
of RGB or HSI within the range specified by the colour 
threshold levels will be accepted and analysed. Careful atten-
tion was given to defining the minimum area required for 
the analysis of each histological section. The total area of 
the section under study was analysed and then compared 
with measurements of that same section but where fewer 
fields were analysed. It was seen that the minimum area 
needed for the correct assessment of the granulomatous area 
and of the collagen deposition within the granulomas was 
6 x 106 urn2 of total tissue and 1 x 106 um2 of granuloma-
tous tissue, respectively. 
Quantification of the granulomatous area and the 
collagen content in the granulomatous lesions 
Both the granulomatous area determination as well as the 
collagen detection was done using programs developed for 
those purposes. Random fields within each section under 
study were analysed, the number of which was the necessary 
so that in the case of the determination of the granuloma-
tous area the total tissue area ranged from 6 to 
9 x 106 um2, while in the case of the collagen content deter-
mination the granuloma area quantified ranged from 1 to 
3 x 106 um2. The number of fields analysed in each section 
was then between 11 and 18 for the first determination and 
between 12 and 31 for the second one. For each group of 
animals being analysed, one section per animal was studied. 
Special attention was given to ensure that every detection 
was done in the same light conditions. All quantifications 
were done using the same threshold values. Measurements 
were done blind, and data presented are mean values ± SD. 
The image settings were controlled by the microscope 
lighting and by the black and white levels of the 3CCD cam-
era that acquires the image. These were always constant in 
all measurements. Both programs allow the operator to indi-
cate the lens being used. This step is very important, as it 
will enable the program to use the correct pixel-um2 conver-
sion needed for all the ensuing measurements. In the case of 
the determination of the granulomatous area, there is a need 
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for the program to determine the tissue area, so that it can 
calculate the percentage of area occupied by granulomas: the 
detection settings for the tissue were established by the user, 
who will teach the program to detect the tissue stained by 
haematoxylin and eosin. In the case of the collagen detection 
settings, also established by the user, the program will then 
be able to distinguish between the collagen, which is col­
oured blue after the Masson's trichrome staining, and the 
rest of the tissue components. The programs will save the 
colour thresholds of these detections, which is done using 
HSI thresholds. It was seen that when the detection was 
done using the HSI approach, it gave more accurate results 
than when the detection was done using RGB thresholds. 
The operator only performs this step once while doing the 
analysis, and the thresholds will be the same for all the 
measurements done. As the program has saved the detection 
thresholds, when a new analysis is initiated the operator uses 
the same thresholds as before. 
Statistical analysis 
Statistical analysis was performed using the Statistica pro­
gram (StatSoft, Tulsa, OK, USA) and the r­test for independ­
ent samples. 
Results 
Mycobacterial growth in iNOS-'' mice 
iNOS_/~ mice and C57BL/6 mice were infected intraven­
ously, and their bacterial load in the liver assessed. As shown 
in Figure 1, strain 25291 proliferated extensively in the 
organs of C57B1/6 mice but not in the organs of iNOS 7~ 
animals where its growth was arrested 1 month after 
infection. In contrast, strain 2­151 proliferated much less 
than the previous strain, and the mycobacterial growth was 
similar in the two mouse strains. Figure 2 shows typical gra­
nulomas, stained for acid­fast bacteria, at the end of our 
study. Differences in mycobacterial loads among the two 
mouse strains are evident for strain 25291. Also, the myco­
bacteria are found in macrophages in the centre of the 
granulomas. 
Development of programs to quantify the granulomatous 
area and the collagen content in the lesions 
Programs were developed to do the analysis, taking into 
account the tissue being analysed as well as the type of 
detection that is needed, i.e. the liver, the collagen content 
within the granulomas therein and the percentage of tissue 
60 
Time (days) 
Figure 1 Growth of Mycobacterium avium strains 2­151 and 
25291 in the livers of C57B1/6 (■) and iNOS­deficient (□) 
mice. Each point represents the mean of the loglO colony­form­
ing units (CFU), and the bars represent the standard deviation 
of the means. Five animals were used per time­point. Only the 
differences in mycobacterial loads at days 60 and 89 between 
C57B1/6 and iNOS­deficient mice infected with strain 25291 
are statistically significant (P < 0.01). 
area occupied by granulomas. With that in mind, both pro­
grams allow the operator to encircle all the granulomas in 
each field being analysed (Figure 3 illustrates this action for 
the collagen detection program). As the system had been cal­
ibrated so that the pixel data acquired by the computer 
could be converted into square micrometers, for each field 
being analysed, the granuloma area and the collagen area 
were determined with the program that detects the collagen, 
and the granuloma area and the total tissue area were deter­
mined with the program that calculates the granulomatous 
area. Granuloma area was assessed in both programs and 
the collagen deposition determined through the quantifica­
tion of the blue staining after Masson's trichrome, which 
© 2006 Blackwell Publishing Ltd, International Journal of Experimental Pathology, 87, 307­315 
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Figure 2 Representative granulomas 
formed in C57B1/6 (left panels) or 
iNOS-deficient (right panels) mice infec-
ted for 89 days with Mycobacterium 
avium strain 25291 (top panels) or for 
123 days with M. avium strain 2-151 
(lower panels). Paraffin-embedded sec-
tions were stained for acid-fast bacteria 
with carbolfucsin and counterstained 
with methylene blue. Final magnifica-
tion: x210. 
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corresponded to the collagen area (Figure 3). As different 
fields were being analysed in the same section, numerical 
information concerning each individual field was sent to an 
excel worksheet. In the end of the analysis of a histological 
section, the percentage of tissue area occupied by granulo-
mas and the percentage of collagen in the lesions were calcu-
lated. The results obtained with the programs developed 
were in agreement with the visual assessment of both the 
granulomatous area and the collagen presence in the tissue. 
Analysis of uninvolved liver tissue, after excluding the portal 
tracts, led to a value of 2.5%. In fact, the trichrome staining 
stains the hepatocytes of purple. As this colour will contain 
some degrees of blue, some of these pixels might be light 
blue and may be detected as positive and probably account 
for the level of detection found. Because the analysis of the 
granulomatous lesion excludes the presence of hepatocytes, 
the distinction between the blue pixels of the collagen area 
and the rest of the lesion tissue is not affected by those cells. 
Also not affecting the results are the dark colours of the 
nucleus of the cells present as these do not contain pixels 
that are light blue. 
Infection, granulomatous response and collagen 
deposition 
Whereas the area of granuloma infiltrating the livers of 
mice infected with the highly virulent strain 25291 was 
similar between C57B1/6 and iNOS_/~ mice, the livers of 
iNOS~/_ mice infected with the lower virulence strain 
2-151 exhibited significantly higher granulomatous involve-
ment than control C57B1/6 animals (Figure 4). As infec-
tion progressed, it was seen that the deposition of collagen 
in the granulomas increased. In the case of C57BL/6 mice, 
this was independent of the M. avium strain being used 
(Figure 4), and differences were significant (/ J<0.01). As 
far as iNOS mice were concerned, this increase with 
time of infection was significant (P < 0.05) when they were 
infected with the highly virulent strain 25291, but not 
when the infection was with the strain of lower virulence 
2-151 (Figure 4). 
Collagen content in granulomas 
For both infections, the collagen deposition observed in 
iNOS_/~ mice was significantly greater than in C57BL/6 
mice (Figure 4). In the case of M. avium 2-151, the collagen 
deposition found in the granulomas was as high as 30% of 
the granuloma area by the second month of infection, as 
opposed to the 10% found in C57BL/6 mice. The former 
value found in iNOS ^ mice did not, however, change with 
time, contrary to what is observed in the WT, where there 
was a significant increase to 15% of collagen quantified in 
the lesions (Figure 4). For M. avium 25291, the collagen 
present in the lesions was always less than what was seen 
for the strain 2-151. By the second month of infection, the 
collagen content varied from 3.53 ± 1.40% in the WT 
© 2006 Blackweli Publishing Ltd, International Journal of Experimental Pathology, 87, 307-315 
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Figure 3 Illustration of the analysis process. On each field being 
analysed (a), the user is asked to encircle the areas where the meas-
urement should be done, namely, the granulomatous area in that 
field (b). Once the detection thresholds are determined, the pro-
gram will detect automatically, and only in the areas that the oper-
ator has identified as granulomatous area, the collagen/blue 
staining. The program will present visual data as well as numerical 
data at the end of each field analysis. On the acquired image, it will 
be shown the positive signal encircled by a green line, and the area 
being analysed - granulomatous area - encircled by a red line (c). 
controls to 11.83 ± 1.86% in the iNOS" /_ mice. At a later 
time point, both values increased to 8.47 ± 1.08% and 
19.16 ± 2.92%, respectively. 
© 2006 Blackwe 
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Collagen disposition within granulomas 
The collagen fibres appeared not to be exclusively located in 
the outside cuff of the lesions but were also intertwined 
within them, as Figure 5 illustrates. This was seen in both 
strains of mice and was independent of the collagen content 
in the granuloma. 
Discussion 
The importance of using an image analysis program, specif-
ically designed so that a measurement of the collagen con-
tent could be done within the granuloma area, is clear. Due 
to the fact that in the liver the granulomas can be better dis-
tinguished than in the spleen, this organ was chosen as 
source of data. However, if we used an approach like others 
have in the case of an infection with M. bovis BCG 
(Wangoo et al. 2000) and quantified the fibrosis content via 
the hydroxyproline determination, the liver tissue itself 
would affect the collagen quantification. Also, the fact that 
the program enables the delimitation of the area being ana-
lysed allows for a more precise approach to the collagen 
content in the granulomas without being affected by any col-
lagen present outside their area. 
Interestingly, in the process of analysing the granulomas, 
it was quite obvious that the collagen fibres did not confine 
themselves to the outside cuff of the granuloma but were 
actually well into the granuloma itself, conferring a mesh-
like structure within the granuloma structure. The fact that 
the collagen deposition increased with time suggests that 
fibrosis and collagen deposition might have a role not only 
in the final granuloma delimitation and confinement but also 
in the development of the granuloma itself, allowing for a 
well-organized structure to be formed, where the collagen 
fibres act as a scaffold for the cells. We show here that the 
activity of iNOS during the inflammation induced by the 
infection inhibits collagen deposition as already described in 
other systems. There are several explanations for this phe-
nomenon (Wynn 2004). iNOS depletes the substrate of argi-
nase, the first enzyme in the transformation of L-arginine 
into L-proline, an aminoacid particularly abundant in colla-
gen. Also, L-hydroxy-arginine, an intermediary in the reac-
tion catalysed by iNOS and leading to NO and L-citrulline 
production, is a direct inhibitor of arginase. Finally, infected 
iNOS mice exhibit higher IFN7 responses than control ani-
mals (Gomes et al. 1999), and IFNy inhibits the expression 
of arginase as well as counteracts the development of pro-
fibrotic Th2 responses. 
Of note was the fact that the less virulent strain 2-151 
always originated granulomas with a higher collagen content 
11 Publishing Ltd, International Journal of Experimental Pathology, 87, 307-315 
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Figure 4 Quantification of granuloma 
formation (as percentage of the liver 
parenchyma occupied by granulomas, 
top panels) and fibrosis (as percentage 
of the granuloma area occupied by col­
lagen fibres, lower panels) in C57B1/6 
and iNOS­KO mice infected with strain 
2­151 or strain 25291. Each value rep­
resents means of three to five determi­
nations (as indicated by the numbers in 
the columns) ± SD. 'significant differ­
ence (P < 0.05) and "'"'significant differ­
ence (P < 0.01) between C57BL/6 and 
iNOS­KO mice. 
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89 
than the highly virulent strain. This was observed not only 
in C57B1/6 mice but also in the iNOS­deficient hosts, show­
ing that the degree of fibrosis induced by different mycobac­
terial strains was not related to the regulation by iNOS and 
NO. Also, because of a given strain fibrosis increased with 
mycobacterial load and the differences in fibrosis observed 
with strains 2­151 and 25291 were inversely correlated with 
the extent of infection, these differences cannot be explained 
on a bacterial load basis. Possibly, slightly different immune 
responses, namely at the level of production of pro­fibrotic 
cytokines, may explain these observations. 
Our method has a few drawbacks. Analysis of tissues such 
as spleen is more difficult, because it is harder to precisely 
delineate the borders of a granuloma. On contrast, precise 
quantification in the lung requires that the fixation procedure 
prevents the collapse of the pulmonary parenchyma. Also, the 
nature of the collagen is not known. In an infection by Taenia 
solium, where granulomas are formed in the brain, the thick 
and dense layer surrounding the epithelioid cells was seen to 
be mostly composed of type 1 collagen and to a lesser extent 
type III collagen (Restrepo et al. 2001). The ratio between 
these two types of collagen is associated with lung fibrosis, 
where a decrease in the type Ill/type I ratio is observed (Phan 
et al. 1985). Hepatic fibrosis has been described as being rich 
in fibrillar collagens, and in particular type I collagen 
(Friedman et al. 1985, 1993; Reeves & Friedman 2002). 
' 2006 Blackwell Publishing Ltd, International Journal of Experimental Pathology, 87, 307­315 
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Figure 5 Typical granulomas induced by Mycobacterium avium 
25291 infection in C57B1/6 (top) or iNOS (bottom) mice 
showing the mesh-like nature of collagen deposition within and 
around the granuloma (Trichrome staining). Final magnifica-
tion: x450. 
Taking this into account, one could expect to observe a simi-
lar pattern in the collagen content found in the granulomas, 
where possibly the majority of the newly deposited collagen 
would be type I. However, a different approach should be 
used to address this particular issue. 
In summary, we provide further evidence for the role of 
the N O pathway in regulating infection-induced fibrosis and 
suggest that the deposition of the collagen fibres in the gran-
uloma participates in the assembly of this structure. 
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Fibrosis analysis - ACIA program 
Objective 
Determination of the collagen content within the granulomas found in the 
livers of mice infected with M.avium by the i.v. route. 
Setting 
- Collagen determination 
Hydroxyproline assay - allows the quantification of the collagen content 
by chemical detection. Since this amino acid derivative is present at a high 
proportion in collagen, this assay quantifies the total amount of collagen in a 
certain sample, without distinguishing between collagen deposition in 
granulomatous tissues and collagen resulting from a general fibrosis that might 
occur in the infected organ. 
Masson's trichrome stain (TRI) - technique commonly used in 
histological sections, where the collagen fibres bind with the aniline blue, and 
therefore can be clearly identified within the tissue section as blue threads. 
- Acquired computerised image analysis (ACIA) 
An acquired computerised image analysis system allows the operator to 
determine particular features in histologic sections, such as area, length, or any 
other feature that, through histological or immunohistochemical procedures, are 
clearly distinguished from the remainder of the tissue. 
This system used consists of a Leica DM-LB microscope (Leica Wetzlar, 
Germany) equipped with a 3 chip charged coupled device (CCD) colour camera 
(XC-003P, Sony), and an image analysis software (Leica QWIn and Quipps 
version 2.3, Leica Microsystems, Cambridge, UK). An acquired colour image 
captured using the referred ACIA system is divided in 756x756 pixels. As the 
system, with the use of a micrometer, has been calibrated previously, and 
taking into account the magnification lens being used, each pixel is then 
expressed in j^m2. The camera has three channels of acquisition - red, green 
and blue - and each is expressed in 256 levels, allowing a separation of 
16,777,216 different colours. The colour threshold values can be applied to a 
red-green-blue (RGB) representation of the colour image or to a hue-saturation-
154 
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intensity (HSI) representation of the colour image. Hue concerns the colour 
itself, saturation relates to the colour depth and intensity reflects its brightness. 
In this manner, the pixels in the colour image with the values of RGB or HSI 
within the range specified by the colour threshold levels will be accepted and 
analysed. 
Design 
Taking into account that the objective was the determination of the 
collagen content within the granuloma, and the fact that an ACIA approach can 
allow for an in situ analysis of a tissue section, a specific program was 
developed in order to quantify the collagen fibres stained with aniline blue after 
TRI procedure. Furthermore, this determination would be done specifically and 
only in the granulomatous area of the tissue being analysed. 
Description 
This program is an adaptation of a program 
Susana_Lousada_include.5QR - developed at the Karolinska Institut 
(Stockholm, Sweden) by Susana Lousada. 
The software used to develop both programs is the one supplied by 
Leica (a detailed description of the program, in the software's language is given 
as an annex at the end of the step-by-step description). 
Step-bv-step description 
The purpose of developing such a program is not only to be able to 
quantify the collagen's content within the granulomas, but also to make it user 
friendly. The operator just has to move the slide into to correct position so that 
the section will be analysed, and then follow the instructions given during the 
running of the program. 
Once the operator has put the slide under the microscope and starts 
running the program (figures 1 and 2} it is asked to specify the image settings 
(figure 3). 
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Figure 1 
These settings will be the same during 
the whole analysis, and it is important for 
these settings to be constant throughout the 
analysis of the different samples. The 
program, as a default, always presents the 
same settings that were used the last 
time a determination was done. As far as 
the microscope lighting itself, it was 
always the same in all determinations 
being done. 
The second action the program 
asks of the operator is to choose the lens 
being used (figure 4). 
Lrta» ^ 8 2 3 ¾ ¾ H S 12:50 
Running tn 
Continue Quit 
Fieure 2 
Leica Meteor Image Setup 
Black Level 
■0.1 
Video 
S\ _ | _ l l Upper G8.G % 
j j _ J j j Lower 32.7 % 
Standard Settings Colour Settings... 
I™" Show Clipping Advanced.. 
Figure 3 
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Figure 4 Figure 5 
The objective of this step is for the measurements to be done with the 
correct pixel-(am2 conversion. The next step (figure 5) concerns the data 
storage: before starting the program the operator should open a new excel 
sheet, and by typing the sheet's name in this step, it will guarantee that the data 
collected for each field analysis will be sent to that excel sheet. The data is sent 
automatically, after the operator has moved on to the next field analysis. 
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Figure 6 
The user is asked to encircle the 
areas, within the field being analysed, 
where the measurement should be 
done, namely, the granulomatous area 
in that field (figures 6 and 7). This action 
will be repeated in each one of the fields 
being analysed. In the case of the first 
field only, the operator has also to 
"teach" the program what a positive 
signal looks like (figures 8-10). So, the 
computer program will be taught to 
detect the collagen/blue staining. This is 
done by clicking with the mouse on the 
blue staining: the program will save the 
colour thresholds of this detection, 
which is done using HSI thresholds. 
Jnjxj ■nning mcluder para o CG 
Continue fluit 
Figure 7 
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It was seen that for this particular 
detection the HSI approach gave more 
accurate results than when the detection was 
done using RGB thresholds. The next time the 
program is run, in this step, it will appear the 
saved thresholds, and hence the operator can 
use exactly the same thresholds in all the 
analysis beinb ->ne. Once the thresholds are 
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determined, the program will detect automatically, in each one of the following 
fields being analysed, and only in the areas that the operator has identified as 
granulomatous area, the collagen/blue staining. The program will present a 
visual data as well as a numerical one at the end of each field analysis (figure 
11). On the acquired image, it will be shown the positive signal encircled by a 
green line, and the area being analysed - granulomatous area - encircled by a 
red line. 
Figure 11 
The operator can then choose 
between proceeding to the next field within 
the section it is analysing, restart the 
analysis, or quit the routine (figure 12). 
Once the new field choice is taken, the 
program will automatically send the data to 
the excel sheet previously identified. 
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Careful attention was given to defining the minimum area required for the 
analysis of each histological section. The total area of the section under study 
was analysed and then compared with measurements of that same section but 
where fewer fields were analysed. It was seen that the minimum area needed 
for the correct assessment of the collagen deposition within the granulomas 
was 1x106 urn2. 
As the program gives, after each field analysis, information on both the 
current field analysis as well as the total area analysed so far, the operator can 
have be certain that it quits the routine after the minimum area has been 
analysed (figure 11). 
Figure 13 
In the end, there will be given the final results, as well as the thresholds 
used in the analysis (figure 13 and 14). This information can also be sent to the 
excel sheet by the EDIT command where a "DDE send" option will send those 
final results to that location, without overwriting any data sent during the running 
of the program. 
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Routine Header: 
Number of fields: 1 
Standard Frames 
Adapted from: Selected Field Measurement Routine - Susana Lousada include.5QR 
©Thomas Fehniger, Karolinska Institute 1998 Lars Bjork, P&U 
Based in large part on Field Measurement Routine - 600POSAR.5QR 
©Lars Bjork, Dept Immunology, Stockholm University 1996 
Modified by Jakob into HSI RGB fall 98 
Adaptado para o IBMC por Susana em Março de 2000, para IHC 
Adaptado para o IBMC por Susana em Novembro de 2003, para determinação de % de colagénio 
Objectivo do programa: 
Após um coloração de Tricrómio de Masson, detectar a quantidade de colagénio presente em granulomas. 
Como essa medição é para ser feita apenas em granulomas, o utilizador terá de definir (com o uso do rato, circundar as áreas) os gran 
ulomas. 
A percentagem de colagénio é feita na área total e não na área celular + colagénio, uma vez que a área total é aquela que na realidade o 
granuloma ocupava no tecido antes da inclusão em parafina (i.e.antes de haver retracção celular devido à desidratação). 
Grey Util (Clear All) 
Configure ( Image Store 760 x 576, Grey Images 15, Binaries 32 ) 
Image frame (xO, yO, Width 736, Height 574) 
Measure frame (xO, yO, Width 736, Height 574) 
Display ( ColourO (on), frames (on,on), planes (off,off,off,off,off,off), lut 0, x 0, y 0, z 1, Reduction off ) 
PauseText ( "Routine 'Susana tissue includer para o colagénio" ) 
IMSGAIN = LBGAIN 
IMSOFFSET = LBOFFSET 
Image Setup [PAUSE] ( Camera 0, Upper 68.62, Lower 32.73, Lamp 100.00 ) 
LBGAIN = IMSGAIN 
LBOFFSET = IMSOFFSET 
Acquire ( into ColourO ) 
NUMFIELDS = 0 
POSAREA = 0 
SUMPOSAREA = 0 
SUMTOTAREA = 0 
TOTAREA = 0 
PauseText ( "Choose lens and magnification"" ) 
Select Lens [PAUSE] ( Transmitted, 100 x, mag changer 0.8 x ) 
***************************DDE Exce|****************************** 
DDE.APP$ = "EXCEL" 
Input (DDE.NAME$) 
DDE.CHAN = 1 
DDE.COLCHAR$ = "C" 
DDE.ROWCHAR$ = "R" 
DDE Initiate ( DDE APP$, DDE.NAME$ on channel #DDE.CHAN, row char DDE ROWCHARS, column char DDE.COLCHAR$ ) 
***************************ge^jng 0 f offset and gain******************************* 
Gosub GETPARAM 
Binary Edit ( Clear BinaryO ) 
PauseText ( "Encircle completely the areas you wish measure" ) 
Binary Edit [PAUSE] ( Draw from BinaryO to BinaryO, nib Fill, width 1 
************Setting of detection values***************** 
Setup Output Window ( "Previous Tresholds", Move to x 114, y 5(\%,f> 356, h 251 ) 
Gosub THRESHOLDS 
includer para o colagenio.Q5R 
Gosub COLDSTAIN 
DETIMAGE = 0 
DETBINARY = 3 
COLSPACEHSI = 1 
Pause Message Group: 
PauseText ( "Detect the COLAGEN staining carefully" ) 
PauseText ( "Use Zoom controls if necessary" ) 
PauseText ( "If needed edit the detection thresholds further" ) 
Colour Detect [PAUSE] ( COLSPACEHSI, COLHUEOFFSET: COLDETTHR1-COLDETTHR2, COLDETTHR3-COLDETTHR4, 
COLDETTHR5-COLDETTHR6, from DETIMAGE into DETBINARY ) 
STAINHUELOW = COLDETTHR1 
STAINHUEHIGH = COLDETTHR2 
STAINSATLOW = COLDETTHR3 
STAINSATHIGH = COLDETTHR4 
STAININTLOW = COLDETTHR5 
STAININTHIGH = COLDETTHR6 
****************************************************^ ^ 
Gosub SAVEPARAM 
Setup Output Window ( "Previous Tresholds", Close ) 
Binary Logical ( C = A AND B : C Binary3, A Binary3, B BinaryO ) 
************************gjnary amendement of the mask p|anes****************** 
Binary Identify ( Outline from Binary3 to Binary2 ) 
Binary Identify ( Outline from BinaryO to Binaryl ) 
*******************************iuigggij|.g—iont a n d Hptact ion************************* 
Gosub MEASUREMENT 
************************************* Qata O Ut D U************************************** 
Gosub DPR 
**********************************f»uo nep npvt ac t i on ******************************* 
Display ( ColourO (on), frames (on,on), planes (off,1,2,off,off,off), lut 0, x 0, y 0, z 1, Reduction off ) 
Binary Edit ( Clear BinaryO ) 
Clear Buttons 
BUTTON = 1 
Define Button ( #1, "New field" ) 
Define Button ( #5, "Restart Analysis" ) 
Pause ( Buttons, "Choose next action" ) 
If (BUTTON=5) 
Chain ( D:\Susana\Leica\Final\Histologia\includer para o colagenioNov-c Q5R ) 
Endif 
**********H*****iHt********^********************************* F IELD 2 un t i l ? 
'Acquire and detection* * * * * * * * * * * * * * * * * A # * m i Í M i o n r l í í a í a p t i n n * * * * * * * * * * * * * * * * * * * * * 
Repeat 
Binary Edit ( Clear BinaryO ) 
Live On [PAUSE] 
Acquire ( into ColourO ) 
CAMERA=0 
LBGAIN = IMSGAIN 
LBOFFSET = IMSOFFSET 
'Include 
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Setup Output Window ( "Results from assessment", Close ) 
Binary Edit ( Clear BinaryO ) 
PauseText ( "Encircle completely the areas you wish to measure" ) 
Binary Edit [PAUSE] ( Draw from BinaryO to BinaryO, nib Fill, width 1 ) 
***********Detection of stain 
Gosub COLDSTAIN 
DETIMAGE = 0 
DETBINARY = 3 
COLSPACEHSI = 1 
Colour Detect ( COLSPACEHSI, COLHUEOFFSET: COLDETTHR1-COLDETTHR2, COLDETTHR3-COLDETTHR4, 
COLDETTHR5-COLDETTHR6, from DETIMAGE into DETBINARY ) 
Binary Logical ( C = A AND B : C Binary3, A Binary3, B BinaryO ) 
************************gjnary amendement of the mask p|anes****************** 
Binary Identify ( Outline from Binary3 to Binary2 ) 
Binary Identify ( Outline from BinaryO to Binaryl ) 
Display ( ColourO (on), frames (on,on), planes (off,1,2,off,off,off), lut 0, x 0, y 0, z 1, Reduction off ) 
BUTTON = 4 
Clear Buttons 
Define Button ( #4, "Accept this" ) 
Define Button ( #6, "Skip this field" ) 
Pause ( Buttons, "Accept" ) 
************Measure and calculate**************** 
If (BUTTON=4) 
Gosub MEASUREMENT 
*Data output* 
Gosub DPR 
Gosub DTR 
Display ( ColourO (on), frames (on,on), planes (off,1,2,off,off,off), lut 0, x 0, y 0, z 1, Reduction off ) 
Endif 
Binary Edit ( Clear BinaryO ) 
Clear Buttons 
BUTTON = 1 
Define Button ( #1, "New field" ) 
Define Button ( #5, "Restart Analysis" ) 
Define Button ( #10, "Quit the routine" ) 
Pause ( Buttons, "Choose next action" ) 
If (BUTTON=5) 
Chain ( D:\Susana\Leica\Final\Histologia\includer para o colagenioNov-c.Q5R ) 
Endif 
Until (BUTTON=10) 
Pause Message Group: 
PauseText ( "Go to the Edit option in the Final results from assessment window, and choose DDE send." ) 
PauseText ( "Just click OK - the default position within the Exceli worksheet will not overwrite previous data." ) 
Setup Output Window ( "Results from assessment", Close ) 
Gosub DTR 
Setup Output Window ( "Final results from assessment", Move to x 127, y 376, w 400, h 391 ) 
Gosub THRESHOLDS 
Display [PAUSE] ( ColourO (on), frames (on,on), planes (off,1,2,off,off,off), lut 0, x 0, y 0, z 1, Reduction off) 
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***********************************^ SUBROUTINES 
Subroutine THRESHOLDS 
Display Line 
Display Line 
Display ( "HSI stain thresholds", no tab follows ) 
Display Line 
Display ( "H", tab follows ) 
Display ( "S", tab follows ) 
Display ( " I " , tab follows ) 
Display Line 
Display ( STAINHUEHIGH, 0 digits after '.', tab follows ) 
Display ( STAINSATHIGH, 0 digits after '.', tab follows ) 
Display ( STAININTHIGH, 0 digits after '.', tab follows ) 
Display Line 
Display ( STAINHUELOW, 0 digits after '.', tab follows ) 
Display ( STAINSATLOW, 0 digits after '.', tab follows ) 
Display ( STAININTLOW, 0 digits after '.', tab follows ) 
Return 
Subroutine COLDSTAIN 
COLDETTHR1 = STAINHUELOW 
COLDETTHR2 = STAINHUEHIGH 
COLDETTHR3 = STAINSATLOW 
COLDETTHR4 = STAINSATHIGH 
COLDETTHR5 = STAININTLOW 
COLDETTHR6 = STAININTHIGH 
Return 
Subroutine MEASUREMENT 
MFLDIMAGE = 3 
Measure field ( plane MFLDIMAGE, into FLDRESULTS(I) ) 
Selected parameters: Area 
POSAREA = FLDRESULTS(I) 
SUMPOSAREA = SUMPOSAREA+FLDRESULTS(1) 
**********Total area measurement and calculation*************** 
Binary Logical ( copy BinaryO to BinaryO ) 
MFLDIMAGE = 0 
Measure field ( plane MFLDIMAGE, into FLDRESULTS(I) ) 
Selected parameters: Area 
TOTAREA = FLDRESULTS(I) 
SUMTOTAREA = SUMTOTAREA+FLDRESULTS(1) 
NUMFIELDS = NUMFIELDS+1 
Return 
**Hk******^******i^*************************************^^ Preliminary Results ÍDPR) 
Subroutine DPR 
Setup Output Window ( "Results from assessment", Move to x 54, y 522, w 388, h 246 ) 
DDE.COL = NUMFIELDS+1 
DDE.ROW = 1 
Display Line 
Display Line 
Display ( "Total area measured (um2)", tab follows ) 
DDE Send ( "Total area measured (um2)" to channel #1, row 1, column 1 ) 
Display ( TOTAREA 2 digits after '.', no tab follows ) 
DDE Send ( TOTAREA, 2 digits after '.' to channel #DDE.CHAN, row DDE.ROW, column DDE.COL ) 
Display Line 
Display ( "Colagen area measured (um2)", tab follows ) 
DDE Send ( "Colagen area measured (um2)" to channel #1, row 2, column 1 ) 
Display ( POSAREA, 2 digits after '.', no tab follows ) 
DDE.ROW = 2 
DDE Send ( POSAREA, 2 digits after '.' to channel #DDE.CHAN, row DDE.ROW, column DDE.COL ) 
Display Line 
Display ( "% colagen in total area", tab follows ) 
DDE Send ( "% colagen in total area" to channel #1, row 3, column 1 ) 
Display ( POSAREAM00/TOTAREA, 2 digits after '.', no tab follows ) 
DDE.ROW = 3 167 
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DDE Send ( POSAREAM00/TOTAREA, 2 digits after V to channel #DDE.CHAN, row DDE.ROW, column DDE.COL ) 
Display Line 
Display ( "Field number ", tab follows ) 
DDE Send ( "Field number" to channel #1, row 4, column 1 ) 
Display ( NUMFIELDS, 0 digits after '.', no tab follows ) 
DDE.ROW = 4 
DDE Send ( NUMFIELDS, 0 digits after '.' to channel #DDE.CHAN, row DDE.ROW, column DDE.COL ) 
Return 
'Display Total Results (DTR) 
Subroutine DTR 
Display Line 
Display Line 
Display ( "Final total area measured (um2)", tab follows ) 
Display ( SUMTOTAREA, 2 digits after '.', no tab follows ) 
Display Line 
Display ( 'Total Colagen Area Measured (um2)", tab follows ) 
Display ( SUMPOSAREA, 2 digits after '.', no tab follows ) 
Display Line 
Display ( "Final % colagen in total area", tab follows ) 
Display ( SUMPOSAREA*100/SUMTOTAREA, 2 digits after '.', no tab follows ) 
Display Line 
Display ( "Total number of fields measured", tab follows ) 
Display ( NUMFIELDS, 0 digits after '.', no tab follows ) 
Return 
Subroutine GETPARAM 
Open File ( D:\Susana\Leica\Final\Histologia\Data\includer para o colagénio.Q5D, channel #2 ) 
File Read ( LBGAIN, channel #2 ) 
File Read ( LBOFFSET, channel #2 ) 
File Read ( STAININTHIGH, channel #2 ) 
File Read ( STAININTLOW, channel #2 ) 
File Read ( STAINSATHIGH, channel #2 ) 
File Read ( STAINSATLOW, channel #2 ) 
File Read ( STAINHUEHIGH, channel #2 ) 
File Read ( STAINHUELOW, channel #2 ) 
Close File ( channel #2 ) 
Return 
Subroutine SAVEPARAM 
Open File ( D:\Susana\Leica\Final\Histologia\Data\includer para o colagénio.Q5D, channel #2 ) 
File ( LBGAIN, channel #2,1 digit after '.' ) 
File ( LBOFFSET, channel #2,1 digit after '.' ) 
File ( STAININTHIGH, channel #2, 0 digits after '.' ) 
File ( STAININTLOW, channel #2, 0 digits after '.' ) 
File ( STAINSATHIGH, channel #2,0 digits after V ) 
File ( STAINSATLOW, channel #2, 0 digits after '.' ) 
File ( STAINHUEHIGH, channel #2, 0 digits after '.' ) 
File ( STAINHUELOW, channel #2, 0 digits after 7 ) 
Close File ( channel #2 ) 
Return 
Subroutine DDEFEATURESEND 
FIELDS = FIELDS+1 
DDE.CHAN = 1 
DDE.COL = FIELDS+(FIELDS-1)+3 
DDE.ROW = 1 
DDE Send Feature Results ( channel #DDE.CHAN, row DDE.ROW, column DDE.COL ) 
Return 
END 
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Mycobacterial infections have been studied at length over the past decades. On the 
one hand tuberculosis is still one the major causes of death worldwide, and has seen its 
mortality rates increase with the AIDS pandemic (Brewer and Heymann, 2005; Murray 
and Lopez, 1997). On the other hand, M. avium has been identified as one of the major 
opportunistic pathogens in AIDS patients, and can also cause disease, such as 
lymphadenitis and pulmonary disease, in non-AIDS patients (Berlin et al., 1984; 
Inderlied et al., 1993; Wagner and Young, 2004). 
The fact that mycobacterial infection in most cases leads to a chronic and lasting 
infection, overcoming the host's immune response, has led the scientific community to 
focus its attention towards the interplay between the mycobacteria and the immune 
system. The result of such an interaction is the maintenance of the pathogen within the 
host's organism, potentially waiting for an opportunity to reactivate and cause active 
disease. 
S. typhimurium, for example, adapts to the host innate immune responses by 
preventing the expression of NO from infected cells, possibly by the downregulation of 
iNOS activity (Rhen et al., 2000). This is not the case in mycobacterial infections, as 
iNOS was detected in established granulomas (Florido et al., 1999; Scanga et al., 2000). 
NO production by macrophages and RNI generation have been identified as 
effective in the protection towards M. tuberculosis but not M. avium. Studies done with 
mice deficient on the iNOS showed that when those mice were infected with the former, 
an exacerbation of the infection took place (MacMicking et al., 1997). In the case of 
being infected with the latter, it was seen by others for a few strains, and here for a 
larger number of them, that such an exacerbation did not occur (Doherty and Sher, 
1997; Gomes et al., 1999a). 
With the purpose of determining if such a difference could be due to an inherent 
resistance towards RNI, a panel of M avium strains was subjected to RNI exposure and 
compared with M. tuberculosis. The values for MIC and MBC obtained for the M. 
tuberculosis strain used was within the range determined previously for a wider number 
of M tuberculosis strains, using the same protocol (Rhoades and Orme, 1997). For that 
reason we compared the values obtained for M avium in our studies with those obtained 
by the referred authors. A clear difference in RNI susceptibility was seen, where M 
avium strains had much higher values than those observed for M. tuberculosis (Lousada 
and Appelberg, 2006). 
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As this determination was done using acidified media containing nitrite, there was 
also the low pH as a factor that could lead to a difference due to the fact that M. avium 
is more resistant than M. tuberculosis to such conditions (Bodmer et al., 2000; Gomes et 
al., 1999b). Another comparison was made, this time at neutral pH, and using a NO-
donor, NOC-18, capable of releasing NO in a controlled manner. Once again, M. avium 
was more resistant than M. tuberculosis. The amount of RN1 production by both 
methods was, except for the highest concentration used for both cases, within the values 
reported to be released by activated M0 upon mycobacterial infection (Chan et al., 
1992; Doi et al., 1993; Flesch and Kaufmann, 1991; Lousada and Appelberg, 2006). 
Therefore, in physiological conditions it is not the iNOS induction and subsequent RNI 
production that restrains the M. avium growth. Hence, as opposed to M. tuberculosis, 
when in the absence of such an induction, M. avium does not see its growth 
exacerbated. 
Studies on gene expression by M. avium in the intracellular environment have 
shown that upon M avium infection of M0 there was an over-expression of nirB, a 
gene that encodes for a nitrite reductase, previously identified in S. typhimurium and 
Bacillus subtilis (Danelishvili et al 2004, Hou et al 2002). The presence of a nitrite 
reductase could armour the mycobacteria in the way that it could be one of the means 
that M. avium uses to overcome the detrimental effect of RNI. 
However, although the RNI resistance justifies the equal growth curves observed in 
immunocompetent mice and iNOS"" mice infected with M. avium, it does not explain 
why, in some of the cases, it was seen that M. avium grows less when no NO or RNI 
production is present, as was seen in the data presented here and elsewhere (Gomes et 
al., 1999a; Lousada and Appelberg, 2005). Additionally, the presence of RNI quantities 
up to 60uM per day was seen to improve mycobacterial growth of strain 25291 
(Lousada and Appelberg, 2006). That same strain, when used to infect iNOS"" mice that 
had been given an iron overload treatment, known to induce exacerbation of 
mycobacterial growth (Gomes and Appelberg, 1998), did not see any change in its 
growth pattern on that host, suggesting that M. avium needs RNI production for 
thriving. 
The fact that, when an improved clearance was observed, the difference between 
iNOS" and the immunocompetent mice was significant when the adaptive immune 
response started, lead us to suggest that the impairment was at the level of the 
adaptation to the granuloma's environment, and possibly in the latent phase. This 
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hypothesis seems to be corroborated by the studies done using a mutant for nitrate 
reductase (discussed further ahead). 
Latency is one of the major concerns related to mycobacterial infection. 
Mycobacteria can remain unnoticed within the host's organism and by being able to 
avoid clearance by the immune system, mycobacteria find in the granuloma a haven 
within the host. What has been believed is that the bacilli remain in the granulomas in a 
latent form. However the latent term has somewhat been used to define a state where no 
clinical signs of active disease are seen, and has not been clearly defined as yet, but only 
suggested as a type of dormant state that mycobacteria acquire. Wayne and Hayes 
suggest that the bacilli are not dormant, but simply adopting a state of non replicating 
persistence (NRP), without replicating, yet with the ability to resume growth and 
activate disease (Wayne and Hayes, 1996). These authors have studied quite thoroughly 
this NRP state mycobacteria acquire, and could induce it by gradual depletion of 
available O2 (Wayne and Hayes, 1996). Interestingly, they found that M tuberculosis 
adaptation to the NRP state implied an increase in the nitrate reduction and that 
reduction was due to narGHJI, a nitrate reductase. Furthermore the adaptation to 
hypoxia upregulated narK2, responsible for the transport of nitrate into the cell and 
nitrite out of the cell (Sohaskey and Wayne, 2003; Wayne and Hayes, 1998). The fact 
that reactivation of M. tuberculosis occurs when iNOS is inhibited and that low 
concentrations of NO were seen to be responsible for the induction of dormancy-related 
genes, which include genes involved in nitrogen metabolism, while at the same time 
inhibited aerobic respiration, support a role of NO and RNI, such as nitrate, in latency 
(Botha and Ryffel, 2002; Voskuil et al., 2003). 
Hence, by upregulating genes involved in nitrogen metabolism, bacteria are induced 
to alter their metabolic state. So not only do bacteria, in hypoxia, upregulate genes that 
will allow them to survive in an environment where RNI are present, but NO itself 
induces such a change in bacteria. 
The metabolic state of mycobacteria in the latent phase within granulomas has 
always been of interest and a better understanding of it would surely help design drugs 
that would efficiently kill these bacteria (Gomez and McKinney, 2004). 
Some studies state that within the granuloma there is a constant bacterial turnover 
and active killing by activated M0 pointing out to an active state of the mycobacteria, 
as opposed to the dormant state suggested by others. Studies done on the adaptation of 
M. smegmatis to nutrient starvation and its entry into a stationary phase support that, 
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even though part of the bacteria might enter a state of dormancy, others seem to 
constitute a dynamic population, where division and continuous cell growth occurs 
(Smeulders et al., 1999). 
The spontaneous degradation products of NO in tissues include nitrate and nitrite 
(Boockvar et al., 1994) so, upon NO production by the activated M0, one would 
suppose that these products would be found, namely within the granulomas. Taking into 
account that nitrate is more stable, we suggest that mycobacteria might use nitrate for its 
own benefit, such as using it as an electron acceptor in order to survive within the 
granuloma, and hence, are not latent but have adopted another type of metabolism. 
Khan and Sarkar have recently shown that, using the Wayne model and looking at 
the anaerobic phase, M. smegmatis sees its growth greatly affected when nitrate 
reductase is inhibited (Khan and Sarkar, 2006). 
Aly and colleagues have seen that, in the mouse model, the granuloma formed upon 
M. avium infection is characterised by a central necrotic core surrounded by hypoxic 
cells (Aly et al., 2006). Taking into account the fact that hypoxia, by interfering with the 
synthase's localization within the macrophage, inactivates iNOS (Daniliuc et al., 2003) 
one could suggest that the M0s in that hypoxic cell area would produce, if any, low 
quantities of NO, while the M0s surrounding these would produce more NO but still, in 
all, probably not enough to induce the stress response genes, but only enough to induce 
the dormancy-related ones. So, on the one hand, there would be the induction of the 
dormancy-related genes by the hypoxic conditions, which would be enhanced by the 
presence of RM. On the other hand, the genes expressed would allow the bacteria to use 
RM, such as nitrate, as their final electron acceptor, therefore adopting an alternative 
metabolism, which would allow them to survive during long periods of time within the 
granuloma. 
This could be a mechanism that occurs in both M. avium and M. tuberculosis, 
suggesting that within the granulomas these mycobacteria have an alternate metabolism. 
So, although active M. tuberculosis is susceptible to RN1 when the host's immune 
response is triggered, when in the latent form this seems not to be the case and M 
tuberculosis seem to depend on the presence of those to be kept on a latent form. 
Furthermore, while M. avium actually seem to partly depend on this metabolism for 
survival, M. tuberculosis is still being restrained by RM. What might happen is that, 
taking into account that gene expression in necrotic lesions from human tuberculosis 
granulomas varies according to the location within the granuloma, suggesting that there 
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are several microenvironments within the granuloma (Fenhalls et al., 2002) in some 
microenvironments within the granuloma, the RNI produced is enough to have an 
antimycobacterial effect on M. tuberculosis, while in other microenvironments within 
the granuloma the RNI induces dormancy-related genes and bacteria can adopt a 
metabolism that involves, for instance, nitrate reduction. 
As M. avium is more resistant to RNI, possibly the first scenario does not apply in 
its case, and only the second one does. 
Studies on gene expression upon adaptation to an intracellular environment have 
shown that both mycobacteria induce genes encoding enzymes involved in nitrogen 
metabolism (Hou et al., 2002). However, M. avium induces such genes earlier than M 
tuberculosis does, supporting that in the case of M tuberculosis the usage of RNI would 
be important in the latent phase of infection, whereas in the case of M. avium this usage 
would begin much sooner. 
Our studies using a nitrate reductase M. avium 25291 mutant showed that these 
bacteria cannot grow as well as the parental strain in immunocompetent mice, whereas 
they can do so in BMM0s, pointing out the importance in the adaptation to the host's 
immune response. Even though the difference is observed, it is not as impressive as the 
one observed when the parental strain is used to infect iNOS" " mice. This can be due to 
several facts. First, Aly and colleagues saw that, in the mouse model and using an 
aerosol infection, hypoxic cells surrounded the necrotic centres (Aly et al., 2006). In our 
model, where an i.v. infection with 106 CFUs is used, that necrosis is not observed and 
therefore the granulomas' environment might be low in oxygen content, but not 
hypoxic. So, in these conditions, mutant bacteria would only be moderately affected. In 
the iNOS ' host, the high content of collagen and subsequent well structured granuloma 
might confer hypoxic conditions that would affect the mycobacterial growth when no 
NO or RNI are available. 
Another aspect we studied was the role an intact immune system had on the impact 
of the absence of NO induction. Studies using mice that were both deficient for iNOS 
and rag2 showed that the presence of such an intact system does play a role in the 
clinical outcome, as double KO mice tended to have less bacterial growth than rag" 
mice, but not equal to the iNOS"". Taking into account that when iNOS"", which have an 
intact immune system, are overloaded with iron prevent the growth exacerbation in the 
same manner as when no iron is given, one might suggest that the immune response is 
interfering with the nutrient availability to bacteria. 
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With respect to granuloma structure, it was seen that collagen fibres were found not 
only in the exterior cuff but also intertwined within the granuloma, suggesting a role in 
the granuloma's organization. A mesh-like structure formed by these fibres could 
facilitate the physical proximity between M0s and T cells, and favour an effective 
immune response, where at least stasis would be achieved. It has been reported that 
granuloma disintegration was associated with virulence and subsequent death of the 
host (Cooper et al., 2000). Indeed, when a highly virulent strain was compared with an 
intermediate one, the collagen deposition was much lower in the first case. In both 
C57BL/6 mice and iNOS " mice this difference was seen (Lousada et al., 2006). The 
difference observed for the strains of different virulence might be related to the fact that 
the highly virulent one induces more cytokines that are anti-fibrotic. IFN-y, by inducing 
iNOS can have such an effect and furthermore, can directly suppress collagen synthesis 
by fibroblast and inhibit arginase (Bronte and Zanovello, 2005). The strain analysed, M 
avium 25291 is a strong IFN-y inducer, stronger than the less virulent strain 2447 
(Florido et al., 1999). Taking into account that both strain 2447 and strain 2-151 SmT 
are moderately virulent, one could suggest that, like the former, strain 2-151 SmT 
induces a lower IFN-y production than M.avium 25291 does, and therefore the higher 
collagen deposition seen in the case of strain 2-151 SmT. The higher the content, the 
tighter the granuloma is, and an effective response can probably be assured. 
Additionally, iNOS"" mice presented a higher collagen content in their granulomas 
(Lousada et al., 2006). The fact that iNOS uses the same substrate - L-arginine - as 
arginase is possibly the reason for such a difference to be observed. In the iNOS" " host, 
arginase can use L-arginine for the induction of collagen synthesis, whereas in C57BL/6 
it has to compete with iNOS for it, as well as being inhibited by one of the sub-products 
of the reaction catalysed by iNOS. 
So, again iNOS seems to play yet another important role during the mycobacterial 
infection. 
Data obtained for M. avium 25291, one of those that exhibited an improved 
clearance when in the iNOS"" host, presents some interesting points. This strain was the 
one that presented a higher RNI resistance, and furthermore was seen to grow better in 
the presence of small amounts of RNI. Moreover, a mutant for nitrate reductase had a 
diminished capacity to adapt to the immune response. However, an intact immune 
system does play a role in the adaptation of M avium 25291 to the immune response, as 
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it is needed in order for the lack of an NO-generating system to have a substantial effect 
in the bacterial growth. A possible scenario of the events after infection is hypothesized: 
right from the start of the infection, this strain is in an advantageous position. First, as it 
can resist RNI production, it can easily establish itself. Once the granuloma is starting to 
be formed, and as this strain is a good IFN-y inducer (Florido et al., 1999), the collagen 
deposition within the granuloma is defective, and hence less organized. Moreover, it 
was seen that this strain induces lymphopenia, a factor that would contribute to the 
abnormal formation of the granuloma (Florido et al., 1999). As an intact system was 
seen to have a role in the containment of the infection, that could involve nutrient 
availability, this lymphopenia could result also in more nutrient availability. Assuming 
that there are areas of the granuloma which, as granulomas tend to be necrotic, are 
hypoxic, mycobacteria would have access to nitrate present within the granuloma, and 
could thrive within this structure. As the granuloma does not confer the usual 
confinement, mycobacteria can spread and infect more host cells, creating new 
granulomatous structures, which will also be defective. In the end the host dies due to 
an exacerbated infection (figure 3). 
One way TO assess if the high IFN-y induced by this strain does have a role in the 
granuloma's organization and collagen deposition would be to treat infected 
immunocompetent C57BL/6 mice with a mAb against IFN-y. This would be given after 
the first month of infection, a time where that cytokine's production is maximum when 
the infection is given i.v. and using a 106 CFU initial inoculum (Florido et al., 2002). 
To see if the lack of availability of nutrients is one of the means used by the immune 
system to contain the disease, one could use the Rag.iNOS"" mice to test that 
hypothesis. If that was the case, these mice would present an exacerbated growth when 
an iron overload was given to them when compared with both iNOS" ~ mice that had had 
the same treatment and with untreated Rag.iNOS"" mice. 
Concerning nutrient and oxygen availability, and taking into account that eNOS 
induction leads to angiogenesis (reviewed in Duda et al., 2004), another factor that 
could be studied is the formation of new blood vessels and see if they play any role. 
Studies using a model that is known to induce necrosis, like using an i.v. infection 
with 102 CFUs (Florido et al., 2002), could be used to address, for example, how 
important is nitrate reductase when hypoxia occurs. 
177 
Discussion 
This strain could possibly be the farthest in the adaptation to the host's immune 
response scale. Other strains do not induce such a strong response, and might not 
depend so much on the host's response as strain 25291 possibly does. This type of 
moderate dependence on RNI is, from the mycobacterial point of view, a better 
compromise to have with the host, as it can that way probably adopt an alternative 
metabolism when hypoxia occurs. Even though NO is not solely responsible for the 
progression of the disease, the fact is that M. avium can take advantage of the immune 
response elicited and profit from it, as conditions are formed that enable the successful 
adaptation and proliferation in the host organism. 
Taken together, these data suggest that the immune response induced by M. avium 
25291, together with its capacity to resist and even use RNI, leads to a setting where a 
good adaptation as well as proliferation in the host is achieved. The observations of this 
study also point to the possibility of yet other factors may contribute to the success of 
this strain. 
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Figure 3 ­ Interplay between M avium and RNI and implications on pathology. 
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